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The synthesis of magnetic nanomaterials (Gd2O3, Mn-doped ZnS and iron oxide with 
different size and morphologies) for potential applications as MRI T1 contrast agents 
was studied. These nanoparticles were characterized by using TEM, XRD, FTIR, Zeta 
potential, DTA/TGA and XPS.  
 
 
(1) Gd2O3 nanoparticles were synthesized with three different morphologies. Four 
synthetic factors were investigated, i.e. temperature, time, solvent and surfactant. It 
was found that the degree of Gd2O3 crystallization was greatly influenced by 
temperature. Sphere shape was selected as the optimized structure to obtain the best 
paramagnetic performance. Yb:Er co-doped Gd2O3 nanospheres were then 
successfully synthesised using thermal decomposition method. They were equiaxed in 
shape, and exhibited T1 effect with r1=1.529s-1mM-1.  
(2) A facile method for fabricating Gd2O3 nanoclusters (GNCs) was demonstrated 
with enhanced T1 effect. It was found that such protection did not only allow the 
Gd2O3 to be applied in wide pH range, but also avoided further aggregation. A 
relationship was demonstrated to exist between Gd2O3 loading and r1 per single 
cluster. The GNCs possessed high r1 values (up to 7.948 s-1mM-1 [Gd]) and low r2/r1 
(down to 1.04). For all of the Gd loadings, polymer nanogel platform materials 
provided higher longitudinal relaxivity than the monodispersed individual Gd2O3. 
Hence, the GNCs were shown to be more effective as contrast agents than Gd2O3 
-based counterparts. In vitro test was performed with cell lines, and clear T1-weight 
images were obtained. Thus, the POMA-g-PEG assisted GNCs were demonstrated to 
be potentially useful for magnetic-assisted delivery systems.  
(3) Dual modal contrast agent was successfully synthesized based on Mn-doped ZnS 
nanoparticles on graphene oxide (ZMGO). The ZMGO nanocomposites with three 
different emission colors, namely, blue, white and red, were synthesized. The average 





various potential bio-applications especially in vivo bio-applications. The 
nanocomposites combined the MRI and fluorescent labels, and graphene oxide (GO) 
offered the nanocomposites superior water solubility due to the oxygenated functional 
groups on the edges of graphene. Mn-doping concentration conferred the 
nanocomposites with tunable emissions. After the hybridization, the ZMGO 
nanocomposites exhibited bright emissions under UV irradiation, as well as 
promising water solubility. After the PEGylation, the nanocomposites prominently 
improved the colloidal stability in PBS solution. Finally the as-obtained ZMGO-PEG 
nanocomposites maintained the bright fluorescence and were successfully used for in 
vitro imaging application. Moreover, the r1 value was 0.616 s-1mM-1, which was 
significant to offer a brightness in T1 imaging, Hence, it was shown that the 
nanocomposites combining fluorescent and MR contrast agent were promising 
candidates for biomedical cellular imaging application. 
(4) A facile approach to synthesize ultra small iron oxide (USIO) that could be used 
as contrast agent in MRI was studied. GO was shown to be a viable substrate for 
growing USIO, resulting in USIO-GO composite, which could combine two 
complementary techniques, namely, T1 MRI and optical fluorescence imaging. An 
energy transfer mechanism was identified from USIO to GO that resulted in its 
photoluminescence. The nanocomposite showed good cell viability with different 
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Chapter 1  
1 Introduction 
Modern medical technology has greatly improved the quality of life of 
humans. In particular, clinical imaging technology that creates images of 
internal aspects of the human body has greatly enhanced medical diagnostic 
capabilities. Clinical imaging technologies, such as x-ray computed 
tomography (CT), positron emission tomography (PET) and magnetic 
resonance imaging (MRI), have obtained more and more interests from 
researchers because they allow high quality acquisitions of the body 
interior for clinical purpose or medical science. MRI has especially gained 
great popularity because it is non-invasive and non-ionizing, providing 
better contrast of body tissues than CT and PET with the comparable spatial 
resolution. 
 
MRI images are generally acquired based on varying hydrogen nuclei 
densities of different tissues, such as the tumour, brain and connective 
tissue. However, only the organisms themselves provide poor quality MRI 
imaging. T1-weight scans, one of basic MRI scans, differentiating fat from 
water with small signal-to-noise ratio (SNR), i.e. better quality, is highly 
recommended in practice. To further improve the MRI quality, contrast 
agents including gadolinium chelates, iron oxide and other magnetic 
materials can be introduced in T1-weighted scans. These T1 contrast agents 
at targeted sites greatly increase contrast in images via indirect interaction 
with surrounding hydrogen nuclei so that problem areas can be more easily 
identified. Traditional T1 contrast agents have been administered to 
millions of patients worldwide since the approval of [Gd(DTPA)(H2O)]2- in 





have short retention time in body, and provide relatively low resolutions. 
Thus, large dose of contrast agent is necessary to be effective but this will 
increase the risk of serious illnesses (for example, nephrogenic systemic 
fibrosis). Hence, it is very useful to develop highly effective contrast agents 
which could enhance contrasts using small dosage, as well as providing 
strong spatial information. 
1.1 Overview of MRI  
Among all the clinical imaging technologies, magnetic resonance imaging 
(MRI) is essential to the acquiring of the images from every part of the 
human body, which is particularly important for tissues with many 
hydrogen nuclei and little density contrast, such as the tumor, brain and 
connective tissue. MRI has further advanced by the development of 
contrast agents that enable more specific and clearer images and 
enlargements of detectable organs and systems, leading to a wide scope of 
applications of MRI not only for diagnostic radiology but also for 
therapeutic medicine.  
 
1.2 Relaxation Theory and Mechanisms  
Generally, MRI is the signal obtained from the oscillating local 
magnetization based on Faraday’s law. Under the magnetic field produced 
by the MRI machine, the magnetizations of some atoms in body (1H, 13C, 
19F, 23Na, and 31P) will align to the external field. Such alignment of the 
magnetizations is also systematically altered by the radio frequency (RF) 
fields.  
 
With the encoding of the strong magnetic field gradients, the nuclei at 
different locations will rotate at different speeds, which could provide a 
rotating magnetic field with labelled characteristic frequencies. Such 
rotating magnetic field can be recorded by the scanner, and it is detected to 





contrasts in different soft tissues of the body.  
 
Bloch equation is one of the most essential models to describe motion of a 
free magnetic moment. It becomes an extremely important tool to analyze 
the dynamics of nuclear magnetization since F. Bloch et al. introduced in 
1946.[1] 
 
Figure 1-1(a) Relaxation of Mz after a 90 degree pulse; (b)decay of Mtr after a 90 degree pulse. 
 
Considering that nuclear magnetization M in a sample after an excitation 
RF pulse. We already know that in thermal equilibrium, Mz lies in the 
direction of an external static field B0 . Bloch suggested that two processes 
were governing the dynamics： Thermal perturbations and internuclear 
interactions, which correspond to two parameters in the relaxation 
phenomena. In the Bloch model,  
                ① 
First, the individual spins experience inhomogeneity magnetic fields due to 
the scanner and the interactions between spins. The spins dephase in the 
xy-plane, which transverse magnetization (Mtr) decreases governed by the 
Larmor equation. So the relationship between the time and the Mtr is shown 
in Figure 1-1(a). This is known as transverse relaxation. (T2 star 
relaxation). So T2 is relative to magnetic interaction between neighboring 
nuclei. Moreover, the loss of energy to the spin-lattice forces the recovery 





magnetization in z direction has been plotted with variations of time in 
Figure 1-1(b). This is known as T1 relaxation. So T1 reflects thermal 
fluctuation in longitudinal relaxation. 
                ② 
           ③ 
 ④ 
  ⑤ 
The proton’s dipole moment vector movement consists of two kinds of 
relaxations, e.g. longitudinal relaxation (T1) and transverse relaxation(T2* 
).  
Typically, basic NMR experiment is carried out as follow. At thermal 
equilibrium (i.e., normal room temperature),  protons (hydrogen atoms in 
human body) produce a small net magnetic field, the net magnetization M0, 
in the direction of strong external magnetic field (that of the scanner), 
referred to as B0, shown in Figure 1-2-(a). Assuming a second RF field Bex 
is in a perpendicular direction to B0,  the spin will end up in the xy-plane 
after Bex field applied sufficiently long enough, which transverse 
magnetization component is Mxy=M0, shown in Figure 1-2-(b). Relaxation 
happens once Bex has been removed. Spins begin to return to the original 
equilibrium situation with the net magnetization aligned with B0. As shown 
in Figure 1-2-(c) to (d), spins spread out or dephase in the xy-plane due to 
spin-spin interaction, resulting in a rapid decay of Mxy to zero. This is 
known as transverse relaxation (or T2*). On the other hand, energy loss to 
the spin-lattice interaction forces the recovery of the magnetization along 
the z-direction. This is known as T1 relaxation and as the spins return to the 
original alignment with B0, the z or longitudinal component of the 





1-2-(e) to (f)). T2* and T1 relaxation time vary from different spices, and it 
can provide unique characteristic information of materials, which is the 
basic of the MR imaging technology.  
 
Figure 1-2 Relaxation process: (a) Proton aligns with net magnetic field B0 (b) The spin will ends 
up in the xy-plane after second RF field Bex applies perpendicular to B0 (c) Relaxation happens 
once Bex has been removed. (d) Spins spread out or dephase in the xy-plane due to spin-spin 
interaction, resulting in a rapid decay of Mxy to zero (e) Recovery of the magnetization along the 
z-direction (f) Spins return to the original alignment 
 
Thus, the signal of whole volume of receiver coil (small part of spins) has 
been recorded. Secondly, the signal must be spatially discriminated in order 
to form an image, which is realized by a method known as slice selection. 





the slice direction causing the frequency of the spins to also align in this 
direction. Only a slim section of spins (the dark color slice in Figure 1-3) is 
excited into the transverse plane. A specially shaped RF pulse, called a sinc 
pulse , containing a bandwidth of frequencies will then added to only the 
spins at corresponding resonance, as illustrated in Figure 1-3 along the 
z-direction. A cross-section is to be selectively excited in this direction by 
turning on the gradient Gz. The resulting change in precessional frequency 
means a 90° pulse with a bandwidth (±△ω) will apply on this small 
section of spins only. The width and location of the slice can be altered by 
changing the gradient and the bandwidth. With the reverse Fourier 
transform, the wave function of the signal will eventually turn into each 
data of intensity in selected area, with which the total image of spins 
distribution can be built up. 
 
Figure 1-3 Schematic explanation of slice-selection (left) and frequency encoding (right). 
 
A repetitive RF pulses and gradients are necessary to acquire the MR 
image. Such RF pulses sequence usually consists of: (1) 90° RF pulse 
which flips the existing longitudinal magnetization from the z-axis 90° into 
the transverse xy-plane; (2) 180° RF pulse which reverses the dephasing 
magnetization in xy-plane sequentially. The interval time between each 90° 
RF pulse is called the "repetition time" (TR), while the amount of time 
allowed for decay to occur (twice time between the initial 90° RF pulse and 





are important programmable sequence parameters. 
 
1.3 Classification of magnetic resonance imaging  
Based on the fact that different tissues (e.g. fat-riched and water-riched) 
possess different T1 and T2., the image contrast can be weighted by altering 
the sequence timings (TE and TR) and sometimes the flip angles. For 
example, to produce a T2-weighted image the T1 differences should be 
minimized by using a short TR and a long TE. To acquire T1-weighting in 
the image, the opposite argument applies: a short TE will reduce the effects 
of T2-weighting, whereas a long TR will enhance the differences in T1 
relaxation times. With both T1 and T2 effects minimized, the contrast will 
be essentially due to the proton density of spins and achieved using a short 
TE and a long TR, which known as PD-weighted image. 
So to summarize: 
z T2-weighting: long TE and long TR (e.g., TE>100ms, TR >3s) 
z T1-weighting: short TE and short TR (e.g., TE<<50ms, TR<<500ms) 
z PD-weighting: short TE and long TR 
 
1.3.1  T2–weighted MRI  
T2-weighted scan is one of basic types of MRI scans. With long TE and 
long TR, fat is differentiated from water since fat shows darker. As 
depicted previously, variations in T2 relaxation time among different tissues 
could be used to produce images with predominant T2 contrast. In practice, 
images with predominant T2 contrast, known as T2-weighted images, are 
acquired with TE approximately equal to or longer than the shortest T2 in 
the tissues of interest. Long repetition time (i.e., TR>T1) is needed to 
reduce T1 modulation of the signal. T2-weighted magnetic resonance (MR) 
imaging has been widely used for clinical detective method to exam disease 
such as prostate cancer, but its accuracy for the detection and localization 





Conventionally, T2-weighted image can be utilized to identify the 
cancerous tissue among normal tissue, which depicts a higher ratio of 
choline and creatine to citrate.[2] With accurate MR technique , it allows 
detection of prostate cancer in the transitional zone in clinical practice. 
Notice that due to the relatively short T2 of the white matter more rapidly in 
the white matter than in the gray matter and cerebrospinal fluid (CSF). This 
causes the dark appearance of the white matter in the T2-weighted images 
of the brain. On the other hand, the very bright appearance of the CSF in is 
due to its long T2 and high proton density. By adjusting the TE value, the 
contrast of the imaging can be well improved. 
 
However, obtaining of T2 imaging requires a long acquisition time. It also 
depicts not the specific illness area. And image quality is frequently 
affected by artifacts. The background noise greatly blurs the image, 
hindering the real-time imaging application. Thus, a comprehensive 
evaluation in which both functional and anatomic MR imaging should be 
used as an understanding of their particular.  
 
1.3.2  T1–weighted MRI 
Besides T2-weight MRI, T1-weighted scans are another standard basic 
scans, differentiating fat from water - but in this case fat shows brighter. 
Body tissues also possess different value of T1 relaxation time when 
experiencing gradient echo (GRE) sequence with short TE and short TR, 
shown in Table 1-1. The tissues with smaller T1 value will restore their 
longitudinal magnetization more rapidly and have greater transverse 
magnetization. Tl-weighted images are normally acquired with TE less than 
T2 in the tissues of interest in order to reduce T2 modulation of the signal. 
Tl contrast can be further enhanced by adjusting the repetition time TR. 
Thus, using short TE and short TR (e.g., TE<<50ms), the contrast of tissue 





brain image, where the fat-containing tissues (smaller T1) have greater 
signal intensity.  
 
 
Table 1-1 Approximate values of relaxation times at 1.5T Adapted from[4]  
Tissue T1 (ms) T2 (ms) 
Gray matter 920 101 
White matter 790 92 
Cerebrospinal fluid (CSF)* 2650 280 
Kidney 650 58 
Liver 490 43 
Skeletal muscle 870 47 
* T1 and T2 values for CSF are from K. G. Dobson. "Magnet design and technology for NMR 
imaging” NMR in Medicine: The Instrumentation and Clinical Applications, S.R. Thomas and 





When doctors diagnose the chest illness, T2 imaging is not so efficient since 
the body noise becomes the primary noise source making signal-to-noise 
ratio (SNR) largely frequency independent at intermediate field strengths 
(0.1-0.5 T). The reduction in the transverse relaxation time, T2, results in a 
decrease in the achievable SNR at higher fields. Theoretically, the effect 
induced by shortening T1 will be more significantly than T2 to reduce 
SNR.[3] For example, Jacobs et al. compared the T1 and T2 imaging results 
of clinical symptoms of uterine leiomyoma (fibroids) treated by 
MRg-HIFUS using an integrated 1.5T MRI-HIFUS system.[4] They found 
that the illness regions depicted in T1 imaging were the one which closely 







1.4 Development of contrast agents 
Certain materials, known as contrast agents, can enhance MR  image 
contrast by altering T1, T2, and T2* relaxation times.  Contrast  agents are 
frequently  used in  diagnostic MRI in  order to  achieve  better 
assessment of local physiologic and anatomic conditions or to  improve 
detection of malignancy. Because contrast agents are usually  
administered internally, they must possess low toxicity and be easily  
excreted from the body. Unlike contrast agents used in  nuclear medicine 
and clinical  radiography,  MRI contrast  agents affect the  signal 
indirectly  via  interaction  with hydrogen nuclei. Most of the  
commonly used MRI  contrast  agents  significantly  alter  T1 and  
T2 relaxation  times  in  tissue because of dipole-dipole interaction with 
water protons. Changes in T1 and T2 caused by a contrast agent can be 
described by the following equations: 
 
                      ⑥ 
                      ⑦ 
 
where T1 and T2 are the observed relaxation times; T1,0 and T2,0 are the  
relaxation times in the absence of the agent; na is the agent's concentration; 
R1 and R2 are the agent's relaxivities ion times in the absence of the agent; 
na is the agent's concentration. R1 and R2 are the agent's relaxivities. 
 
The first review describing their synthesis and applications for 
gadolinium-based T1 contrast agents were reported in 1987.[5] The use of  
T1 MR imaging for clinical application has generated a tremendous amount 
of interest, and several reviews and perspectives have also appeared.[6-8] It 
has been concluded that paramagnetic ions with a number of unpaired 





causes water around to relax quickly, enhancing the final T1 value in 
equation.  
 
Practically, gadolinium-enhanced T1 MRI has been used successfully for 
the detection of tissue abnormalities. For example, in the brain, Gd-DTPA 
usually remains in the vasculature in normal tissue but can extravasate into 
the interstitial space in malignant tumors because of the locally disrupted 
blood-brain barrier.[9] This allows detection of brain tumors based on the 
observed intensity changes in post-contrast brain images. Another example  
is contrast-enhanced T1 MRI of the breast cancer. A number of studies have 
demonstrated intense, rapid signal enhancement in malignant breast tumors 
as compared to the enhancement in normal tissue.[10] 
  
1.4.1  Traditional small molecules 
There are currently eight clinically approved gadolinium-based contrast 
agents: (1) Magnevist®( (gadopentetate dimeglumine, Gd-DTPA), (2 
Dotarem®(gadoterate,Gd-DOTA),(3)ProHance®(gadoteridol,Gd-HP-DO3
A),(4)Gadovist®(gadobutrol,Gd-BT-DO3A),(5)Omniscan® (gadodiamide, 
Gd-DTPA-BMA), (6) OptiMARK® (gadoversetamide, Gd-DTPA- 
BMEA), (7)MultiHance®(gadobenate dimeglumine,Gd-BOPTA),and(8) 
Eovists® /Primovist® (Gd-EOB-DTPA). The chelates fall into two classes: 
cyclic and acyclic. Chelating agents do reduce the number of coordinated 
water molecules in comparison to free metal ion. For instance, there are 
approximately 8-9 coordinated water molecules with one Gd3+ ion, while 
one water with Gd3+-DTPA, and the corresponding relaxivities are 7.0 and 
2.0, respectively, at 37°C, 20 MHz, and 0.5T.[11] However, other factors 
also determine the in vivo efficacy of an agent in obtaining quality images, 







Clearance is dependent on a number of properties such as size, shape, 
surface charge and chemical makeup of the agent. Gd3+ chelates are 
generally excreted unchanged by passive glomerular filtration. They are 
typically hydrophilic, extracellular-fluid markers with low molecular 
masses of ~500 Da. These agents are rapidly cleared from the intravascular 
space through capillaries and into the interstitial space, but do not cross an 
intact blood-brain barrier. The biological elimination half-life is 
approximately 1.5h with no detectable biotransformation, decomposition, 
or serum protein binding.[12] When observed in mice and rats after 14 
days, residual whole body Gd3+ for acyclic agents was found to be higher 
than macrocyclic agent with the order from least to most being: 
Gd3+-HP-DO3A ≈ Gd3+-DOTA =Gd3+-DTPA< Gd3+-DTPA-BMA.[13]  
For Gd3+-DPTA, 90% of the injected dose is cleared by renal filtration and 
vessel leakage in less than an hour.[14] For patients with normal renal 
function, rapid clearance improves the safety profile. The converse of that 
same rapid clearance is that it can pose a challenge for conducting 
time-dependent imaging studies or obtaining highly resolved images.  
 
1.4.2  Macromolecules  
Macromolecular metal-chelate complexes, sometimes known as blood pool 
agents or macromolecular contrast media (MMCM), are larger agents with 
a molecular weight greater than 30kDa that were originally designed to 
address these issues. Their size limits extravasation through healthy 
vascular endothelium, but favors enhanced permeability and retention 
(EPR) in leaky vasculature that may be present where there is a pathology 
such as cancer[15]  or arthritic inflammatory response.[16] Furthermore, 
because of increased steric hindrance, these agents have greater relaxivity 
than low molecular weight agents such as Magnevist and Dotarem. As 
described, slower molecular tumbling increases rotational correlation time, 





Additionally, multiple chelates and metal ions can be appended to a 
macromolecular platform thereby also increasing enhancement and 
reducing dose of agent needed for satisfactory image acquisition.  
 
A plethora of MR macromolecular contrast agents have been reported over 
the last 30 years, ranging from protein- to polymer- to dendrimer-based 
molecules. As reviewed by Venditto et al.[17], it divided into different 
kinds:Dendrimers, Linear polymers, Protein-based agents, Carbohydrate- 
based agents, Liposomes agents, Micelles, Viral Particles, Gadofullerenes 
and Gadonanotubes.[14, 17-23] 
 
1.4.3  Nanomaterials 
Thus far, we have described the organic-based contrast agents. Although 
small molecule chelates and macromolecular metal complexes were wildly 
used in the clinical practice, it still suffer from the disadvantage of adverse 
reactions. For instance, toxicity Gd3+ are present at both standard and high 
doses of these two contrast agents with no clinically relevant difference. 
Adverse events, mostly mild and transient, are observed with an incidence 
of around 2%.[2] It includes nausea, headache, vomiting and pain, warmth 
and localized edema at the injection site. Anaphylactic reactions have been 
reported with a prevalence of 0.0002 – 0.001%,[24] but mostly in patients 
with a history of respiratory difficulties or respiratory allergic disease.  
 
The major concern is for patients with compromised kidney function who 
may develop nephrogenic systemic fibrosis (NSF).  
 
NSF, first described in 2000,[25] is a systemic disorder characterized by 
widespread tissue fibrosis that can develop rapidly, confining patients to a 
wheelchair within a few weeks. Increased tissue deposition of collagen is 





Involvement of other tissues such as lung, skeletal muscle, heart, 
diaphragm, and esophagus can occur,[26] and while the disease sometimes 
stabilizes, it rarely spontaneously remits. No effective treatment exists, and 
so prevention is the currently the only approach.[27] Of the more than 200 
cases identified in the last decade, NSF is almost exclusively found among 
patients with advanced kidney disease.[28] Since it was first proposed that 
gadolinium agents might be associated with NSF,[29] much literature has 
been published supporting this relationship. It is theorized that lowered 
renal clearance of gadolinium increases tissue exposure to the metal and its 
dissociation from the chelate.[8] Though the actual mechanism remains 
unclear, the result is an inflammatory reaction and fibrosis.[30-32] A 
meta-analysis of the controlled studies examining gadolinium agents and 
the development of NSF, suggests a causal relationship.[8] The Food and 
Drug Administration (FDA) and American College of Radiology (ACR)'s 
recommendation is to withhold all gadolinium-based agents from patients 
with Stage 4–5 chronic kidney disease (CKD). If patients with severe CKD 
need gadolinium contrast media, the FDA recommends prompt 
haemodialysis following contrast administration, while the ACR only feels 
this is warranted in patients who are already on dialysis. The 
recommendation from these two authorized organizations is to consider the 
risks of initiating haemodialysis against that of developing NSF.[33] And it 
has been proved that intake of Gd3+-DTPA-BMA, one of the traditional 
small molecule contrast agents, lead to a greater risk of NSF.  
 
Comparing with the organic complex, inorganic oxides (e.g. gadolinium 
oxide, iron oxide) with the ion bound possess higher stability. Recently, 
inorganic particles which range in the nano size received more and more 
attentions. Once the particle becomes nano-scale, the surface area per 
volume will dramatically increase. Surface area provides the active sites for 





promising to T1 MRI. In 1988, Skelton et al. and many researchers firstly 
demonstrated that paramagnetic ultrasmall gadolinium oxide nanoparticles 
can act as advanced T1 MRI contrast agent at relatively low concentrations. 
[34]Since then, magnetic nanomaterials, such as ultrasmall iron oxide, 
gadolinium oxide, manganese oxide and cubic mesoporous silica have 
attracted more and more interest as T1 contrast agents.[35, 36] It has been 
recently suggested that they are more advanced (i.e.more sensitive) than 
Gd(III)-chelatesneeds. They possess many attractive properties just like 
narrow particle size distribution, high MR signal enhancement per each 
particle and lower cytotoxicity than traditional metal-chelate.[5] For 
example, gadolinium oxide nanoparticles could be ideal blood-pool contrast 
agent because they not only possess larger r1 values than Gd(III) chelates, 
but also exhibit slow extravasation in human body. As a result, the time 
window for MR angiography is much wider than Gd(III) chelates, largely 
improving the acquisition of high-resolution angiographic images.[13] 
 
1.5 Enhancement for nano T1 contrast agents  
Even though magnetic nanomaterials possess such outstanding properties 
with low cytotoxicity, they still suffer from some limitations according to 
the recent researches. Firstly, the synthesis is time consuming and 
crystallization is poor. For example, ultra small gadolinium oxide was the 
first nano materials with the extremely low crystal quality, which showed 
week XRD peak intensities. It is because that colloidal precipitation 
synthesis has led to bottom-up assemble of ultra-small crystals (2-3 nm 
diameter) with lots of defects. [34] It would benefit to the performance with 
better crystallization. Moreover, the shape effect of the nanoparticles is 








Besides the material, it should be valuable to exploit multi functional 
platform which could introduce multi-modalities to contrast agents. Firstly, 
the properties of individual detect technologies, i.e. , optical imaging and 
T1 MRI have different advantages and disadvantages. MRI itself possesses 
good resolution agents with relatively poor sensitivity. It takes hours to 
prepare the scan after intake of contrast agents. Secondly, it lacks 
functional group on the nano particle surface, which is unable to graft 
additional functionalities. 
 
To overcome these two disadvantages, efforts of developing highly 
efficient magnetic contrast agents appear to be shifting to improve the 
nanomaterials’ exploitation of multi-modalities. For example, researchers 
confer contrast agents photoluminescent properties, which has been proved 
to be very useful because it could alter highly efficient contrast agents with 
spatial details at molecular level. As of today, the optimizations of nano 
materials recently reported present several advantages. Firstly, it could 
directly decrease the intake dose of contrast agents since same latter dose 
perform better. Secondly, it could reduce the time for post procedure by 
monitoring the physical properties of intermediate products. 
 
The review of nano T1 contrast agents for clinical imaging will focus on 
two main points: (1) Formation of magnetic nanomaterials and (2) 
functionalized platform such as polymer-based nanogel. A brief 
experimental review on the theoretical studies is also presented for a better 
understanding of complexity of designing strong contrast agents. 
 
1.5.1 Synthesis of magnetic nanomaterials 
Recent improvements in colloidal synthesis have led to the establishment of 
reliable methods for synthesizing nanoparticles, such as Gd2O3, of very fine 





areas on which paramagnetic ions accelerate the process of proton 
relaxation, crystallization quality could largely influence the total 
efficiency. Wet chemical methods in colloidal synthesis guarantee the good 
crystallization with low defected surfaces. However, the detail study of 
various surfactants’ effects on the morphological control is still limited. 
Therefore, in order to quantitively study the improvement of clinical 
imaging, parameters in colloidal synthesis need to be investigated. 
 
1.5.1.1 Gadolinium oxide nanoparticles 
Skelton et al. and many researchers demonstrated that paramagnetic 
gadolinium oxide (Gd2O3) acted as advanced T1 MRI contrast agents at 
relatively low concentrations.[7,31-34] Marc-Andre et al. reported a new 
contrast agent consisting of small Gd2O3 particles capped with diethylene 
glycol (DEG), which provided enhancing proton relaxivities compared with 
Gd–DTPA.[37] Gadolinium oxide nanoparticles were milestones in the 
development of Gd-based contrast agents. Gd2O3 nanopartilces possessed 
many attractive properties like narrow particle size distribution, high MR 
signal enhancement per each particle and lower cytotoxicity than traditional 
magnetic materials.[38] Recently, differnet methods were developed to 
synthesize Gd2O3 nanoparticle. The reaction between GdCl3 and NaOH at 
elevated temperatures yielded the gadolinium oxide nanoparticles with 
particle diameters of 2~15 nm.[34] The gadolinium oxide nanoparticles 
with an average diameter of around 10 nm were synthesized from the 
combustion of Gd(NO3)3 and amino acid glycin.[23] The gadolinium oxide 
nanoparticles were also synthesized by dehydrating Gd(OH)3.[13] Smaller 
gadolinium oxide nanoparticles with an average diameter of 2.3 nm were 
synthesized by decomposing Gd(III)-acetates encapsulated in single-wall 
carbon nanotubes. [41] Most of these nanoparticles showed larger r1 values 
than the Gd(III)-chelates, depending on their diameter. So far, however, the 





nanoparticle precursor. Moreover, a comprehensive characterization of the 
size and magnetic properties of Gd2O3 was reported by Skelton et. al.. [39] 
They suggested that surface treatments were necessary to prevent the 
agglomeration of Gd2O3 nanoparticles. Therefore, the main challenge of 
Gd2O3  for T1 application is to suppress the aggregation of Gd2O3 
nanopartilces. Taylor et al. showed that small polymer coating was one of 
the best protections for Gd2O3 nanopartilces.[40] Low molecular weight 
dendrimers and liposomes were selected as the potential protections.[18, 
19] However, the small polymer were not suitable since the cross-linking 
between different ions may cause aggregation, even decrease the efficiency 
of T1 imaging. Therefore, macromoleculars with a molecular weight greater 
than 30kD are highly desirable as the protector and carrier for Gd-based 
contrast agents. [11-14]  
  
1.5.1.2 Manganese-based nanomaterials 
The first contrast agent for MRI was not Gd3+ based, but instead centered 
on the use of Mn2+.With an administration of manganese salt, Lauterbur et 
al.[42] found T1 enhancement, particularly in liver, kidney, and heart. [43] 
Mn2+ is dominated by a dipole-dipole contribution to T1  and a strong 
scalar contribution to T2. Manganese chloride (MnCl2) can be administrated 
orally at a dosage of 0.8–1.6 g per patient where it reaches from the 
gastrointestinal tract to the liver through the portal system.[44] However, 
interests in Mn-based agents had decreased, and the development was 
significantly less than Gd3+-based agents because of concerns over free 
Mn2+ toxicity. Parkinsonism-like symptoms occur when the ion blocked 
normal calcium fluxes in the heart.[45] To avoid cardiotoxicity, two 
strategies were considered: (1) administration in combination with Ca2+ 





chelation to control or modulate the concentration of free Mn2+.[7, 47] Both 
approaches reduced toxicity. Recently, Mn based T1 contrast agents which 
can reduce the free Mn2+ have attracted more and more attentions. For 
example, manganese-containing nanoscale metal−organic frameworks 
(NMOFs) with very high in vitro and in vivo r1 values were reported by 
Taylor et al..[23] In 2011, mesoporous silica-coated hollow manganese 
oxide (HMnO@mSiO2) nanoparticles were developed as a 
novel T1 magnetic resonance imaging (MRI) contrast agent, and effective 
longitudinal  relaxation (r1) was measured to be 0.99 mM−1s−1 at 11.7 T.  
1.5.1.3 Ultra-small Iron Oxide Nanoparticles  
Ultra-small iron oxides (USIOs) are also of interest in T1-weighted MRI. 
USIOs have crystal size of less than 4 nm and their prolonged blood 
half-life time that affords them the opportunity to eventually cross capillary 
walls and have more widespread tissue distribution. The main problem of 
USIOs for T1 contrast agent is the low productivity and complex 
post-procedures for surface modification. Martins et. al. (1999) firstly 
demonstrated that USIOs were very promising as clinical T1-weighted MRI 
contrast agents. [12]  Martins also argued that solubilization of USIOs via 
the surface adherent carbohydrate played an essential role in their T1 effect. 
However, the effect of enhancement on imaging may vary depending on 
crystallization of USIOs. Hence, it is a good idea to exploit improvement in 
the USIO crystallinity.  
 
In 2009, Park et al. developed a simple one-step hydrothermal synthesis of 
surface modified USIO with an average particle diameter of 1.7 nm.[13] 
Since then, hydrothermal processes with monomeric stabilizers such as 
carboxylates, phosphates and sulfates [31-34,48] have been widely used to 






Surface modified USIOs synthesized in triethylene glycol were nearly 
monodispersed in diameter and highly water-dispersible in nano scale. 
USIOs without a strong enough surface charge to maintain electrostatic 
repulsion would be flocculated in suspension, forming large 
aggregates.[43] Post-treated USIOs were tested for use as magnetic 
resonance (MR) contrast agents. They had a low r2/r1 relaxivity ratio of 3.4 
(r1= 4.46 and r2= 15.01 mM-1s-1) and showed clear dose-dependent T1 and 
T2 map images, indicating that they were useful as both target-specific T1 
MR contrast agents due to their ultra small size. It paved the way to the 
development of USIO for T1 imaging application. 
 
1.5.2 Formation of functionalized clusters  
Besides developing nanosized magnetic materials, many efforts have been 
devoted to the conjugating the nanosized magnetic materials with polymers. 
The main purpose of introducing polymer is to obtain the contrast agent 
clusters. The conjugating polymer of the clusters not only acts as an inert 
media, but also endows the magnetic nanomaterials with new 
functionalities, such as water solubility, chemical conjugation, 
stimuli-response, and so forth. Agglomeration of the nanoparticles is a very 
common phenomenon in water suspension. Macedo et al. (1999) presented 
a theoretical analysis of the relationship between signal intensity 
enhancement (MRI signal) and aggregation. [29] This study was important 
in the research for contrast enhancement because it told us that it was 
possible to alter signal intensity by adjusting the aggregation.  
 
As an extension of this work, Borel et al. (2008) carried out a test on the 





gadolinium oxide. [8,9] This was done with the aim of inferring the formula 
with various enhanced performance parameters. It paved the way for 
predicting how to form highly effective MRI contrast agents with 
secondary structure——nanoclusters. Moreover, Faucher et al. (2011) 
presented the formation of nanocluster through solvent evaporation. 
Individual stock solutions of  different concentrations of the magnetic 
nanomaterials were dissolved in chloroform. It was then observed that 
highly monodisperse spheres in nanosize scale could be obtained 
consistently. Such materials possessed a maximum relaxivity at a high 
aggregation, which had been characterized by 3T clinical MRI scan. [5,6]   
In general, there are many approaches for fabricating nanoclusters in 
polymer matrix, including chemical preparation and physical confinement. 
However, the nanoemulsion approach is one of the most important. 
Emulsification was one of the first applications of powerful ultrasound, and 
the first related patent was taken out more than fifty years ago.[49] Since 
then, many scientists and industrialists have used different types of 
ultrasound devices to make emulsions. The distributions of particle sizes 
produced by this approach appear to be narrower and smaller than the 
products of traditional homogenization. Eugene et al. (2011) showed that 
small paramagnetic ion oxide (SPIO) nanoclusters, which was coated by 
amphiphilic polymer, performed well in clinical imaging.[50] The 
hydrophobic SPIOs were successfully phase-transferred to water soluble by 
nano-emulsion approach. Recently, amphiphilic poly(ethylene glycol) 
diglycidyl-grafted poly(maleic anhydride-alt-octadecene) (PMAO-g-PEG) 
were reported as a polymer matrix on quantum dots and up-conversion 
particles systems, resulting in better biocompatibility.[51] However, no 
report was presented on the successful synthesis of gadolinium oxide 
nanoclusters using nano emulsion methods. Significant challenges remain 
for using novel PMAO-g-PEG to form clusters for the purpose of 







Based on the literature review, it was found that developing nanomaterial 
and conjugating contrast agent with functionalized polymer were dominant 
and influential in forming effective contrast agents for T1 MRI. It is 
necessary to improve the structure of traditional materials as well as to 
optimize magnetic nanomaterials’ synthesis. Despite the great progress that 
have been already been made, there are still many challenges remaining.  
 
Therefore, I focused on the wet chemical synthesis method in order to 
control the structure and the surface morphology of the nanomaterials. 
Several parameters have been specifically considered to control the phase 
formation, crystallization and microstructure. This thesis examines the 
possibility of enhancing contrast agents’ efficiency by optimizing structure 




Herein, the improvement of the contrast agents will be realized by two 
approaches: First, three types of magnetic nanomaterials of interest, i.e. 
gadolinium oxide, Mn-doped ZnS and ultra small iron oxide, were 
systematically studied. Moreover, novel methods to form multifunctional 
clusters were carried out, and the clusters loading with contrast agents were 
further tested for clinical imaging applications.  
 
The investigations carried out in the study do not adequately account for 
deducing exact mechanism of the efficiency enhancement. Preliminary idea 





improve the total efficiency. 
 
The specific objectives of this study are the following: 
 
(1) Fabrication of Gd2O3 nanoparticles with optimized paramagnetic 
properties. Investigation of various parameters to determine which is 
dormant (in Chapter 3). In particular: 
 
-To investigate the effects of temperature, time, solvents and surfactants 
on the magnetic properties of Gd2O3 nanoparticles. 
-To  explore the method of controlling the morphology of Gd2O3 
-To  study the possibility of introducing fluorescent properties into 
Gd2O3 for bio imaging applications under the optimal conditions. 
 
(2) Demonstration of controlled loading of contrast agent (Gd2O3) in 
PMAO-g-PEG nanocluster as effective T1-weighted MRI contrast 
agents.(in Chapter 4) 
 
-To determinate if controlled aggregation is suitable for contrast agents 
on enhancing the T1 MRI efficiency.  
-To investigate the effect of the Gd2O3 loading amount in clusters on the 
spin-lattice relaxation time (r1) in MRI. 
 
(3) Exploration  of  novel  oxide  systems  which  can  be    
potential  candidates  for T1 imaging applications, e.g. Mn doped ZnS 
(in Chapter 5) and ultra small iron oxide nanoparticles (USIO) (in 
Chapter 6).  
 
-To investigate the effects of synthesis parameters on their 





-To combine two modalities (namely, T1 imaging and fluorescent 
imaging) for high efficient imaging applications. 
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2 Experimental techniques 
2.1 Nanocrystal synthesis: Thermal-decomposition method 
In recent decades, the nanomaterials were widely synthesized in two 
general approaches: breaking bulk materials into small pieces using 
mechanical, chemical and other form of the energies(top-down) and the 
opposite way of growing the atomic or molecular species in size 
(bottom-up).  Thermal-decomposition method is one of the bottom-up 
synthesises with great advantages, shown in Table 2-1. In this thesis, all the 
magnetic nanoparticles were synthesized using the thermal decomposition 
method. 
 
Table 2-1 Comparison of typical wet chemical methods for nanoparticles. 
 
Methods Advantages Disadvantages 
Co-precipitation Economy, easily transfer to hydrophilic Vulnerable to aggregation 
Sol-gel Economy Calcinations required, hard to control 
Solvothermal Good Crystallization 
High Temperature and 




Narrow size distribution, 
easy to control Expensive precursors 
 
Setup of the equipment is shown in Figure 2-1. Typically, precursors with 
surfactants were dissolved in organic solvent and then passed through a 
0.22 μm filter (Millipore) to remove any residues. After exhausting the air 
using Nitrogen, vigorous stirring was applied in the flask. The temperature 
was increased to destined temperature at the rate of 10 °C/min. The reaction 
was maintained at such temperature for certain time. The final solution was 
obtained after removing heating equipment. The as-synthesized 
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nanoparticles were isolated by centrifugation and subsequently dispersed in 
solvent. The surfactants on these particles could be removed by centrifugal 
washing in excess ethanol. 
 
Figure 2-1 Setup of the thermal-decomposition method. 
2.2 Structure and microstructure characterization  
2.2.1 X-ray diffraction (XRD)  
XRD is a major tool for the study of crystallographic structure. XRD is 
used in this study to identify the crystallographic phases of nanoparticles, to 
calculate the lattice constants, to investigate the crytallinity of composite 
and to check the preferred orientation of nanomaterials. XRD has the merits 
of being nondestructive and structural study from a relatively large area. 
The physical principle of XRD is based on the Brag’s law[11] 
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as shown in Figure 2-2, where n is the integer number corresponding to the 
order of diffraction,  is the wavelength of the incident Cu-Kα radiation 
( =1.5418Å), d is the inter-planar spacing of the reflecting (or diffracting) 
plane, and θ is the angle of the incidence relative to the reflecting plane. 
 
Figure 2-2 Schematic illustration of X-ray diffraction. 
The relative intensity and corresponding 2θ values, which were retrieved 
for each plot from the computer, were replotted and analyzed using 
graphical (origin) software. According to the θ positions of the diffraction 
peak, crystal phases can be identified according to the standard database 
from the Joint Committee on Powdered Diffraction Standard (JCPDS). 
The uncorrected FWHM (β) measured from the plot has several 
components other than broadening due to crystallite size. They were 
instrumental broadening and broadening due to stress in the crystal. 
Therefore, the corrected FWHM (βC) was calculated using the Warren’s 
formula [b]: 
 
WhereβM = measured full width at half-maximum intensity, and βS = peal 
width of the standard silicon material. 
The average crystallite size of the nanoparticles was determined using 
 





where Dhkl means the size along the (hkl) direction, K is a constant (0.89), λ 
is the wavelength of X-ray that was used (0.15406 nm), β is the corrected full 
width at half-maximum, and θ is the diffraction angle. 
2.2.2 Scanning electron microscopy (SEM)  
SEM is essential technique to study the surface structure of conductive 
sample. The SEM images are easy obtained and full of spacial information. 
The electron source is conventionally of the tungsten filament thermionic 
emission type and the electrons generated are accelerated by a potential 
between 1 keV and 30 keV [c]. The schematic of SEM components and 
imaging process is illustrated in Figure 2-3. The equipped condenser lens and 
objective lens are mainly to focus the incident electron beam onto the sample 
surface. When focused incident electrons hit the sample surface, their energy 
are dissipated to some extent, resulting in mainly in two types of escaping 
electrons: secondary electrons and backscattered electrons. SEM images can 
be formed by detecting either backscattered electrons or secondary electrons. 
 
Figure 2-3 Schematic illustration of SEM components and mechanism. 
 




The backscattered electrons are generated by inelastic scattering of the 
primary incident electrons pumping on the surface of samples. These 
electrons can be detected by the Robinson detector designed to maximize the 
solid angle of collection. This type of detector provides rapid response time 
and fast scan rate. Another type of detector is the p-n junction solid state 
detector. When the backscattered electrons reach the semiconductor 
detector, electron-hole pairs are generated, resulting in current formation and 
thus image formation. 
On the other hand, the secondary electrons are generated by both the primary 
incident electron beam on the sample and the escaping backscattered 
secondary electrons. Unlike the backscattered electrons detection, the 
secondary electrons are detected by a scintillator photomultiplier known as 
the Everhart-Thornley detector [c]. A small positive bias is applied on the 
detector to collect negatively-charged secondary electrons to improve the 
collection efficiency. 
To obtain a topographic image of a specimen, both secondary electrons and 
backscattered electrons are used. The image obtained by secondary electrons 
detected by the Everhart-Thornley detector looks like the image of a solid 
object viewed with light. In contract, the image generated by backscattered 
electrons is more sharp. It is easy to distinguish the peaks from the troughs in 
the image using backscattered electrons detection. Except for obtaining the 
topographic images of a sample, SEM can provide the compositional images 
as well by utilizing the backscattered electrons from the specimen. 
In this project, Philips XL30-FEG-SEM was used to investigate the surface 
morphology. The beam energy was generally set to 5 eV or 10 eV. For a 
non-conductive sample, Au coating with thickness of 3 nm on the surface 
was required through sputtering. 
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2.2.3 Transmission electron microscopy (TEM)  
TEM is a powerful technique to investigate the internal structure. The most 
common types of TEM have thermionic guns generating accelerating 
electrons through potential of 100-300 kV. When the accelerating electrons 
pass through the sample, the intermediate image and diffraction patterns are 
formed by the objective lens on the back focal plane, which are further 
enlarged by the intermediate lens and displayed on the viewing screen, as 
illustrated in Figure 2-4 [e]. 
 
Figure 2-4 Schematic diagram for TEM bright field imaging. 
There are two common image modes in TEM: the bright field and dark 
field modes. A parallel beam of electrons past through the sample, where 
part of the beam was scattered by atoms to different directions, as shown in 
Figure 2-4. Two dimensional array of spots were formed corresponding to a 
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particular set of plane for a single crystal when beams were brought into 
focus in back focal plane of objective lens. In bright field imaging, an 
aperture is placed in the back focal plane of the objective lens that allows 
only the electrons in the transmitted beam to pass and contribute to the 
resulting bright field image. On the other hand, in dark field imaging, the 
image occurs when the objective aperture is positioned off-axis from the 
transmitted beam in order to allow only a diffracted beam to pass. If a 
sample is crystalline, many electrons will undergo elastic scattering from 
the various (hkl) planes. This scattering produces many diffracted beams. If 
any one of these diffracted beams is allowed to pass through the objective 
aperture, an image can be obtained. This image is known as a dark-field 
image. Dark-field images are particularly useful in examining grain size in 
a crystalline phase. 
For polycrystalline samples, ring patterns are observed. From diffraction 
pattern, the inter-planer spacing can be derived using the relation: 
dhkl R= L λ 
where, dhkl is the inter-planer spacing for a particular set of reflecting 
planes {hkl}, R is the radius of a particular diffraction ring, λ is the 
wavelength of the electron beam and L is the distance between the sample 
and the back focal plane. The produc λL is known as the camera constant. 
In this study, the structural properties of samples were characterized by the 
HRTEM (JEOL 2010 / 3010) with the accelerating voltage of 20 keV. The 
bright field mode was used to image the microstructures. 
 
2.2.4 X-ray photoelectron spectroscopy (XPS)  
X-ray photoelectron spectroscopy (XPS) is a surface-sensitive quantitative 
spectroscopic technique for chemical analysis. A sample maintained under 
ultra high vacuum (UHV) is bombarded with X-rays. The X-rays penetrate a 
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substantial distance into the sample and excites electron (referred to as 
photoelectrons). A small fraction of these photoelectrons (from the top 1 to 
10 nm on the surface) escape from the sample, as shown in fig. The kinetic 
energy of these photoelectrons is measured by an analyzer. 
s 
Figure 2-5 Schematic diagram of XPS emission process. 
Because Mg Kα (1253.6 eV) or Al Kα (1486.6 eV) X-rays sources are 
usually used in the XPS analysis, the electron binding energy of each of the 
emitted electrons can be determined by using an equation: 
KE=hν­BE­φs   
where һυ is photon energy, BE is the binding energy of the electron, KE is 
the kinetic energy of the electron as measured by the instrument and φs is 
the work function of  the sample. 
A typical XPS spectrum is a plot of the number of electrons detected 
(intensity) (Y axis,ordinate) versus the binding energy of the electrons 
detected (X-axis, abscissa). The chemical states of the present elements can 
be determined by the chemical shift analysis with the reference of C 1s line 
located at 284.8 eV. And then all characteristic peaks corresponded to the 
electron configuration of the electrons are identified and quantitively 
analyzed. The number of detected electrons in each of the characteristic 
peaks is directly related to the amount of element within the area (volume) 
irradiated. To generate atomic percentage values each raw XPS signal must 
be corrected by dividing its signal intensity (number of electrons detected) 
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by a "relative sensitivity factor" (RSF) and normalized over all of the 
elements detected. 
In this work, powder samples were analyzed using XPS (Kratos AXIS Ultra 
DLD) to investigate adsorbed organic coating on to the surface of the 
nanoparticles. Samples were loaded into a vacuum chamber with the lowest 
pressure of 10-8 torr. A Mg Kα (1253.6 eV) X-ray source was applied. 
2.2.5 Fourier transform infrared spectroscopy (FTIR)  
Molecular bonds vibrate at various frequencies upon different electronic 
bonds. For any given bond, there are several specific frequencies at which it 
can vibrate. According to quantum mechanics, specific frequencies 
correspond to certain ground state (lowest frequencies) and excited states 
(higher frequencies). One way to cause the frequency of a molecular 
vibration to increase is to excite the bond by absorbing photon energy. For 
any given transition between two states the light energy (determined by the 
wavelength) must exactly equal the energy difference between the two states 
(usually ground state (E0) and the first excited state (E1)), as shown in the 
following equation 
 
Where h is Plank’s constant, c is speed of light, and λ is the wavelength of 
incident light. 
The energy corresponding to these transitions between molecular vibration 
states is generally 1~10 kilocalories/mole that corresponds to the infrared 
portion of the electromagnetic spectrum. FTIR is a powerful tool for 
identifying types of chemical bonds (functional groups). The wavelength of 
light absorbed is characteristic for the chemical bond. By interpreting the 
infrared absorption spectrum, the chemical bonds in a molecule can be 
determined. 
 




Figure 2-6 A simple FTIR spectrometer layout. 
In infrared spectroscopy, IR radiation is passed through a sample (Figure 
2-6). Some of the infrared radiation is absorbed by the sample and some of 
it is passed through (transmitted). The resulting spectrum represents the 
molecular absorption and transmission, creating a molecular fingerprint of 
the sample. Like a fingerprint no two unique molecular structures produce 
the same infrared spectrum. 
In this work, powder samples were characterized FTIR (Varian 3100) to 
investigate structure of the particles especially to indentify adsorbed 
coating molecules onto their surface. Samples were prepared as follow: less 
than 0.1 mg particles were mixed with 17 mg KBr powder (highly 
transparent substance in IR range) , and then the resulting mixture was 
compressed into a pallet. Finally, IR spectra of the samples were recorded 
on a computerized spectrophotometer in wave number range of 4000~400 
cm-1. 
2.2.6 ICP-MS analysis 
The specific element concentration of the samples was determined by 
ICP-MS analysis. A known volume of as-prepared samples were put in a 
glass test tube, then 2mL of high concentration hydrochloric acid (37.5%) 
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was added. The tube was bath sonicated for 10mins to make species 
completely dissolve in hydrochloric acid. It was analyzed using ICP-MS 
(Agilent ICP-MS 7500 Series) after sufficient dilution with milli-Q water. 
The analysis of sample was done in comparison with the ICP-MS standard 
(Sigma).  
2.3 Optical properties characterization  
2.3.1 UV-visible-IR spectroscopy 
Ultraviolet-visible (UV-vis-IR) spectroscopy refers to the absorption 
spectroscopy or reflectance spectroscopy in the ultraviolet-visible spectral 
region. The wavelength range for light source used is from 200 nm to 800 nm 
(from UV to IR range). The electronic transition takes place when the 
incident light beam shines on a sample. In both absorption and reflectance 
modes, the incident light with a certain wavelength is absorbed by the sample 
through electronic excitation from the ground state to the excited state. For 
example, ZnS has a band gap of 3.91 eV (hexagonal, 300K) and the 
incident light with photon energy higher than 3.91 eV is absorbed by ZnS, 
resulting the sharp decrease of the intensity. 
In the transmission mode, the transmitted light is measured as a function of 
wavelengths. The transmittance is defined as 
 
where R is the reflection coefficient, α is the absorption coefficient, d is the 
sample thickness. θ is given by θ=4πn1d/λ, where λ is the wavelength of the 
incident light. The band gap (Eg) of a semiconductor material can be 
determined by measuring the absorption coefficient as a function of the 
photon energy of incident UV-vis light. There are two different methods for 
direct and indirect bandgap semiconductors respectively in order to 
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determine the band gap. For indirect band-gap semiconductor such as Si, 
α1/2 is plotted against the photon energy, the extrapolated intercept on the 
photon energy axis yields Eg. The plot is known as a Tauc plot [d]. In 
contrast, for direct band-gap semiconductor like ZnS, α2 is plotted against 
the photon energy and Eg can be determined from the extrapolated 
intercept.  
In this study, UV-1600 PC spectrophotometer (Shimadzu) was to detect the 
optical transmission and absorption coefficients of samples with respect to 
different wavelengths. The background scan was performed at first as a 
reference. The resultant transmission or absorption coefficient was obtained 
with the subtraction of background signals. 
2.3.2 Photoluminescent spectroscopy (PL) 
PL occurs when a semiconductor absorbs a photon and excites to a higher 
energy level, and then spontaneously decays to a lower energy level by 
emitting a low energy photon. A semiconductor material possesses an 
energy band gap (Eg) between the valence band and conduction band. The 
band gap varies for different semiconductor materials, in which the band gap 
can be considered as an intrinsic property of a particular semiconductor. 
When a light particle (photon) with energy greater than the energy of band 
gap, an electron in valence band is excited to the conduction band by 
absorbing this photon. This excited electron generally jump back to the 
valence band by emitting a luminescent photon, which has an energy 
equivalent to the band gap energy of the semiconductor. Thus, by 
measuring the wavelength and wherein the energy of the luminescent 
photon, the band gap of the semiconductor can be deduced. 
There are several applications for photoluminescence: (1) to determine the 
band gap energy of a semiconductor; (2) to determine impurity levels by 
analyzing the minor PL spectrum from the impurity and (3) to investigate 
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the possible structural defect presents in the surface [d]. It is particularly 
suited for detection of shallow-level impurities in II-VI and III-V 
semiconductors such as ZnS due to the high internal efficiency. 
In this study, the PL analysis was carried out using Labram HR800 (Jobin 
Yvon Horiba), same as the Raman characterization. A He-Cd laser with the 
wavelength of 325 nm (UV region) was used as the excitation source. The 
laser power was approximately 5 mW. 
2.4 Biocompatibility studies  
2.4.1 Dynamic Light scattering (DLS)  
Dynamic Light scattering (DLS) spectrum refers to the intensity distrbution 
spectrum of scattered light. Brownian motion is the essential factor in 
scattering, and size information is closely relative to the diffusion rate of 
brownian motion. To obtain the diffusion rate, Stokes einstein equation is 
applied: 
 
Where d(H) is the hydrodynamic diameter of the particles in solution, k is 
boltzmann’s constant, T is absolute temperature, η is the viscosity of the 
solvent and D is the diffusion coefficient.  
 




Figure 2-7 Installation of a Malvern zetasizer instrument 
A DLS measurement system comprises of six main components (Figure 
2-7). First of all, a laser is used to provide a light source to illuminate the 
particles within the sample. This light source is splitted to provide an 
incident and reference beam. The reference beam is also ‘modulated’ to 
provide the doppler effect necessary. The laser beam passes through the 
centre of the sample cell, and the scattering at an angle of 173° is detected. 
When backscatter detecion is applied, any particles moving through the 
measurement volume will cause the intensity of light detected to fluctuate 
with a frequency proportional to the particle speed. This information is 
collected and inputted inside the computer, where the Zetasizer Nano 
software produces a spectrum of size distribution. 
In this work, Zeta potential of diluted ferrofluid samples were measured 
Zetasizer (Malvern Nano-ZS) to determine hydrodynamic diameter of the 
nanoparticles. 
2.4.2 In vitro cytotoxicity studies 
In vitro biocompatibility of the nanoparticles was evaluated by 
cytocompatilibility studies with NIH-3T3 mouse fibroblast cell lines (3-day 
transfer, inoculum 3 X 105 cells) using MTT assay (3-(4,5- 
 
Chapter  2  Experimental  technique 
52 
 
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide). The NIH-3T3 
cells were seeded in 96-well plates (Costar, IL, USA) at the density of 5000 
viable cells/well and incubated 48 hoursto allow cell attachment. The 
NIH-3T3 cells were incubated for 24 h with media containing nanoparticles 
at different concentrations. Wells without the nanoparticles treatment were 
used as control. 10 μLof MTT was added into the 96 well plates at five 
hours prior to the time point. The cells were incubated till the time point. 
After incubation, the media solution was removed from the wells, leaving 
the precipitate. Dimethylsulphoxide (100μL) was added to the wells to 
dissolve the formazan crystals which were formed. Finally, the absorbance 
in each well was measured using a microplate reader (GENios, Tecan, 




2.5 MRI relaxivity studies  
2.5.1 MRI relaxivity studies 
The longitudinal (T1) and transverse (T2 and T2*) relaxation times of samples 
containing various Gd (or Mn) concentrations were measured at 20°C using 
a Siemens Symphony 1.5T MRI and a Varian 9.4T MRI scanner with a head 
coil. Gradient echo images for calculation of T2* were acquired at 4 to 5 echo 
times (TE) for individual bottles as single 2D coronal slices ( FOV: 6.4cm; 
Matrix: 64x64; Voxel dimension(VD): 1mm x 1mm x 5mm; repetition 
time(TR): 1.6s; TE: 5ms to 60ms; flip angle:90° ). T2 relaxation times were 
determined from a multi-echo spin-echo sequence of all bottles (32 echoes; 
TR: 1600 ms; TE: 15–480 ms; FOV: 18cm; Matrix: 256x256; VD: 0.7mm x 
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0.7mm x 5mm). T1 relaxation times were determined from a saturation 
recovery experiment using spin-echo images obtained with a number of TRs 
(7 TRs;TR: 100–6400 ms; TE: 15 ms; FOV: 18cm; Matrix: 256x256; VD: 
0.7mm x 0.7mm x5mm). The T1, T2 and T2* relaxation time was computed 
using in-house software (MATLAB V7) by fitting appropriate exponential 
functions. Based on the T1, T2 and T2* values, the specific relaxivities (r1, 
r2, and r2*), which are a measure of the induced change of the spin-lattice 
relaxation rate (T1–1), spin-spin relaxation rate (T2–1and T2*–1) per unit 
concentration of Gd (or Mn), were calculated. The T1, T2 and T2* 
relaxation times of ferrofluid samples containing various Gd (or 
Mn)concentrations were also measured using a Varian 9.4T MRI scanner 
(Palo Alto, CA, USA). The T2 and T2* were measured using multiple spin 
echo sequence at TR=10000 ms and TE=5.69 ms while the T1 was 
measured by using inversion recovery spin echo sequence. 
2.5.2  In vitro MRI imaging 
NIH/3T3 cells were trypsinized and an aliquot of cell suspension was added 
to each culture fl ask to obtain a cell density of 6.0 x 106 cells per flask, 
followed by growth media (7 mL). The flasks were incubated (37oC， 5% CO2) 
for 18h. The media was then removed and replaced with 2.5mL of fresh media, 
PBS, and hydrophilic samples(in PBS), totaling 0.5 mL per flask. Final sample 
concentrations were 0 and 0.15 mg mL-1. The flasks were incubated for 1.5h 
after which the cells were trypsinized, resuspended in 200μL PBS, and finally 
centrifuged at 3000 rpm for 15mins to obtain the cell pellets. T1-weighted 
images of the pellets were obtained on a 3 T MR scanner (Siemens Magnetom 
Trio). Cell pellets were digested in concentrated HNO3 for 24 h and diluted to 
4 mL with MilliQ water. The samples were filtered with Nalgene PTFE 0.22 
μM filters to remove undigested cellular material. The amount of Gd3+ 
incorporated with each cell pellet was then determined by ICP-MS. 
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3 Controlled Gd2O3 nanoparticles with various morphologies 
as effective T1-weighted MRI contrast agents  
3.1 Introduction  
Gadolinium oxide is one of the most commonly available forms of the 
lanthanide series element gadolinium. The symmetry of the electronic 
S-state of Gd3+ makes it a broadening “relaxer” whose major effect is to 
increase longitudinal and transverse relaxation rates of the solute without 
shifting proton resonance frequencies. With its seven electrons forming a 
half-filled f-shell, Gd3+ has an isotropic S-ground state with no net orbital 
momentum and little spin-orbit interaction. This configuration leads to long 
electronic relaxation times, or slower relaxation rates, which make suitable 
for potential contrast agent of MRI.  
 
Gd2O3 exhibits a cubic structure (cI80, Ia3, No.206) at room temperature. It 
can be synthesized by thermal decomposition of the carbonate, nitrate, 
oxalates or hydroxide. To meet the increasing demand of high quality 
contrast agents for MRI imaging technique, synthesis of gadolinium oxide 
with highly effective surfaces, good crystallinity and precise morphology 
control has been intensively studied in the last decade. [57-60] The major 
difficulty in the synthesis of gadolinium oxide particles is to expose surface 
gadolinium ions to the reaction sites. This difficulty arises because the ultra 
small nanoparticles form aggregations and continuously grow to minimize 
the overall free energy during the synthesis. Moreover, the paramagnetic 
properties significantly decrease from that of the bulk materials.[61] 
 
To avoid the aggregation, various methods using different surfactants have 
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been applied and, therefore, the choice among these existing synthetic 
routes is extremely essential to further optimize T1 contrast agents. Several 
synthesis procedures like direct air oxidation, solvothemal decomposition, 
chemcial coprecipitation, microemulsion and thermal decomposition 
methods have been adopted. [62] In this thesis, three different synthetic 
routes (direct air oxidation, chemcial coprecipitation and thermal 
decomposition) were employed to achieve the goal of producing 
monodispersed paramagnetic nanoparticles. 
 
Recently, the development of dual- or multi-modal imaging probes based 
on engineered nanoparticles has emerged, since no single modality is 
perfect and sufficient to obtain all the necessary information. [3, 62, 63] 
The most popular nanostructured multimodal imaging probes are 
combinations of magnetic resonance (MR) and optical imaging modalities. 
Optical imaging provides the high sensitivity and spatial resolution for in 
vitro imaging, while magnetic resonance imaging provides an excellent 
spatial resolution and depth for in vivo imaging. By combining optical and 
magnetic resonance imaging probes, it is possible to obtain multiple 
imaging data while exploiting the advantages of both techniques. Very 
recently, various optical/MR imaging probes have been developed by 
combining different functional nanoparticles. For example, the combination 
of fluorescent materials (such as quantum dots, Au, and lanthanide 
compounds) and superparamagnetic magnetite nanoparticles yielded 
dual-modality imaging probes that allied the high sensitivity of the 
fluorescence imaging to the high spatial resolution, non-invasive and 
real-time monitoring abilities of magnetic resonance imaging.[64, 65] 
However, introducing two or more kinds of nanoparticles into one 
nano-system is difficult and may cause some unwanted side effects (for 
example, Fe3O4 may quench the fluorescent materials). Hence, it is a good 
idea to synthesize nanoparticles with combined fluorescent and magetic 
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properties for multimodal imaging purposes.  
 
Herein, we reported the synthesis and application of Yb,Er-codoped Gd2O3 
nanoparticles with dual modality (upconversion luminescence imaging and 
magnetic resonance imaging functionalities). Upconverted luminescence 
from the Gd2O3 doped with Yb, Er was observed, which offered the optical 
imaging modality for the nanoprobes. Gd3+ ions on the surface of the 
particles provided high contrast magnetic resonance imaging modality. In 
addition, the size of the particles could be fine-tuned from three different 
morphologies, which could be very important for their applications in this 
study.  
Morphology control 
To date, lots of research indicated that particles with different 
morphologies were obtained by modulating the growth kinetics. [66] In the 
case of Gd2O3, Gossuin et. al. reported the shape-tunable synthesis of 
Gd2O3 particles with different surfactants.[43] As mentioned in Chapter 3.1, 
there are still many challenges remaining in synthesizing Gd2O3 
nanoparticles with thermal decompose method, especially ones related to 
morphology control.  
In order to study the influence of S/V on T1 relaxation enhancement, we 
proposed to synthesize these three morphologies (namely, sphere shape, rod 
shape and tripods shape) of gadolinium oxide, and performed MRI tests to 
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Table 3-2 the comparisons of three distinct morphologies and the calculation about the ratio of 
surface area to total volume  
 
Table 3-2 exhibited three typical morphologies, namely, sphere shape, rod 
shape and tripods shape, in nanoparticle system. We compared the surface 
area, volume and ratios of surface area dividing to total volume (S/V) in 
Table 3-2. It was assumed that samples with three morphologies were 
obtained under the same conditions. Since the rod shape can be considered 
as a sphere anisotropically growing along specific direction, the radius of 
rod was the same as the one of sphere, which was labelled as r in Table 3-2. 
As to the tripods shape, it can be divided into three rods with the same r. 
According to the calculation, three ratios of S/V corresponding to 
morphologies showed big discrepancy. As shown in line of S/V in Table 
3-2, sphere shape possessed the ratio of 3/r, which is the maximum in the 
case of rod shape. Moreover, the tripods shape did reduce the surface area 
by combining three rods into one. In general, sphere shape, rod shape and 
tripods shape were listed in descending order of S/V. 
 
 




Absolute ethanol, hexane, toluene and chloroform were used without 
purification. Oleylamine (CH3(CH2)7CH=CH(CH2)8NH2, 70%), oleic acid 
(OA, 90%), 1-octadecene (ODE, 90%), ytterbium chloride hexahydrate 
(YbCl3.6H2O, 99.99%), erbium chloride hexahydrate (ErCl3.6H2O, 99.99%), 
were obtained from SigmaAldrich (SigmaAldrich, Singapore). Ultra pure 
water (18.0 MV) from a MilliQ deionization unit was used throughout the 
experiment. Rare earth chloride stock solutions with a concentration of 0.2 
M were prepared by dissolving YbCl3.6H2O and ErCl3.6H2O in deionized 
water. The final solutions were adjusted to pH = 2 to avoid hydrolysis. 
 
The Gd2O3 nanoparticles  suspended  in  hexane samples were  
characterized  by  transmission  electron  microscopy  (TEM,  JEOL  
2010)  while  dry  powder samples  were  characterized  by  X-ray  
diffraction  (XRD,  Bruker  D8  Advance), thermogravimetric  analysis  
(TGA,  DMSE  SDTQ600) and vibrating sample magnetometer (VSM, 
Lakeshore, Model 665) measurement. Crystal structure of the as-synthesized 
nanoparticles was identified by XRD while their size and  morphology  
were  investigated  by  TEM.  The  organic  coating  adsorbed to  the  
particle  surface  was  determined  by TGA  measurements.  Magnetic 
properties  of  the particles were studied using VSM measurement. 
Thermal decomposition method 
There are three important procedures to synthesize gadolinium oxide 
according to literature review, namely, direct decomposition, precipitation 
and thermal decomposition. [38, 60-62] These methods were performed in 
our experiments, and the obtained nanoparticles were washed by repeated 
dispersion and precipitation using hexane and ethanol, respectively. The 
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resultant three samples were performed in further characterizations. Table 
3-1 shows the summary of the three methods regarding both advantages and 
disadvantages in respect of synthesis. 
 
 
























To satisfy the requirement of the universal manufacture and high 
magnetization, thermal decomposition method is the most promising among 
the three. Typically, Ln series’ oxides are predominantly synthesized by 
thermal decomposition method. [64] Gadolinium is one of the common 
elements in Lanthanides, so its oxide nanoparticles also can be prepared by 
thermal decomposition of Gd oleate. 
 




Figure 3-1 Schematic representation of synthesis procedure and chemical reaction formula of 
Gd2O3 precursor Gd Oleate. 
Oleate was prepared in situ from the reaction of gadolinium chloride and 
oleic acid, which was decomposed at high temperature and acted as a ion 
source for synthesizing nanoparticles.[65] The overall synthetic procedure 
was depicted in Figure 3-1, and the detailed experimental procedures were 
listed as follows: 
 
Figure 3-2 Chemical structure of Gd(III) Oleate complex(Gdoleate), trioctylamine (TOA), oleic 
acid (OA) and oleylamine (OM). 
 
Synthesis of Gd Oleate Complex：The synthesis of Gd oleate was carried 
out using a reported procedure. [65]  In a typical experiment, 3.24 g of  
GdCl3•6H2O (12 mmol) was dissolved in 12 mL of distilled water, filtered, 
and mixed with 10.95 g of sodium oleate (40 mmol), 24 mL of ethanol, 6 
mL of distilled water, and 42 mL of hexane. The solution was heated to 70 
°C and stirred at this temperature for 4 h in fumehood. The obtained Gd 
 
Chapter  3  Controlled  Gd2O3  nanoparticles  with  various  morphologies 
61 
 
Oleate (around 5 mmol) was dissolved in hexane.The chemical structure of 
Gd(III) Oleate complex was shown in the Figure 3-2.  
 
Figure 3-3 Schematic diagram of Gd2O3 formation through thermal decomposition. 
 
Synthesis of Gd2O3 nanoparticles:Under vigorous stirring in a 50 mL flask, 
the mixture of Gd oleate, oleic acid and oleylamine was heated in argon to 
100 °C and kept for 10 min, then the temperature was increased to 360 °C at 
the rate of 10 °C/min. The reaction maintained at 340 °C for 1 h. As shown in 
Figure 3-3 the thermal decomposition of Gd oleate resulted in formation of 
Gd2O3 nanoparticles. A transparent yellow solution was obtained. The 
as-synthesized nanoparticles were then isolated by centrifugation and 
subsequently dispersed in hexane. The surfactants on these particles could be 
removed by washing in excess ethanol. 
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3.3 Results and discussion 
 
Figure 3-4 X-Ray powder diffraction pattern of as-synthesized Gd2O3 nanoparticles. The vertical 
bars below corresponding to pdf standard card of Gd2O3. (JCPDS File No. 000110604) 
 
 
Figure 3-4 showed the XRD pattern of pure Gd2O3 nanocrystals. The pattern 
exhibited strong  (222), (400) and (440) peaks for the cubic crystal group. 
Comparing with the standard data, the x-ray peak positions and intensities 
generally matched well with the reference (Gd2O3, pdf file No. 11-604). As 
reported in literature, the appearance of (222) peak in the plot was a 
signature of well crystallization, confirming the successful synthesis the 
Gd2O3. No characteristic peak from impurities was detected. The width of 
the diffraction peak lines were broadened because of the small size of the 
crystallites. The theoretical size of the as-prepared Gd2O3 was calculated by 
Scherer’s equation. From Figure 3-4, the full width at half maximum was 
measured as 2.7 degree, which located at (222) the strongest peak. The 
X-ray peak broadening was used to estimate the average crystallite using 
Scherer’s equation.  
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Dhkl = Kλ/(β cosθ) 
where Dhkl means the size along the (hkl) direction, K is a constant (0.89), λ 
is the wavelength of X-ray that was used (0.15406 nm), β is the full width at 
half maximum, and θ is the diffraction angle. The average crystallite size 
was estimated as 11.7 nm. 
 
Figure 3-5 (a) TEM image of monodispersed 10 nm Gd2O3 nano sphere with 3mL OA. (Inset: A 
DLS pattern of Gd2O3, maximum intensity is 15%). (b) High resolution TEM image of Gd2O3 
(inset: SAED ring patterns of Gd2O3) 
 
Figure 3-5 showed the TEM images of the samples. It demonstrated that the 
size distribution of the as-prepared particles was uniform. The average 
particle sizes measured from the TEM images were about 10±2 nm, which 
matched with the hypothetic results obtained by Scherer’s equation. The 
selected area electron diffraction (SAED) pattern in inset of Figure 3-5(b) 
which had been indexed against the characteristic lattice planes of Gd2O3 
further verified the cubic phase of Gd2O3. These results suggested that 
thermal decompose method was suitable to obtain the uniform 
nanoparticles. 
 
To investigate the synthetic parameters, seventeen samples were prepared 
by varying the reaction temperature (300 to 200 ℃) with different 
surfactants in different solvents, as listed in Table 3-3. To compare the 
temperature effect, sample A1, A2 and A3 were prepared using different  
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reaction temperature (300, 270 and 200ºC, respectively) for 30 mins. To 
study the effect of reaction time, samples B1 and B2 were prepared at 
different reaction time (15 and 60 mins, respectively). To investigate the 
solvent effect, sample C1, C2 and C3 were prepared in three different 
solvents, namely, 1-octadecene (ODE), paraffin oil (PO) and trioctylamine 
(TOA) respectively, in same reaction time and temperature. To study the 
surfactant effect, sample D1,D2 and D3 were prepared varying the reaction 
temperature (300 to 200 ℃) with OM in solvent TOA for 30 mins. Sample 
D4, D5 and D6 were prepared varying the reaction temperature (300 to 
200 ℃) with OA in solvent TOA for 30 mins. Sample D7, D8 and D9 were 
prepared varying the reaction temperature (300 to 200 ℃) with mixture of 
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3.3.1 Effect of temperature 
To determine the temperature influence, XRD patterns of the Gd2O3 
synthesized at 200℃, 270℃ and 300℃ were collected in Figure3-6.  
 
Figure 3-6 Comparisons of X-Ray powder diffraction patterns of as-synthesized Gd2O3 by 
heating up at (a) 200 ℃ (black line for A3 sample), (b) 270 ℃ (red line for A2 sample) and (c) 
300 ℃ (brown line for A1 sample), respectively.  
 
The patterns of A1, A2 and A3 samples (listed in Table 3-3) using different 
reaction temperature (300℃ , 270℃  and 200ºC, respectively) clearly 
showed that the products were Gd2O3 (JCPDF No. 11-604). Apart from this, 
the peak intensity of Gd2O3 gradually became stronger as the decompose 
temperature increased, suggesting the decomposition at higher temperature 
promote the phase formation and enhanced crystallinity. 
According to TGA results in Section 4.3,  the oleate began to decompose 
at 200 ℃. And XRD pattern of A1 (Figure 3-6 (a)) verified that there was 
no peak for Gd2O3 prepared at 200℃. 
 




Figure 3-7 (a) TEM image of A3 Gd2O3 sample. (b) TEM image of A2 Gd2O3 sample. (c) TEM 
image of A1 Gd2O3 sample. 
 
Figure 3-7 showed TEM images of A1, A2 and A3 samples, which 
illustrated the morphologies of the products obtained at different 
temperature. The size distribution of Gd2O3 prepared at low reaction 
temperature was quite narrow as shown in Figure 3-7(a). However, the  
particle size distribution became very wide when they were prepared at 
higher  reaction temperature as shown in Figure 3-7(c). The average 
particle sizes measured from the TEM images were about 8, 10 and 15 nm 
for the particles prepared using the reaction temperature 200 ºC, 270 ºC and 
300 ºC respectively, which demonstrated that size of the particles increased 
as reaction temperature increased.      
 




Figure 3-8. Magnetization curves of three samples (a) A1, (b) A2 and (c) A3. 
 
Figure 3-8 showed the magnetization curves of the A1, A2 and A3 samples, 
respectively. We compared three curves with the maximum value (Mmax) in 
H=5000 G. Mmax increased from 0.1 to 0.6 emu/g as increasing reaction 
temperature  from 200 ºC  to 300ºC. The increase of Mmax could be due 
to the increase of either particle size or crystallinity of the particles. Zero 
remanence and zero coercivity (i.e. no hysteresis) in magnetization curves 
indicated that samples were paramagnetic in nature.  
In summary, 300 ℃ should be the optimized reaction temperature, at 
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3.3.2 Effect of time 
 
Figure 3-9 X-Ray powder diffraction pattern of as-synthesized Gd2O3 nanoparticles and 
standard reference (a) black for B1 and (b) blue for B2  
 
To study the effect of reaction time, the sample B1 and B2 were prepared 
using different reaction time intervals (15 and 60 mins respectively) at 
300 ℃ (Table 3-3). Figure 3-9 (a) and (b) showed the XRD patterns of B1 
and B2 samples, respectively. Diffraction peaks of B1, which assigned to 
the (222), (400) and (440), matched well with standard Gd2O3 peaks (pdf 
file No. 11-604). The peak intensity became stronger as time increased, 
indicating the better crystallinity of the as-prepared sample with prolonging 
the reaction time. 
  
 




Figure 3-10 (a) TEM image of B2 Gd2O3 sample. (b) TEM image of B1 Gd2O3 sample. 
As shown in Figure 3-10, average size of the particles again increased from 
5 to 25 nm, and size distribution of the particles became wider as the 
reaction time increased from 15 mins to 60 mins. This may be due to 
“Ostwald ripening” i.e. small particles became smaller and large particle 
became larger with prolonging the reaction time. [67] 
 
Figure 3-11 VSM comparisons between two samples (a) B1 and (b) B2. 
 
Figure 3-11 (a) and (b) were the M-H curves of the B1 and B2 samples, 
respectively. No hysteresis indicated that samples were paramagnetic. It 
can be seen that Mmax remained around 0.4 emu/g regardless reaction time 
changed from 15 mins to 60 mins. It indicated that the heating time hardly 
influenced crystallization situation. 
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3.3.3 Effect of solvent  
 
Figure 3-12 Comparisons of X-Ray powder diffraction patterns of as-synthesized Gd2O3 using 
(a) ODE (black curve for C1 sample), (b) paraffin oil (pink curve for C2 sample) and (c) TOA 
(blue curve for C3 sample), respectively. 
 
To study the solvent effect, C1, C2 and C3 samples were prepared in three 
different solvents, namely, 1-octadecene (ODE), paraffin oil (PO) and 
trioctylamine (TOA). Besides these, C1, C2 and C3 samples were 
synthesized with same reaction temperature (300 ℃ ), reaction time 
interval (30 mins) and surfactant (OM+OA), as shown in Table 3-3. Figure 
3-12 (a), (b) and (c) were the XRD patterns of the C1, C2 and C3, 
respectively. Diffraction peak assigned to (400) showed increasing intensity 
from (a) to (c). The discrepancies could be contributed to the polarity of 
different solvents. According to the table of solvent polarity indexes, the 
polarity of ODE is smaller than PO, and PO is smaller than TOA. These 
indicated that the growth of Gd2O3 nanoparticles was promoted by polar 
solvent TOA. 
 




Figure 3-13 (a) TEM image of C1 Gd2O3 sample. (b) TEM image of C2 Gd2O3 sample. (c) TEM 
image of C3 Gd2O3 sample. Inset: DLS comparisons of C1, C2 and C3 
Figure 3-13 (a), (b) and (c) showed the TEM images of C1, C2 and C3  
samples, respectively. Particles remained the same size even if they were 
synthesized in three different solvents individually. Thus, the size of Gd2O3 
nanoparticles was not sensitive to the solvents. However, there were 
obvious discrepancies among C1, C2 and C3 in morphology. sample C3 
synthesized with TOA, as shown in Figure 3-13(c), was the most uniform 
among the three, which agreed with the observation in Figure 3-12. 
 
 
Figure 3-14 Magnetization M-H curves of three samples (C1, C2 and C3), which were 
synthesized in three distinct solvents of ODE, PO and TOA, respectively. 
 
Figure 3-14 implied the magnetization M-H curves of the C1, C2 and C3 
samples. All samples’ coercivity were zero in M-H curves, and Mmax 
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remained the same in three samples. It indicated that the solvent did not 
influence paramagnetic properties of the particles.  
In summary, Gd2O3 synthesized in TOA had relatively narrow size 
distribution and well defined shape. TOA should be selected as the ideal 
solvent in thermal decompose method. 
3.3.4 Effect of surfactant  
 
Figure 3-15 X-Ray powder diffraction patterns of as-synthesized Gd2O3 nanoparticles: (a-c) 
blue, purple and black curves for sample D1, D2 and D3, respectively, which were synthesized 
with OM as surfactants; (d-f) black, blue and purple patterns for sample D4, D5 and D6, 
respectively, which were synthesized with OA as surfactants; (g-i) black, light red and dark red 
curves for sample D7, D8 and D9, respectively, which were prepared with OA and OM mixture 
as surfactants. Standard reference (JCPDS File No. 110604) was the black lines at the bottom. 
 




According to Chapter 3.5.1-3.5.3, temperature is the most important 
parameter to improve Gd2O3 paramagnetic properties. To optimize Gd2O3 
nanoparticles for T1 contrast agent application, Gd2O3 with different 
morphologies were synthesized using different surfactants (OM, OA and 
their mixture, respectively) at different reaction temperature (200, 250 and 
300℃, respectively), as shown in Table 3-3. Sample D1,D2 and D3 were 
prepared varying the reaction temperature (200 to 300 ℃) with OM in 
solvent TOA for 30 mins. Figure 3-15 (a), (b) and (c) showed the XRD 
patterns of D1, D2 and D3, and Figure 3-17 (a), (b) and (c) depicted the 
TEM images of D1, D2 and D3 samples, respectively. Sample D4, D5 and 
D6 were prepared varying the reaction temperature (200 to 300 ℃) with 
OA in solvent TOA for 30 mins. Figure 3-15 (d), (e) and (f) showed the 
XRD curves of D4, D5 and D6, and Figure 3-18 (a), (b) and (c) depicted the 
TEM images of D4, D5 and D6 samples, respectively. Sample D7, D8 and 
D9 were prepared varying the reaction temperature (200 to 300 ℃) with 
mixture of OM and OA in solvent TOA for 30 mins. Figure 3-15 (g), (h) 
and (i) showed the XRD patterns of D7, D8 and D9, respectively. In Figure 
3-15, positions of the diffraction peaks assigned to the (222) and (440), 
matched well with the standard XRD data for Gd2O3 (JCPDS File No. 
110604), which proved that it was successful synthesis of the Gd2O3. 
However, minor difference existed between the samples. XRD patterns of 
sample D1, D2 and D3 showed similar peaks, while that of D4, D5 and D6 
showed slightly different peaks. The other sample D7, D8 and D9 had the 
identical patterns, which were not similar with the previous. According to 
Figure 3-15, the surfactant change was dominating factor which caused the 
discrepancy in XRD patterns. 
Since XRD patterns also reflected the quality of crystal by comparing peak 
intensity, the temperature did influence Gd2O3 growth with different 
surfactants respectively. Sample D1-D3 using OM as surfactant showed 
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clearer peak outline as the temperature increased from 200 to 300℃. 
Similarly, peaks of sample D6 had stronger intensity than that of sample D4 
and D5. Temperature improved the crystallization situation. Same 
phenomena were present in D7-D9 which used OM and OA mixture 
as .surfactants, which showed sharper and stronger (440) peaks as 
temperature increased. Eventually, we selected sample D3, D6 and D9 as 
the best quality samples, and detailed comparisons in TEM were shown in 
Figure 3-16. 
Hence, discrepancy in XRD patterns preliminarily implied that morphology 
control was achieved by altering the surfactants. 
 
 
Figure 3-16 (A) TEM image of D3 tripods shape Gd2O3 sample (B) TEM image of D6 rod shape 
Gd2O3 sample. (C) TEM image of D9 sphere shape Gd2O3 sample. Inset of each TEM are the 
DLS results of (A) D3, (B) D6 and (C) D9, respectively 
 
To validate the XRD results, TEM of typical D3, D6 and D9 were carried 
out. Figure 3-16(A), (B) and (C) showed the TEM images of the sample D3, 
D6 and D9, respectively. Preliminarily, it can be observed three distinct 
morphologies of Gd2O3 with narrow size distribution in the low magnitude 
TEM. (DLS results showed in Figure 3-16 insets). Sample D3 exhibiting in 
Figure 3-16(A) possessed tripods shape outline, while sample D6 in Figure 
3-16(B) and sample D9 in Figure 3-16(C) were rods shape and sphere shape 
respectively. As mentioned in section 3.4, morphology factor may alter the 
performance of the Gd2O3 contrast agents. According to Figure 3-16, three 
distinct morphologies with different ratios of surface area to total volume 
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(S/V) were successfully obtained. By comparing the paramagnetic 
properties of Gd2O3 with three morphologies, correlation between the 
surface area ratios and T1 performance could be deduced. Though it 
remained unclear that how three structure form, these three morphologies 
were obtained repeatedly by following same recipes, which paved the path 
to study the morphology factor on the T1 performance. 
 
Figure 3-17 (a) TEM image of D1 tripods shape Gd2O3 sample (b) TEM image of D2 multi-pods 
shape Gd2O3 sample. (C) TEM image of D3 multi-pods shape Gd2O3 sample.(D) EDS of single 
tripods nanoparticles with clear rings. 
 
As such, Figure 3-17 showed typical experiment results for Gd2O3 
nanoparticles in multi-pods shape. Figure 3-17(a) demonstrated the low 
magnitude TEM images of D1. In this 2-D projective view, tripods shape 
shadows were observed. It was clearly identified as multi-pods 
morphology. Sample D2 obtained in 250OC was shown in Figure 3-17(b), 
while sample D3 obtained in 300 OC was shown in Figure 3-17(c). Figure 
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3-17(a) to (c) exhibited increasing multi-pods’ average length, from 26 nm 
± 5 nm to 38 nm ± 8 nm estimated from measuring 100 particles, which 
agreed with the increasement of XRD peak intensity in Figure 3-15(a) to 
(c). The multipods had 2 nm thickness calculated by lateral view of 
multipods in Figure 3-17(c). Moreover, more pods appeared in D2 and D3 
instead of tripods in D1, which also could ascribe to better crystallinity at 
higher temperature. Figure 3-17(d) showed the selected area electron 
diffraction (SAED) pattern from which the diffraction rings were referenced 
to the characteristic lattice planes {222} {440} of Gd2O3. As conclusion, 
well-crystallized Gd2O3 multipods structure were obtained using OM as 
surfactants in 200-300 OC. 
 
 
Figure 3-18 (A) TEM image of D4 rod shape Gd2O3 sample (B) TEM image of D5 rod shape 
Gd2O3 sample. (C) TEM image of D6 rod shape Gd2O3 sample. (D) EDS of nanorods with clear 
diffraction rings. 
As such, Figure 3-18 showed typical experiment results for Gd2O3 
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nanoparticles of rods shape. Figure 3-18(a) demonstrated the low magnitude 
TEM images of D4. In this 2-D projective view, line shape observed in 
view clearly testified that it was rod structure. Figure 3-18(b) exhibited the 
D5 sample synthesized in 250 OC with similar rod shadow, as well as  
Figure 3-18(c) D5 in 300 OC, As depicted by XRD patterns in Figure 
3-15(d)-(f), Figure 3-18(b) and (c) exhibited increasing rate of average rod 
length comparing to Figure 3-18(a), from 51 nm ± 9 nm to 67 nm ± 9 nm 
estimated from measuring 100 rods. Figure 3-18(d) showed the selected area 
electron diffraction (SAED) pattern from which the diffraction rings were 
referenced to the characteristic lattice planes {222} of Gd2O3.  The results 
suggested that the successful selective growth of Gd2O3 along this direction. 
As conclusion, well-crystallized Gd2O3 nanorods were obtained using OA 
as surfactants in 200-300 OC. 
 
 
Figure 3-19 VSM comparisons among three series of samples (tripods, rod and sphere shapes) 
synthesized in three different temperatures (200, 250 and 300 degree), respectively. 
 
Figure 3-19 implied the magnetization M-H curves of D1-D9 samples. All 
samples’ remanence and coercivity were zero in M-H curves. As mentioned 
in section 3.4, surface Gd(III) ions cooperatively induced the longitudinal 
relaxation of the water proton, which made surface to volume ratio (S/V) 
important to T1 performance. As shown in Table 3-2, nanoparticles with 
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ultra-small radius (r) which corresponding to the highest surface to volume 
ratio, i.e. 3/r, should be more paramagnetic than nanorods and multipods 
structures. Actually, it can be seen that maximum magnetization of each 
line (Mmax) of three shapes did differentiate from each other. The samples 
with same shape, such as D1, D2 and D3, showed nearly same Mmax, e.g., 
0.32 emu/g, 0.41 emu/g and 0.42 emu/g, respectively. Mmax of sample D4, 
D5 and D6 increased to 0.61~0.73 emu/g, since S/V of rod shape was larger 
than of multipods shape. The max of Mmax (0.79~0.85 emu/g) was obtained 
in sphere shape samples (D7, D8 and D9), which validated that morphology 
factor could improve the particles’ paramagnetic properties. High S/V 
shape (i.e. nano sphere shape) samples should be the best candidate among 
samples with different morphologies for MRI contrast agents. 
 
3.4 Identification of organic coating 
 
Figure 3-20 FTIR spectra curve of as prepared the OM (oleylamine, 
CH3(CH2)7CH=CH(CH2)8NH2) capped Gd2O3  
 
The chemically adsorbed organic coating on the particle surfaces was 
recognized by FT-IR. Figure 3-20 showed the FTIR spectra of typical sample 
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D3 which was prepared in OM surfactant media. 
 
 
Table 3-4 The FTIR peaks assignment for OM capped Gd2O3 
Wavenumber (cm−1) Assignment 
3321 NH asymmetric stretching vibration 
1577 NH scissoring vibration 
1615 stretching vibrations of C=C 
3006 stretching vibrations of =CH 
722 inplanar swing (CH2)n (n > 4). 
2852 symmetric stretching vibration of the CH2 
2922 antisymmetric stretching vibration of the CH2 
 
After the decomposition process, the assynthesized nanoparticles were 
collected, washed and dried before the FTIR test. The characteristic peaks of 
Gd2O3 disappeared and new absorption peaks were found in Figure 3-20. 
The peaks at 3321 cm-1 and 1577 cm-1 were ascribed to the asymmetric 
stretching vibration and scissoring vibration of NH2 respectively. The 
presence of CH=CH group was suggested by the peaks at 1615 cm-1 and 3006 
cm-1, which were assigned to the stretching vibrations of C=C and =CH. The 
peak at 721 cm-1 was assigned to the inplanar swing of (CH2)n (n > 4). The 
sharp peaks at 2852 cm-1 and 2922 cm-1 were assigned to the symmetric and 
antisymmetric stretching vibration of the CH2 group (summarized in Table 
3-4). These results suggested that the precursor was deposited at high 
temperature to form Gd2O3 nanoparticles which were capped with 
oleylamine. The surface capping with oleyamine was a key factor for 
obtaining the high quality nanoparticles and making it redispersible in 
solvent such as hexane or chloroform.  
 
3.5 Conclusion of Gd2O3 synthesis 
The growth of particles was better at higher reaction temperature, which 
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formed bigger particles with higher saturate magnetization. Moreover, the 
reaction time did influence particle size, while it showed little effect on the 
value of saturate magnetization. However, the solvent of reaction played an 
important part in the quality of the particles. With the non-polarized 
solvent,  size  distribution  of  those  particles was found to be narrow. 
In general, the uniform size particles can be synthesized at high  reaction  
temperature  in short reaction  time  by  reacting with non-polarized 
solvent. Such particles possessed high saturate magnetization.   Three 
distinct shapes, e.g. tripods, rod and sphere, were obtained by altering the 
surfactants. The magnetizations of samples using same surfactants in 
different reaction temperatures were relatively consistent with each other, 
while samples using different surfactants had big discrepancies. The sphere 
shape which own the highest surface area to volume ratio did have the best 
performance in paramagnetic properties. 
3.6 Doping with Yb:Er to introduce the optical properties to Gd2O3 
nanoparticles system 
3.6.1 Doping method 
 
Figure 3-21 Structure and basic mechanism of the Yb Er codoped Gd2O3 
As the preponderance of recent reviews and attentions at scientific meetings 
will attest, there has been a surge in research on contrast agent with 
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fluorescent properties over the past few years. [69-71] This rises spark the 
hopes to detect multiple molecular targets simultaneously. With the 
combination of fluorescent and MRI, it synergistically allows high 
resolution, high sensitivity investigation of biological activity.  
As Upconversion own the advantages of “optical window” properties, the 
excitation wavelength can penetrate the tissue, while the emission 
wavelength can easily be probed. Thus, it is suitable for bio labelling 
application. Although some transition metal ions also exhibit UC properties, 
such as Ti2+(3d2), Cr3+(3d3), Ni2+(3d8), Mn2+(3d5), Mo3+(4d3), Re4+(5d3) and 
Os4+(5d4). Their optical properties change a lot in different host materials for 
lacking of shielding effect as RE ions [72]. As a result, RE ions are normally 
recommended, and chosen as the doping elements. Gaspar et al. reported the 
attempt of doping RE into gadolinium oxide using modified homogeneous 
precipitation method for further bio application. [73]  
On the other hand, efficient upconversion can only be achieved from a few 
upconversion materials with combination of certain host and dopants, as 
illustrated in Figure 3-21. The upconversion materials mainly consist of host 
materials and dopants, which can be further divided into sensitizer and 
activator. In fact, the upconversion luminescence efficiency is quite low 
based on this single activator, thus the sensitizer is used to improve the 
efficiency. Generally, a sensitizer has a single excited level which does not 
show upconversion property itself. They should be able to absorb the 
pumping photons and resonate with the activators. For example, Yb3+ is a 
typically sensitizer for 980 nm excitation, and commonly used. Herein, Yb 
Er upconversion system was selected to efficiently introduce fluorescent 
properties in gadolinium oxide contrast agents.  
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3.6.2 Results and discussion 
 
Figure 3-22 X-Ray powder diffraction patterns for Yb,Er-doped Gd2O3 nanoparticles of (a) B1 
and (b) B2. 
Herein, we added the Yb/Er oleate complex with the Gd oleate complex. 
When it heated up, Yb Er ions released and distributed inside the Gd2O3 
matrix. The doping concentration of Yb wt% was 12%. The particles then 
further coated with pure Gd2O3 shell. Figure 3-22 showed a typical XRD 
patterns of samples B1 and B2. Diffraction peak assigned to the (400) had 
stronger intensity in B2 comparing to B1. It was because B2 had a extra 
coating layer of Gd2O3. Comparing with the standard data (Gd2O3, pdf file 
No. 11-604), both x-ray peak positions of B1 and B2 slightly shifted to low 
angles, which could testify the doping of Yb Er ions in Gd2O3 crystals. 
 




Figure 3-23 Typical TEM bright field image of (A) and (B) Yb:Er codoped Gd2O3 nanoparticles: 
B1 with the size of 5 nm and B2 with size of 8 nm, respectively; (C) and (D) High resolution TEM 
of B1 and B2:  
 
 
Figure 3-23(A) showed a typical TEM bright field image of the B1 Gd2O3 
nano sphere before the coating process, and the corresponding HRTEM for a 
single nanoparticle was recorded in Figure 3-23(C). Assynthesized 
nanoparticles in TEM were both quite uniform in size and morphology. The 
average size of B1 sample, estimated from measuring 100 particles, was 5 
nm ± 2 nm, while size of B2 was 8 nm ± 1 nm 
 
 




Figure 3-24 Upconversion fluorescence spectra of Yb:Er codoped Gd2O3 nanoparticles with two 
different diameters 1# (red curve B1), 2# (blue curve B2); Insets are the upconversion 
luminescence taken by camera of corresponding B2 as-synthesized Gd2O3. 
The room-temperature up-conversion fluorescence spectra of the colloidal 
Yb:Er codoped Gd2O3  nanocrystals were performed under 980 nm NIR 
excitation. (sample B1 and B2 in Figure 3-24 (1) and (2), respectively) The 
peak at 545 nm was assigned to Er transitions from 4S3/2 to 4I15/2 (green 
emission), and the peak at 660 nm was assigned to Er transitions from 4F9/2 
to 4I15/2 (red emission). The higher red emission peak contributed to the 
observed green color. The emission peak position did not show observable 
shift, indicating the energy level of Er3+ remained the same. More samples 
with thicker layer had been demonstrated in Figure 3-25 to investigate the 
correlationship between the coating thickness and the emission intensity. 
 
Figure 3-25 showed the increase of emission intensity of the Gd2O3 with as 
size of particles increased to ~ 12.5 nm. An increase in shell thickness to 4.4 
nm did not result in total intensity improvement, showing that the critical 
shell thickness appeared to be ~ 2.5 nm for these particles. 
 




Figure 3-25 The relationship of total emission intensity enhancement of nanoparticles of shell 
size. 
Due to the above, a crystalline shell provided a strong crystal field for 
surface ions, protecting them from the high vibration groups on the surface 
which caused nonradiative relaxation processes. Eventually, the total 
intensity increased. The critical shell thickness appeared to be ~ 2.5 nm. The 
0.8 nm shell did not seem to provide a sufficient protection, whereas 4.4 nm 
shells did not result in further emission increase. It has been found that the 
electric dipoledipole resonance energy transfer process occurred when the 
distance was in order of ~ 1 nm [74]. The 0.8 nm shell might not be thick 
enough to prevent the nonradiative relaxation due to interactions with the 
environment. When the thickness reached ~ 2.5 nm, the shell may provide a 
complementary crystal field to the RE3+ ions staying on the doped core 
surface and a sufficient barrier to nonradiative multiphonon relaxation 
induced by the environment.  
 
3.7 Magnetic properties  
 
To study the MR properties of luminescent Gd2O3, as-prepared codoped 
Gd2O3 nanosphere were transferred into hydrophilic by ligands exchange 
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method, and hydrophilic Gd2O3 were tested using a 3T magnet. The r1, r2, 
and r2 / r1 constants were calculated from the slopes of the linear plots of 
relaxation rates (1/T1 and 1/T2, respectively) against gadolinium 
concentration [Gd].The results obtained were recorded in Table 3-5. The 
longitudinal relaxivity of monodispersed Gd2O3 was observed to be just half 
of Gd-DOTA (r1=3.560s-1mM-1 ). Generally, codoped Gd2O3 nanoparticles 
still reserved paramagnetic properties as T1 MRI contrast agents. 
 
Table 3-5  Results of the r1 and r2 values of coped Gd2O3 comparing with references 
Sample name 
r1    
(s-1mM-1) 





Gd2O3-PEG-silane 0.100 8.16 81.6 14 
Gd-DOTA 3.560 4.75 1.3 1 
Yb, Er-coped 
Gd2O3 
1.529 50.17 32.8 - 
 
However, our sample was still much better than the data of PEG-silance 
coating Gd2O3 (r1=0.10s-1mM-1). Apparently, Yb, Er-codoped Gd2O3 
nanoparticles were still reserve r1 enhancement with r1=1.529s-1mM-1 per 
single particle in unit volume. The results showed that a preferential decreased 
after the rare earth doping, yet it still could be significant for further imaging 
in 3T magnet. 
 




Figure 3-26 Longitude relaxivity per single particle (R1) versus varying Gd2O3-loading 
Figure 3-26 showed the T1-weighted MR images of Yb,Er-codoped Gd2O3. 
The sample exhibited a T1 enhancement effect as seen by the observed 
reduction in signal intensities with respect to [Gd], which was evidence of 
potential application as T1 contrast agent.  
 
Figure 3-27 Transverse relaxivity per single particle (R2) versus varying Gd2O3-loading 
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Figure 3-27 showed the T2-weighted MR images of Yb,Er-codoped Gd2O3. 
The sample exhibited a relative high r2 value (r2=50.17 s-1mM-1 ) as seen by 
the observed increasement in signal intensities with respect to [Gd], which 
may cause by the aggregation of the samples. 
 
3.8  Summary  
Gd2O3 nanoparticles were synthesized in three different morphologies. Four 
synthetic factors were investigated, i.e. temperature, time, solvent and 
surfactant. It was found that temperature highly influence the degree of 
Gd2O3 crystallization. The surfactant played a key role to control the 
morphology. Sphere shape was selected as the optimized structure to obtain 
the best paramagnetic performance. Yb:Er codoped Gd2O3 nanosphere were 
then successfully synthesised using thermal decomposition method. They 
were equiaxed in shape, and exhibit T1 effect with r1=1.529s-1mM-1. 
Moreover, the optical properties were successfully induced in Gd2O3 
contrast agents, which were further optimized by altering the coating 
thickness. It paved the way to explore the dual-modalities detect agents 
using the traditional T1 agent Gd2O3 in cellular imaging.
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4 Controlled loading of Gd2O3 nanoparticles in functional 
nanogels as effective T1-weighted MRI contrast agents 
4.1 Introduction  
Magnetic resonance imaging (MRI) utilizes magnetic field to obtain 
3-dimensional images of patients without ionizing radiation media. It is a 
non-invasive diagnosis technology and relatively harmless to human body as 
compared with X-ray tomography and positron emission computed 
tomography (PET). There are two important MRI imaging techniques: 
T1-weighted MRI and T2-weighted MRI. T1-weighted MRI is a bright field 
imaging method (fat-containing tissues are bright under T1-weighted scan, 
while water-, and fluid-containing tissues are dark) and allows better 
signal-to-noise ratios and finer resolution than T2 imaging. Hence, it is more 
promising to develop MRI contrast agents with high r1 values for better 
clinical T1 imaging. Traditionally, gadolinium chelate is used in clinical 
diagnosis. However, it exhibits a very short blood circulation time and so a 
large amount of such small molecule contrast agents are needed to achieve 
strong contrast effects. Furthermore, it is believed that gadolinium chelates 
internalized in cells may lead to the leaching of Gd3+ ions, which is 
responsible for nephrogenic systemic fibrosis (NSF) in patients.[41, 75] 
Thus, more effective contrast agents with low intake dose, such as 
gadolinium oxide nanoparticles, are more promising. 
 
Much research has been done on gadolinium oxide in literature because it is 
more stable than Gd chelates and the surface Gd(III) ions, which are very 
closed to the surrounding protons, provide a high r1 relaxivity of 3-5 
s-1mM-1.[38] For example, ultra-small gadolinium oxide nanoparticles were 
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utilized to image mice brain cancer cells in vivo. However, due to the large 
specific surface area, these nanoparticles tended to aggregate over time in 
aqueous medium. [34] Faucher et al. provided a comprehensive investigation 
about the relationship between agglomeration and relaxivity based on 
aqueous suspensions of DEG covered gadolinium nanoparticles.[76] The r1 
values under different frequencies were decreased in the presence of 
aggregation, suggesting that the self-aggregation of hydrophilic Gd2O3 
suppressed the T1 effect of the Gd species. [40] Hence, it will be favorable to 
encapsulate the Gd2O3 nanoparticles inside a carrier, in which the 
nanoparticles are fixed in position and separated with each other. 
Mesoporous silica nanospheres (MSNs) has been firstly utilized as carriers 
by Taylor et al. since 2008.[44] However, the thick layer (~20nm) of the 
silica coating is still challenged, which may result in the inefficeint contact 
with water proton.[77] In this regard, smaller polymer coating is used as the 
better protection. Low molecular weight dendrimers and liposomes were 
selected as the potential carriers.[18, 19] However, it limits in specific size 
range，and cross-linking among differnt gadolinium ion, which length just 
1~2nm, would cause aggregation and even alter the efficiency of T1 effect. 
Therefore, novel macromolecular, with a molecular weight greater than 
30kD, is highly desirable in the fabrication of nanocomposites with 
different geometrical dimensions, as well as minimizing their 
aggregation.[45-48] Recently, amphiphilic poly(ethylene glycol) 
diglycidyl-grafted poly(maleic anhydride-alt-octadecene) (PMAO-g-PEG) 
based macromolecular platforms have been reported on quantum dots and 
up-conversion particles systems, resulting in better biocompatibility.[49] 
However, none has been reported in Gd2O3 system.  
 
Herein, we proposed to load paramagnetic gadolinium oxide nanoplates in 
PMAO-g-PEG nanogel to form  Gd2O3 nanoclusters (GNCs) as effective 
T1-weighted MRI contrast agents. The nanogel not only formed a protective 
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coating over Gd2O3 nanoplates, but also hold water around the nanoplates. 
The procedures for the formation of GNCs involved a facile combination of 
nanoemulsion and solvent evaporation techniques. The polymeric material 
chosen for the formation of the nanogel was an amphiphilic brush copolymer 
that obtained by grafting PEG to PMAO. The resultant brush-structured 
copolymer was amphiphilic, and highly versatile. It is also possible to graft 
additional functionalities, such as fluorescein, to confer photoluminescent 
properties. As such, the GNCs were investigated in detail and its 
characteristics were analyzed according to morphology, particle size, 
composition, colloidal stability, magnetic properties and MR sensitivity. The 
maximum r1 value of 7.948 s − 1mM−1 , is 2.23 times higher than Gd-DOTA 
and the highest r2/r1 ratio (1.04) was obtained. The cytotoxicity test on 
NIH-3T3 cells also proved that the GNCs were relatively safe  for 
bioapplications. 
. 
4.2 Experimental part 
Raw materials preparation: Cetyltrimethylammonium bromide (CTAB) 
(99%)was purchased from Fisons, and poly (maleic anhydride 
-alt-1-octadecene) (PMAO, powder, Mn = 30000–50000,) sodium oleate 
(powder, ≥99%), gadolinium(III) chloride hexahydrate (powder, 99%), 
Poly(ethylene glycol) (PEG, powder, Mn=2,000), oleic acid (liquid, 
99.99%), 1,2-hexadecanediol (powder, 90%) and trioctylamine (liquid, 98%) 
were purchased from Sigma-Aldrich. All chemicals were used as received. 
 
Synthesis of PMAO-g-PEG: To synthesize the functional amphiphilic 
copolymer, the PMAO was grafted with PEG, which the publication of Yu et 
al..[16] PMAO (3g sigma 419117), PEG (2.25g sigma 295906) were mixed 
in THF (20mL), wherein PMAO was initially insoluble. The reaction flask 
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was then heated to 80 oC to ensure the complete reaction. In the presence of 
concentrated hydrochloric acid (37 wt%), the reaction mixture was incubated 
over 24h to ensure complete reaction. After the sample has been cooled down 
to room temperature, the mixture was neutralized with sodium hydroxide. 
Subsequently the mixture was precipitated using excess acetonitrile and 
collected by centrifugation. The final product was extracted by solvent 
evaporation and then dried in vacuum at room temperature for 2 days to 
obtain a white powder. In this process, approximately 16.7% of the maleic 
anhydride rings in PMAO has been grafted with PEG through esterification 
process. 
 
Synthesis of 10nm core Gd2O3 nanoplates:  
Oleate decompose method was used. For the synthesis of gadolinium oleate, 
gadolinium(III) chloride hexahydrate (2 mM), sodium oleate (6 mM), ethanol 
(4 ml), deionised (DI) water (3 ml), and hexane (7 ml) were mixed and heated 
in a round-bottomed flask to 70 oC for 4 h, while stirring continuously. The 
upper organic layer containing the Gd oleate complex was collected and then 
washed with 30mL of distilled water several times and dried overnight at 
room temperature to evaporate water and hexane. The waxy Gd oleate 
obtained after drying was mixed with 20 mL of trioctylamine, 0.3 g 
1,2-hexadecanediol and appropriate oleic acid according to different 
conditions in a three neck flask. The reaction flask was purged with nitrogen 
gas for 15 min prior to reaction. The temperature was then raised to 100 oC 
for 1h to completely remove the water. The solution was then heated to 380 
oC at a rate of 10 oC / min under the blanket of N2. Bubbles appeared and the 
suspension was cooled 10 min later and washed by repeated dispersion and 
precipitation using toluene and ethanol, respectively. The final product was 
dispersed completely in chloroform (50 mg mL -1) and the resultant liquid 
was sealed in a glass vial for storage. 
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Preparation of GNCs: The formation of GNCs was obtained from solvent 
evaporation. Individual stock solutions of PMAO-g-PEG and Gd2O3 
dissolved in chloroform were prepared. Predetermined amounts of polymer 
and Gd2O3 stock solutions were mixed together and then emulsified with 
water (10X vol excess, 1 wt% PVA as stabilizer) using an ultrasonic 
homogenizer (SONICS VCX 130 PB) at 20 kHz frequency and 60% 
amplitude for 5 min. The emulsion was then heated at 60 oC in an open glass 
beaker under rapid stirring to allow the chloroform to evaporate. All samples 
in this report were prepared with a fixed amount of polymer stock solution 
(20 mg mL-1), while varying the amounts of Gd2O3 injected. The as-prepared 
colloids firstly underwent centrifugation at 2000 rpm for 10 min to remove 
unusually large aggregates. The colloid was then purified by centrifugation at 
8000 rpm for 10 min for complete separation of the GNCs, which were then 
redispersed in water/methanol (50: 50). Purification was repeated at least 
twice before the GNCs were finally redispersed in water or appropriate 
aqueous medium. Final products were dialyzed against Millipore water for 
days in a dialysis sac (molecular weight cut-off = 20 kDa). The products 
within dialysis sac were retained for further studies 
 
Phase transfer of hydrophobic Gd2O3 Nanoplates: The hydrophobic Gd2O3 
nanoplates were phase-transferred to water using CTAB as surfactant. To 
achieve monodispersed nanoplates, 1 mL solution of chloroform containing 
10 mg of Gd2O3 nanoplates was added to 5 mL 0.25 M CTAB solution. After 
vigorous vortex and sonification for 40 minutes, the opaque solution became 
semitransparent gel. The gel was then heated to 70 oC to evaporate the 
chloroform, leaving a transparent light white solution. To purify colloid 
solution of Gd2O3, the reactants were dialyzed against Millipore water for 3 
days in a dialysis sac (molecular weight cut-off = 20 kDa).  
 
Magnetic relativity measurements: To evaluate the potential application of 
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the GNCs as MRI contrast agents, magnetic relaxivities were measured in a 
3T clinical MRI instrument (Siemens Magnetom Trio) equipped with a head 
coil. T1 and T2 relaxation times were measured for samples with varying Gd 
concentrations. T1-weighted images were obtained with spin echo sequences 
using multiple TRs (TE: 9.1 ms, TR: 6400–100 ms). T2-weighted images 
were obtained by single echo pulse sequences (6 echoes; TE: 9.1–160 ms, 
TR: 1600 ms). All measurements were performed at room temperature. 
Relaxation rates of each sample were computed using in-house software 
(MATLAB V7.1) by nonlinear least squares fitting of appropriate 
exponential functions (exponential decay and saturation recovery for T1 and 
T2, respectively). Relaxivities were calculated using linear regression 
analysis (Microsoft EXCEL) to correlate relaxation rates and molar Gd 
concentrations.  
 
Cell labelling: To assess the potential of GNCs as optical labelling agents, 
NIH/ 3T3 cells were used as a model for study. NIH/3T3 cells were incubated 
in an 8-well plate at 37 oC and 5% CO2 environment. After 24 h, the GNCs 
(10 mL, 40 mg mL-1) were injected into each well. The particles were then 
incubated a further 24 h. The cell samples were washed to remove free 









Figure 4-1. TEM images of Gd2O3 synthesized with different amount of oleic acid, e.g. (a) 0mL, 
(b) 1mL and (c) 2mL, (c) inset: DLS size distribution of Gd2O3, maximum intensity is 30%. (d) 
high-resolution TEM  image of Gd2O3 nanoplate (Inset: SAED of Gd2O3 nanoplate labelledwith 
corresponding rings) 
 
The plate shape of Gd2O3 is much preferred for T1 effect due to its large 
surface area exposed to water. [17, 18] In order to prepare Gd2O3 
nanoplates, gadolinium oleate was thermally decomposed in the presence of 
oleic acid which acted as an effective morphology controller.  [19-22] 
Figure 4-1(a), (b) and (c) showed the Gd2O3 nanoplates obtained in the 
presence of different amounts of oleic acid, i.e. 0 µl, 1µl and 2 µl, 
respectively. Without adding oleic acid (OA), the obtained nanoplates were 
irregular in morphology and had a large size distribution as shown in Figure 
4-1(a). Upon adding 1µl oleic acid, it was observed that the obtained 
nanoplates tended to be more regular in morphology. Figure 4-1(c) showed 
the TEM images of the Gd2O3 nanoplates when the oleic acid amount was 
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increased to 2 µl. In this 2-D TEM image, two types of particle 
morphologies, rod shaped and round shaped, were observed. It was believed 
that the rod shaped image was actually the projection of the standing 
nanoplates, suggesting the successful formation of nanoplates. Figure 4-1(c) 
Inset showed that the size distribution of the as-synthesized particles was 
from 8 to 13 nm. The high resolution TEM, shown in Figure 4-1(d), 
revealed the crystalline fringes of  cubic crystal group with lattice spacing 
of 0.19 nm, which was characteristic of vector  <101> of Gd2O3,  
corresponding to the (222) facet. Figure 4-1(d) inset showed the selected 
area electron diffraction (SAED) pattern, from which the diffraction rings 
were referenced to the characteristic lattice planes {222} {440} of Gd2O3.     
 
 
Figure 4-2 XRD pattern of Gd2O3 nanocrystal. All peaks are assigned to standard reference 
(JCPDS File No. 00-011-0604) 
 
Figure 4-2 showed the XRD of Gd2O3 nanocrystals with hydrophobic 
surfactant and the vertical bars below are the corresponding standard card 
of Gd2O3. For the pure Gd2O3, the (222), (440) and (622) peaks had distinct 
intensities, corresponding to a cubic crystal group. Comparing with the 
standard data, the X-ray peak positions and intensities generally matched 
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well with the reference (Gd2O3, pdf file No. 11-0604) 
 
Synthesis and characterization of PMAO-g-PEG 
 
Figure 4-3. 1H NMR spectrum of PMAO-g-PEG in CDCl3. (Solvent peaks at 7.28 ppm), and 5 
distinct peaks are indicated by red alphabetic symbols a to e. Theoretical formula predicted by 
the Chemdraw Ultra 8.0 was present in dashed line box at the up-left corner 
 
To give a low adsorption of the serum protein, poly (maleic 
anhydride-alt-1-octadencene) (PMAO) was grafted with poly (ethylene 
glycol) (PEG) to form a brush-structured copolymer.[78] The acid anhydride 
groups of PMAO molecules were easily hydrolyzed with PEG to generate 
free carboxylic acid groups (–COOH).[84] The chemical structure of 
PMAO-g-PEG was verified using 1H NMR (300 MHz, CDCl3, δ)  and 
FT-IR for the chemical analysis. In Figure 4-3, both simulations from 
software and NMR results were presented. Figure 4-3 showed the molecular 
structure predicted by dehydrating with calculated chemical shift of each 1H. 
The peak at 10.07 ppm was evident for the formation of the carboxyl bond 
that followed the ring-opening of the anhydride rings after reaction with 
PEG. In NMR results of  Figure 4-3, all characteristic peaks could be 
matched as follow: 4.25 ppm,( A,-OC(=O)-C) 3.6 ppm (B, -O-C) 2.6 
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ppm(C,-C(=O)OR) 1.8 ppm (D, alpha-C),1.28 ppm (E, 2-beta-C), 0.9 ppm 
(F,-C-R), which  indicated the complete hydrolysis of the anhydride and the 
formation of the carboxylate and ester carbonyl.   
 
Figure 4-4 FTIR spectra of PMAO, PEG (Mn=2000), and PMAO-g-PEG 
Further verification was performed using FT-IR spectral analysis, shown in 
Figure 4-4. From the FT-IR spectra, it could be observed the diminishing 
absorption peaks at 1865 and 1784 cm-1 which were contributions by the 
stretching of the C=O bonds of the anhydride. The absorbance peaks at 1577 
and 1733 cm-1 due to stretching of the C–O bonds of carboxylate were also 
found following reaction. It proved that PEG grafting process was 
successful. Note that PMAO is soluble in common organic solvents, such as 
CHCl3 and THF, and PEG is soluble both in THF and water. After the 
reaction, however, the product was no longer soluble in the solvents and 
precipitate from the reaction liquid. This further confirmed that the products 
were a new polymer formed grafting reaction.  
 




Figure 4-5. Schematic illustration of procedure for synthesizing Gd2O3  nanocluster with 
amphiphilic PMAO-g-PEG using nanoemulsion/solvent evaporation technique 
 
To obtain suitable platform for T1 contrast agents, we applied 
nanoemulsion/solvent evaporation technique to form Gd2O3 nanoclusters 
(GNCs).Figure 4-5 showed the schematic illustration of GNCs formation 
via this procedure. First, PMAO-g-PEG and Gd2O3 nanoplates with oleic 
acid surfactant were dissolved in chloroform. The obtained solution was 
then mixed with water using PVA as stabilizer. And then ultrasonication 
was applied at room temperate. Small oil droplets were formed as depicted 
in Figure 4-5, in which Gd2O3 nanoplates were surrounded with 
PMAO-g-PEG. As PMAO-g-PEG possessed hydrophobic backbone and 
many side chains in a brush-like structure, the copolymer could act as a very 
effective binding material for the nanoplates. Stable spheres of  
PMAO-g-PEG and Gd2O3 could be formed due to strong interdigitated 
hydrophobic interactions between the alkyl chains of PMAO-g-PEG  and 
oleic acid ligands of Gd2O3 nanoplates, as shown in Figure 4-5. 
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Overview of the obtained GNCs at low magnification SEM imaging was 
observed in Figure 4-6(a). The GNCs were spherical and uniform in size, 
i.e. 250 nm ± 15 nm estimated from measuring 100 particles.  It was also 
observed that that there was no individual Gd2O3 nanoparticles dispersed 
outside the nanoclusters. Figure 4-6(b) showed the TEM image of the 
obtained nanoclusters. Each cluster contained black dots insides, indicating 




Figure 4-6. (A) TEM images of GNCs at low magnifications; (B) single GNCs with a sphere 
outline and monodispersive nanoplate inside (C) high-resolution TEM  image of GNCs (inset: 
SAED ring patterns of GNCs). (D) EDX elemental analysis of GNCs.  
 
Additionally, Figure 4-6(c) showed a single naocluster under high 
magnification. The Gd2O3 nanoplates were seen as obvious dark spots 
embedded in the low contrast nanogel matrix. Dark spots with various and 
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clear outlines, such as plate shape, rod shape and round shape, could be 
ascribed to different orientations of the Gd2O3 nanoplates, confirming that 
the Gd2O3 nanoplates were randomly and evenly embedded in the nanogel 
without obvious aggregation. Figure 4-6(d) displayed a high resolution TEM 
image, which illustrated more details of the Gd2O3 nanoplates embedded in 
the nanogel matrix. Rod-shape shadow, corresponding to the side facet, 
exhibited lattice spacing of 0.31 nm which was similar to that of  Gd2O3 
(222). The Inset showed the selected area electron diffraction (SAED) pattern 
from which the diffraction rings were referenced to the characteristic lattice 
planes (222) (440) of Gd2O3.   
 
 
Figure 4-7. (a)-(d) TEM images of GNCs  prepared with (a) lowest concentration of  Gd2O3 (m 
= 2 mg) ), to (d) highest concentration of Gd2O3 (m = 8 mg), labelled as GNC-1 to GNC-4 
correspondingly.  All physical properties of GNC-1 to GNC-4 are recorded in Table 1.  Scale 
bar: 50 nm. 
 
By varying the amount of Gd2O3 added, the loading of Gd2O3 nanoplates in 
clusters could be well controlled. Four GNC samples with different Gd2O3 
loading amounts were thus prepared. The obtained samples were named as 
GNC-1, GNC-2,GNC-3 and GNC-4 in the order of increasing 
Gd2O3-loading, as shown in Figure 4-7(a), (b), (c) and (d), respectively. 
From the phase contrast image of Figure 4-7(a), round shape cluster in 
diameter of 207 nm contained several black dots was observed in the low 
magnitude TEM, same as shown in Figure 4-6(c). It confirmed that the 
prepared GNCs had a spherical shape and contain Gd2O3 nanoplates with an 
average size of about 10 nm ± 2 nm (estimated from measuring particles 
encapsulated inside), which were consistent with hydrophilic Gd2O3 
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nanoplates pre-described. Similar well-defined Gd2O3 cluster was observed 
when different concentrations of Gd2O3 were used, as shown in Figure 
4-7(b). Nanoplates had a heterogeneous distribution inside GNCs, which 
could contribute to the completely embedding of amphiphilic polymer 
during nanoemulsion process. As shown in Figure 4-7(c),(d), round sphere 
with uniform-distributed dark plates were likewise obtained for high 
concentrations of Gd2O3 with respect to 6 mg and 8 mg. Conclusively, a 
gradient change in Gd2O3 loading density was observed based on the 
increasement of dark spots’ number from Figure 4-7(a) to Figure 4-7(d).  
 
The precise Gd2O3 loading was obtained using TGA (see in Figure 4-8).The 
number of nanoplates within single cluster calculated by TGA clearly 
indicated that the Gd2O3 loading in GNCs increased as increasing amounts 
of Gd2O3 injected, which agreed well with TEM observation. (Gd2O3 
injection amount was shown in Table 4-1) 
 
Figure 4-8 TGA profiles of SPIONs and IONCs in increasing order of Gadolinium oxide 
composition from bottom to top. 
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Firstly, the average number of SPIONs in a sphere was estimated on the 
basis of Gd2O3 nanoplates loading obtained from TGA measurements. The 
densities of Gd2O3 and the polymer matrix were taken be 5.15 g·cm-3 and 
1.3 g·cm-3, respectively, as adopted from common online resources. n, the 
number of Gd2O3 nanoplates in single GNC, was calculated by the 
following deduction: 
Volume:                         ① 
 
Volume  of  each  plate:                                   
  ② 
 





                                                ④ 
 
  ⑤ 
                    ⑥ 
Parameters provided by observation: ρ is density, m is mass (from weight 
measurement), wt% is Gd2O3 loading (from TGA results), h is thickness 
Gd2O3 nanoplates, r1 is the radius of nanoplate (from TEM) and r2 is radius 
of each sphere respectively (from Zetasizer DLS) 
 
 




Figure 4-9 (a) VSM profiles of Gd2O3 nanoplate-loading GNCs in increasing order of 
magnetization from lowest to highest: GNC-1, GNC-2, GNC-3, GNC-4 (b) Plot of saturation 
magnetization against Gd2O3 nanoplate-loading. 
Moreover, from VSM data of, increasing of saturation magnetization was 
consistent with increasing order. The trend of increasing  maximum 
magnetization may be due to increasing proportion of paramagentic Gd2O3  
possess. And the liner fitting, shown in Figure 4-9(b), indicated intercept of 
100% loading (theoretical pure Gd2O3) should be 1.0036 emug-1 (at 5kOe), 
consisting with 1.01 emug-1 (at 5 kOe) of pure Gd2O3 nanorod reported by 
Das et al. [62] 
 
Table 4-1 Summary of the physical characteristics of GNC and hydrophobic Gd2O3 










Gd2O3 - - 10.3 - 
GNC-1 2 mg 9.0  199.5  90 
GNC-2 4 mg 27.9  203.1  1065 
GNC-3 6 mg 35.6  226.6  1598 
GNC-4 8 mg 44.5  251.3  2079 
Weight percentage of Gd2O3 in GNCs as determined using TGA. b Z-average size values measured using a Zetasizer 
DLS. c Number of Gd2O3 estimated values calculated basing on TGA  results (see support info).  
 
Table 4-1 recorded all physical characteristic parameters, i.e. loading 
percentage from TGA, Z-average size obtained by DLS and number of 
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Gd2O3 in a single GNC. Row one of Table 4-1 showed the hydrophilic  
Gd2O3  nanoplates diameter (10.3 nm) which used as the core of GNCs. 
Line of Z-average size demonstrate that the size of GNC proportionally 
increases from 199.5 nm of GNC-1 to 251.3 nm of GNC-4, indicating the 
present of Gd2O3 nanoplates encapsulated. The number of  Gd2O3 was 
calculated by formulation ⑥, which results were listed in last line of Table 
4-1. In volume formula deduction, all parameters were known except Gd2O3 
loading ( wt%from DLS data in Table 4-1), and calculated number (from  
90 of GNC-1 to 2079 of GNC-4) was proportional to the Gd2O3 loading. It 
concluded that we can facilely control the loading by changing the injection 
amount of Gd2O3 in such nanoemulsion process.  
 
Figure 4-10. (a) UV absorption of samples with the Ag-loaded polymers in different time intervals. 
(b) Comparisons between two loading of Ag, 0uL in black and 200uL in red respectively (c) 
Digital photos showed the colour changes as time increased.  
 
Water penetration properties were important factors that influenced the T1 
effect, and the PMAO-g-PEG polymer platform was testified before further 
used through the reduction reaction of a model organic dye, methylene blue 
(MB). PMAO-g-PEG grafted Ag nanocluster were prepared, in which Ag 
particles were well dispersed inside the polymer. As depicted, Ag 
nanoparticles can catalyze MB decompose in present of NaBH4 aqueous 
solution.[84, 85] This decompose highly rely on interaction between Ag 
surface and sodium borohydride solution.[86]. PMAO-g-PEG possesses 
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hydrophobic backbone and many hydrophilic side chains in a brush-like 
structure, greatly embedding and hindering water molecules. In Figure 4-10, 
color of polymer-coated Ag sample faded within 10 mins, much faster than 
control group with no Ag but only NaBH4 solution. It could be attributed to 
the incompact structure of PMAO-g-PEG based cluster allowed the solution 
to penetrate through and meanwhile hinders water`s brownian 
movement.[87] So such structure should be suitable for Gd2O3 contrast 
agent application by  increasing the interaction between water and Gd2O3 
nanoplates.  
 
To emphasize the advantage of this amphiphilic platform, we compared the 
r1 value of the GNCs with the hydrophilic Gd2O3 nanoparticles using 
traditional ligand exchange method. And, this method was selected since it 
was well received and facile.[88, 89] As mention in experiment section, the 
hydrophobic nanoplates were phase-transferred using CTAB as surfactant, 
which was named as HG. Pre-synthesized Gd2O3 nanoplates (HG) 
possessed well paramagnetic property, as VSM data shown in Figure 4-9(b). 
And the final product showed a well define of DLS plot, which hydrophilic 
diameter size was 20 nm. It seemed to reserve all qualities of Gd2O3 
nanoplates and was suitable for bioapplication. However, the r1 value of 
such Gd2O3 was only half of the commercial contrast agent Gd-DOTA, 
shown in Table 4-2. 
 
 




Figure 4-11. (a) Longitudinal relaxation rates (1/T1) of the GNC2, Gd-DOTA and HGs. (b) 
transverse relaxation rates (1/T2) of HGs, GNC2 and Gd-DOTA. 
MR studies of the GNCs(GNC-1, GNC-2, GNC-3 and GNC-4), 
gadolinium-tetraazacyclododecanetetraacetic acid (Gd-DOTA) and HGs 
were performed using a clinical magnet in order to investigate effect of 
controlled clustering of GNCs on magnetic relaxivity and their potential as 
MRI contrast agents. Typically, Figure 4-11(a) showed the longtitudinal 
relaxation rate against [Gd] for Gd-DOTA, HG, and GNC-2. Figure 4-11(b) 
showed the transverse relaxation rate against [Gd] for GNC-2, Gd-DOTA 
and HG. Both relaxation rates, 1/T1 and 1/ T2 exhibited linear relationships 
with respect to [Gd]. The slopes of the relaxation rate versus [Gd] lines 
were used to obtain the r2 and r1 relaxivities values. Gd-DOTA was 
measured to exhibit an r1 of 3.56 s-1mM-1[Gd], while the HG had an r1 of 
1.529 s-1mM-1[Gd]. Gd-DOTA was clearly more effective T1 contrast agent 
than the HG. This could be attributed to the greater solubility of chelate 
which were much smaller hydrodynamic diameter than the HG (3 nm 
compared to 10.3 nm). [41] Nevertheless, a greatly improved r1 of 7.948 
s-1mM-1[Gd] was achieved for GNC2. Samples solutions containing blank 
nanogel colloids were also prepared, tested and were found to have no 
effect on either r1 or r2 , which confirmed that the nanogel was 
non-magnetic.[84] Hence, these results proved that the relaxivity 
enhancement caused by GNCs was solely due to the clustering effect of 
Gd2O3, and it eventually improved the performance of  Gd2O3 comparing 
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to CTAB transfer method. 
 





r2/ s-1mM-1[Gd] r2/r1  
GNC-1 2.392 4.03 1.68 
GNC-2 7.948 8.29 1.04 
GNC-3 6.113 18.77 3.07 
GNC-4   5.797 55.40 9.56 
Gd-DOTA 3.560 4.75 1.33 
Gd2O3  1.529 50.17 32.81  
 
Table 4-2 recorded all r1, r2, and r2 / r1 results calculated from the slopes of 
the linear plots of relaxation rates (1/T1 and 1/T2, respectively) against 
gadolinium concentration [Gd]. All cluster samples (GNC-1 to GNC-4) and 
CTAB coated hydrophilic Gd2O3 nanoparticles (HG) were promising as r1 
effect can be achieved (r1 of 0.1 and 1.529 s-1mM-1[Gd], shown in Table 4-2 
respectively). However, HG was opt to aggregate, and some paper stated that 
aggregation largely hindered the MRI performance.[76] The unstable of the 
ligand on HG surface and aggregation was observed in such case as time goes 
by. Herein, we proposed the amphiphilic platform which can prevent further 
aggregation even in much long time. As depicted previously, 
water-penetrated PMAO-g-PEG platform fixed Gd2O3 nanoplates with 
distances. It could be a possibility factor for increasing r1 value. Water 
trapped within PMAO-g-PEG was cooperatively induced by multiply Gd2O3 
nanoplates and, as a result, accelerated it. Compared with the commercial 
contrast agent Gd-DOTA, all nanocluster samples showed better r1 values. 
Moreover, increasing r2 values, for instance, GNC-1 exhibited an r2 of 4.03 
s-1mM-1  [Gd], and GNC-4 exhibited an r2 of 55.4 s-1mM-1  [Gd], confirmed 
increasing loading of Gd2O3.  
Importantly, GNC-2 exhibited relatively high r1 values of 7.948 s-1mM-1 , 
2.23 times higher than Gd-DOTA（3.560 s-1mM-1）and the best r2/r1 ratios ( 
1.04 ),  which proved the validation of enhancement induced by 
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PMAO-g-PEG platform. However, GNC-3 and GNC-4 samples did not show 
further improvement of r1 even had more nanoplates than GNC-2 in a single 
sphere, seen in Table 4-1. On the contrary, as the loading per single GNC 
increased from 1065 to 2079, the r1 value slightly decreased from 7.948 
s-1mM-1 [Gd] to 5.797 s-1mM-1[Gd]. As predicted by Faucher et al., the 
formation of nanoparticle nanocluster would meet the saturation and further 
loading would suppressed the T1 effect of the Gd species.[76] 
  
 
Figure 4-12. MTT assay of NIH/3T3 cells‘ lines incubated with different amount of GNC-4 for 24h 
and the incubated with CCK-8 for differentiation.  
 
To validate GNC for biological applications, the in vitro cytotoxicity of the 
GNC-4 sample was conducted, as shown in Figure 4-12. We used GNC 
sample solution of 18 μM. No marked cell death or proliferation defects 
were observed with NIH-3T3 cell lines cultured in GNC. It showed that 
PMAO-g-PEG coated gadolinium oxide nanoplates are not toxic for the 
tested concentration range of Gd(III) ion. To further investigate the nanogel 
confinement, 24h dialysis procedure was applied. No further Gd species were 
detected in the dialysate solutions for all 1mM samples, e.g. GNC-1, GNC-2, 









Figure 4-13. (a) T 1 –weighted MR images (TR = 1600 ms, TE =40 ms) of various nanocluster 
samples for different Gd concentrations at 25 OC in a 3T magnet. It shows alginate phantoms 
doped with different concentrations of GNCs (b) T1–weighted MR images demonstrated the in 
vitro label of NIH-3T3 cells, the treated sample is cells incubated in the media with GNC-2 at 50 
μgml-1 for 2h. 
 
Figure 4-13 showed the T1-weighted MR images of nanoclusters samples, 
GNC-1, GNC-2, GNC-3 and GNC-4, respectively. All the samples exhibited 
T1 enhancement effects as seen by the observed reduction in signal intensities 
with respect to [Gd], which was evidence of improvement caused by 
PMAO-g-PEG coating. The GNC-2 showed much brighter than GNC-1 as 
loading increased, however, GNC-3 and GNC-4 performance were not as 
good as GNC-2, which agreed with the observations in Table 4-2. It was 
important to mention that all MRI images and relaxation parameters shown 
here were obtained with samples that were dialyzed for 24 h. These imply 
that nanogel could fix Gd species and reserve their qualities in a long time. 
Figure 4-13(b) showed NIH-3T3 cells T1-weighted MR image in agarose 
phantoms. The control blank cell samples without incubating with GNC 
exhibited little contrast different comparing with the pure agarose, which 
hardly can be seen. With strong T1 contrast GNC-2, labelled cell samples 
could be clearly indicated, and no obvious aggregation, was shown in images. 
It provided clear evidence for potential in vitro application, and paved path to 
the in vivo application. 
 




Figure 4-14. (a) DLS intensity-weighted size measurements of GNC-4 in millipore water, PBS 
and serum solution up to 10 days. The PBS consist of blue line (pH=4) and purple line (pH=10), 
respectively. (b) Relaxation rate (both 1/T1 and 1/T2) as a function of Gd3+ concentration [Gd] of 
GNC-4 before (×) and after (▽) being left standing in a 3T magnet for 24 h. T1 obtained using 
the CPMG spin-echo sequence T2 values were obtained using the CPMG spin-echo sequence 
(32 echoes; TE: 9.2 ms, TR: 3000 ms).  
 
Importantly, the stability of the aqueous suspension GNCs was monitored by 
dynamic light scattering(shown in Figure 4-14(a)). Preliminary studies 
showed that the GNCs exhibited excellent colloidal stability in both water 
and PBS, no obvious differential shown with wide range of pH value (similar 
curves shown in pH4 and  pH10) after 10 days of incubation at 37 °C.  The 
results obtained within 10 days were slight changed in size of 5% , 1% and  
6%, in pH4, pH7 and pH10 respectively. There was no observable 
aggregation of highest loading sample GNC-4  in  DLS  results after 10 
days, and final size was still around 250 nm, which was consistent with 
observation in TEM. And red line in Figure 4-14(a), GNC-4 dispersed in 
serum solution, showed little increase in size comparing to other conditions, 
which may due to scatter of the surrounding proteins.  
These can be deduced that PMAO-g-PEG served as a good bio-compatible 
platform within wide range of bio environment Another simple test was 
performed to test the colloidal stability by leaving the sample solutions to 
stand inside a MRI clinical magnet. At first, T2 measurements were acquired, 
followed by leaving the samples to stand in the magnet for 24h, and acquired 
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a second set of MRI measurements. Figure 4-14(b) showed relaxation rate 
(both 1/T1 and 1/T2) as a function of Gd3+ concentration [Gd] of GNC-4 at 0 h 
and 24h. The gradient represented the magnetic relaxivity (r1) of water 
remained nearly unchanged after the 24 hour period. Moreover, r2 was 
observed to slightly increase after 24h treatment for all GNC samples in the 
magnet. This implied that there was no appreciable agglomeration of the 
GNCs in solution, because agglomeration would result in a significant 
decrease in r1 relaxation behaviors. Therefore, GNC was one of the best 
candidates as bio friendly platforms.  
 
Figure 4-15. Schematic diagram showing that (a) four surface Gd(III) ions as an example 
cooperatively induce the longitudinal relaxation of the water proton, whereas (b) such an effect 
does not exist in individual Gd(III)chelates. The interacting and non-interacting Gd(III) ions with a 
water proton are denoted as dotted and solid arrows for their spins, respectively. The ligands are 
drawn arbitrarily. 
 
T1 effect consisted of three parts: inner sphere, second sphere and 
outersphere.[59] Outersphere-proton-relaxation enhancement, due to protons 
diffusing past the agent, was most often described by translational diffusion. 
According to rigid-sphere model, the translational modulated outersphere 
diffusion contribution. The amphiphilic copolymer structure did hinder the 
diffusion of the water, which resulted in higher outsphere-proton-relaxation 
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enhancement. On the other hand, the formation of aggregations appeared to 
effectively suppress the T1 effect of Gd species. Such observation was 
consistent with results reported by Roch et al., whereby there was observed 
flattening of NMR dispersion profiles with agglomeration.[90] It is 
necessary to fix Gd contrast agent space location utilizing soft nanogel 
matrix. One possibility factor for increasing r1 value was longitudinal 
relaxation of water proton bonded with PMAO-g-PEG. This was 
schematically shown in Figure 4-15, where water with red hydrogen bond 
with carboxyl group of PMAO-g-PEG stayed in out sphere region (highlight 
in green color). The PMAO-g-PEG possessed hydrophobic backbone and 
many hydrophilic side chains in a brush-like structure, embedding large 
amount of water molecules. As hydrodynamic theory assumed that one 
layer of solvent sticks to the surface of the solute as the solute rotated. The 
exchangeable protons occasionally bonding with carboxyl group 
surrounding Gd2O3 should stick and form a thin water layer under out 
sphere model. Therefore, it was reasonable to hypothesize that “stick” 
protons may account for part of the so-called “outer-sphere” relaxation and 
potentially may confer significant relaxation to the solvent protons.  As 
effective distant within 5nm digging from surface Gd(III) ions still interact 
with water, reported in a paper using Gd3+ doped RE oxide-matrix for MRI 
and upconversion application, the plate shape with the thickness less than 
10 nm would do great benefit to completely utilize all Gd(III) ions. 
4.4 Summary and conclusion 
 
In summary, we demonstrated a facile method for fabricating nanocluster of 
Gd2O3 with enhanced T1 effect. It was found that such protection not only 
help the Gd2O3 broader the application in wide pH range, but also avoid 
further aggregation. A relationship was demonstrated to exist between 
 
Chapter  4  Controlled  loading  of  Gd2O3  nanoparticles  in  nanogels 
114 
 
loading and r1 per single cluster  as derived from experimental data. The 
GNCs possessed high r1 values (up to 7.948 s-1Mm-1 [Gd]) and low r2/r1 (up 
to 1.04). For all of the Gd loadings, polymer nanogel plateform materials 
provided higher longitudinal relaxometric parameters than the 
monodispersed individual Gd2O3 and, consequently, could be more effective 
as contrast agents than Gd2O3-based counterparts. In vitro tests were 
demonstrated in NIH-3T3 cell lines, and clear T1-weight images were 
obtained. Thus, the POMA-g-PEG assisted GNCs were potentially useful 
for magnetic-guided and magnetic-assisted delivery systems. This 
investigation suggested a key technological design that can be applied for 
enhancing T1 relaxivities to current MRI contrast agents.  
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5 Controlled Mn-doped ZnS nanoparticles with the high 
luminescent properties 
5.1 Introduction 
The design of hybrid nanomaterials with specific properties, such as 
fluorescence and magnetism, is desirable in clinical/biomedical 
applications.[1-3,81] In particular, magnetic resonance imaging (MRI) has 
become one of the most important non-invasive imaging tools for obtaining 
3D images of soft tissues with high spatial resolution. However, the low 
sensitivity of MRI requires the synthesis of contrast enhancement agents 
with high proton relaxivity, which often involves the use of gadolinium (Gd, 
paramagnetic), iron oxide (ferromagnetic/superparamagnetic) and 
manganese (Mn, paramagnetic) nanoparticles. Paramagnetic ion-doped 
semiconductors or diluted magnetic semiconductors have attracted 
significant attention recently. Doping enhances the properties of 
semiconductors by providing a powerful method to control their optical, 
electronic, spintronic and magnetic properties.[82-84] For example, 
Mn-doped ZnS nanorods are synthesised using a solvothermal method, 
whereas Mn-doped ZnSe nanowires are prepared using a single-source 
precursor method. However, the synthesis of high-quality Mn-doped ZnS 
with finely tuned and uniform diameters, high quantum yields and a good r1 
value in MRI imaging remains challenging. 
5.2 Literature review 
The first contrast agent for MRI was based on Mn2+. With the administration 
of manganese salts, Lauterbur et al.[82] observed a T1 enhancement, 
particularly in the liver, kidney, and heart.[83] Mn2+ is dominated by a 
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dipole-dipole contribution to the T1.[84] 
 
At the same time, fluorescence technology allows for high speed 
bio-imaging with sensitivity at the cellular level, which can complement the 
low sensitivity of the MRI technique. Quantum dots have been widely used 
as fluorescent agents over the last two decades. However, quantum dots are 
not suitable for widespread applications because they often contain Cd, a 
heavy metal, which makes them highly toxic.[85] In recent years, high 
quality doped semiconductor nanocrystals have been explored as viable 
alternatives to undoped nanocrystals. These materials exhibit additional 
advantages such as larger Stokes shift to avoid self-absorption, enhanced 
thermal and environmental stabilities, and reduced toxicity. Mn-doped ZnS 
(ZnS:Mn) semiconductors are promising candidates as substitutes for 
Cd-based QDs.[86] Moreover, they contain Mn2+, which may be beneficial 
for in vivo disease diagnosis and in vitro monitoring of living cells via the 
combination of magnetic and fluorescent imaging techniques in a single 
system. However, these compounds exhibit low solubility in water and their 
surface modification is often very challenging because the nanoparticles are 
synthesised by a thermal decomposition process in a non-polar solvent[87]. 
Traditional phase transfer methods such as ligand exchange and silica 
coating can significantly reduce or shift the emission of the semiconductor, 
making the entire synthetic procedure too complicated for the lab 
environment. [88] 
 
Carbon-based hybrid systems such as carbon nanotubes with various 
nanoparticles are being widely examined in biological applications because 
of their interesting thermal and electrical properties, as well as their ability to 
cross the cell membrane. [80] Graphene oxide (GO) is a fairly new graphene 
system based on a 2D carbon honeycomb lattice whose backbone is 
decorated with numerous functional groups. These functional groups make 
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GO an excellent platform for attachment to the nanoparticles. The large 
surface area and the non-covalent interactions between amine groups make 
GO an excellent system for biomolecular applications and drug attachment. 
[11] Hitherto, studies have demonstrated the synthesis of nanocomposites 
based on semiconductors and GO, including GO-TiO2, GO-CdTe, GO-CdS, 
GO-AIZS. [89-91] Thus, it is possible to use the GO-assisted method to 
transfer ZnS:Mn particles into an aqueous medium. To the best of our 
knowledge, there are only a few reports in the literature on the use of 
ZnS:Mn and GO-based composites for dual functionality imaging 
applications. 
 
Herein, we report the successful synthesis of nano-sized fluorescent T1 
contrast agent nanocomposites consisting of ZnS:Mn nanoparticles and GO 
(ZMGO) for clinical imaging. Without any surface modification, the 
as-prepared hydrophobic ZnS:Mn nanoparticles can be conveniently 
attached on the olecylamine-modified GO sheets. The synthetic strategy for 
preparing the nanocomposite is illustrated in section 5.4. The detailed 
experimental procedures are described in the experimental section. In this 
study, the emission colours of ZMGO can be easily tuned by changing the 
amount of Mn added to the ZnS. In this manner, nanocomposites with blue, 
white and red colours were prepared. In comparison with other phase transfer 
methods such as ligand exchange, which usually leads to significant 
cytotoxicity, the method used herein is more biocompatible due the presence 
of hydrophobic-hydrophobic interaction between the GO sheets and the 
ZnS:Mn nanoparticles.[13] The emission of the nanocomposites exhibits no 
obvious shifts in wavelength, whereas the PL intensity remains strong even 
after hybridisation. The PL intensity values are comparable to those reported 
for colloidal ZnS:Mn QY (18%) [14]. Although the negatively charged 
groups on GO cause instability in phosphate-buffered saline (PBS) solutions, 
PEGylation using EDC/NHS chemistry can improve the colloidal stability. 
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In this study, the PEGylated ZMGO nanocomposites exhibit low cytotoxicity 
and successful cell up-take and can be imaged using the NIH/3T3 cell line as 
a model. 
5.3 Experiments  
Synthesis of nano-sized Graphene Oxide (nano-GO) and surface modification 
Nano-GO was synthesized using modified Hammers’ method.[15] 
Typically, 0.5g graphite (2~15 µm), 0.5 g NaNO3, and H2SO4 were mixed 
together in ice bath, while KMnO4 were added slowly into the mixture. The 
obtained green sticky mixture was left stirring for one hour before it was 
heated up to 35ºC for overnight. Approximately 20 mL of H2O was added 
drop wisely, much heat generated and another 100 mL H2O was added after it 
become stable. After 12 hours, 3 mL H2O2 were added drop by drop into the 
brown solution. The finally product was washed with 4% HCl and DI-H2O 
repeatedly until the solution reaches almost neutral. The obtained graphite 
oxide (nano-GO) solution was ultrasonicated for 2 hours at 20GHz (130W), 
followed by centrifugation at 10000rpm for 30 minutes to remove the 
precipitate which contained large GO sheets. 
To prepare oleylamine modified GO nanosheets (OAM-nGO), the nano-GO 
solution (containing ~250 mg GO) was dried and then sonicated with 30 mL 
oleylamine and 50 mL hexane for 1 hour. Centrifugation was allowed to 
remove the unreacted GO and other precipitates. A black homogenous 
suspension of OAM-nGO (~50mg/mL) was obtained by redissolved in 5mL 
chloroform. 
 
Synthesis of Mn doped ZnS nanoparticles (ZnS:Mn) 
The ZnS nanoparticles were synthesized according to Srivastava et al. 
report.[8] Typically, to synthesize ZnS:Mn nanoparticles with red emission, 
62mg Zinc stearate, 6mg Manganese stearate, 680mg Octadecylamine 
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(ODA), and 10 mL of 1-octandecene (ODE) were loaded into a three-neck 
flask. The mixture was then heated to 70ºC and 9mg sulfur dissolved in 
oleylamine (OM) was injected at this point. Then the flask was heated to 270 
ºC in the 40 ºC/min heating rate. 312mg zinc stearate dissolved in 700 µL 
oleic acid (OA) and 400µL OM was injected and remained for 15 min. Then 
the mixture was quenching to 200ºC quickly, followed by annealing at this 
temperature for 60 minutes. The mixture was then cool down to room 
temperature. The product was collected by adding ethanol and 
centrifugation. The collected ZnS nanoparticles were then dispersed in 
toluene and washed with ethanol repeatedly for purification. The final 
product can be dispersed in chloroform. As suggested by the reference, the 
emission colors of the ZnS nanoparticles can be easily tuned by adjusting the 
injection manganese source. In this study, the ZnS nanoparticles with 
emission from blue to orange-yellow were prepared by changing the 
injection of 1mg, 4mg and 16mg Manganese stearate respectively.  
 
Assemble ZnS:Mn nanoparticles on OAM-nGO sheets (ZMGO) 
To synthesize ZMGO nanocomposites, the ZnS nanoparticles have to be 
dispersed in chloroform first. The OAM-nGO sheets were allowed to wash 
once to remove extra oleylamine by adding 2 times excess volume of 
ethanol. Approximately 50mg OAM-nGO sheets and 50µL of the ZnS 
suspension was mixed by 5 min bath sonication. 10 times volume of DI-H2O 
was then added into the mixture and ultrasonication was carried out to form 
stable turbid suspension. The suspension was then heated to 60ºC for 30 
minutes to evaporate all chloroform. During the heating process, the turbid 
solution gradually turned into transparent, indicating the successful 
assembly of the ZnS nanoparticles on the nano-GO sheets. As for sample 
ZMGO1, ZMGO2, and ZMGO3, different amount of ZnS nanoparticles was 
used. We also found that elongated sonication time could lead to smaller 
average size of ZMGO.  
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The values of the fluorescence quantum yield (QY) were determined by 
comparing of the integrated fluorescence intensity over the absorbance of 
sample’s solutions with that of a standard organic fluorescent dye 
(Fluorescein in H2O, QY95%, Rhodamine B and Rhodamine 101 in ethanol, 
QY100%). The absorbance of all solutions was below 0.1 at the excitation 
wavelength (300 nm). Four different concentrations for each sample were 
tested for determining the QY. 
 
PEGylation of ZnS:Mn decorated nano-GO sheets (ZMGO-PEG) 
Before the colloidal stability, cytotoxicity and cell imaging tests, the ZMGO 
nanocomposites were conjugated with PEG. Typically, to synthesized red 
emitting ZMGO-PEG nanocomposites, 5mL (~10mg ZMGO) was mixed 
with 10mL aqueous solution of PEG containing 270 mg methoxyl PEG 
amine (mPEG-NH2, MW2000)by bath sonication. 500μL EDC (20mg) 
aqueous solution and 500 µL NHS(16mg) aqueous solution was added 
subsequently. This mixture was then left stirring for over 24 hours to 
complete the conjugation. The final product was allowed to be dialyzed to 
remove the unreacted PEG, NHS and EDC and byproducts. The ZMGO-PEG 
nanocomposites were dispersed in DI-H2O and phosphate buffered saline 
(PBS 1×, pH 7.4) solutions for colloidal stability tests. 
 
in vitro cytotoxicity of ZMGO-PEG on NIH/3T3 fibroblast cells 
To assess the cytotoxic effect of the final product ZMGO-PEG 
nanocomposites, in vivo cell viability tests were performed by incubating 
NIH/3T3 cells with the nanocomposites at different concentrations for 24 
hours using a CCK-8 assay. NIH/3T3 fibroblast cells were grown in DMEM 
(Dulbecco’s Modified Eagle Medium) culture growth medium (10% bovine 
calf serum) at 37 ºC in a 5% CO2 humidified environment. The cells were 
then transferred to 96-well cell culture plate (TPP 96) at an identical 
concentration of 7.5×104 cells·mL-1 (0.1 mL). These cells were allowed to be 
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incubated overnight at the same conditions before the injection of the 
ZMGO-PEG nanocomposites. Following the incubation, 20 µL of the 
nanocomposites at different concentrations (from 100µg/mL to 1 µg/mL) 
was added into each well. After that, the cells were incubated at 37 ºC in a 
5% CO2 environment for 24 hours. Before the cell viability test, 10 µL cell 
counting kit-8 (CCK-8) was added into the culture media, followed by 4 
hours incubation in the same environment. Absorbance readings were 
analyzed spectrophotometrically at 355 nm using a FluoStar Optima 
microplate reader. 
 
in vitro cellular imaging of ZMGO-PEG on NIH/3T3 cells 
To demonstrate the cellular imaging application of the ZMGO 
nanocomposites, NIH/3T3 fibroblast cells were chosen as a model. The cells 
were grown in DMEM culture growth medium at 37 ºC in a 5% CO2 
humidified environment. The cells were then transferred to 8-well cell 
culture plate at an identical concentration 2.5×104 cells·mL-1 (0.8 mL). The 
estimated number of cells in each well was approximately 2.0×104 cells per 
well. These cells were cultivated at the same conditions for 24 hours. 
Subsequently 10 µL of the ZMGO-PEG nanocomposites with different 
concentrations were added into desired wells, followed by another 24 hours 
incubation at 37 ºC in a 5% CO2 condition. Following the incubation, the cell 
cultures were rinsed 2 times to remove dead cells and extra nanocomposites. 
The cellular imaging was carried out using a scanning confocal microscope 
(LSCM, Leica, TCS SP5, Germany).. The samples were illuminated with 
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5.4 Results and Discussion 
 
Figure 5-1 schematic illustration of ZMGO nanocomposite synthesis process 
 
The nano-sized graphene oxide (nano GO) particles were synthesised using 
Hummers’ method with some modification. During the synthesis of 
nano-GO, graphite becomes oxidised, and the bonds between carbon atoms 
became broken. To guarantee that the graphite powder was fully oxidised, 
the solution was allowed to stir at 35 ºC for over 24 hours after the addition of 
H2SO4 and HNO3. Subsequently, H2O was added to penetrate the oxidised 
graphite layers and form oxygenated groups such as epoxy, hydroxyl and 
carboxylic acid, as well as to increase the distance between the layers. [16] 
Moreover, longer ultrasonication times can be used to allow graphite oxide 
to be broken into smaller pieces. To ensure that the final product was 
nano-sized GO, the sample was centrifuged at 10000 rpm for 30 minutes. 
The supernatant was then collected and dried in an oven.  
 




Figure 5-2 A) AFM image of obtained nano-GO B) Cross-sectional analysis of the 
corresponding AFM (insert: XRD pattern of nano-GO)  
Figure 5 2 showed the physical properties of the obtained nano-GO including 
AFM and XRD results. The resulting nano-GO sheets were approximately 
160 nm in size, as can be observed in Figure 5-2(a). The small size could be 
attributed to the extended oxidisation and ultrasonication steps. The inset of 
Figure 5-2(b) provided the XRD pattern of the corresponding nano-GO. The 
sharp peak appearing at 10.2º corresponded to the (001) reflection of 
graphene oxide[16], indicating that the spacing between sheets was 0.865 nm 
due to the presence of oxygenated groups on the surface of GO.  
 
Figure 5-3 Wide scan XPS spectra of (A) GO and (B) OMA-nGO. (C) Convoluted C(1s) XPS 
spectra of GO and (D)Convoluted C(1s) XPS spectra of OMA-nGO 
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The obtained nano-GO samples were also characterised by X-ray 
photoelectron spectroscopy (XPS), as shown in Figure 5-3. There were 
distinct peaks for C-O (286.8 eV) and C=O (288.1 eV) bonds in addition to 
peaks for the C-C bond (284.5 eV), suggesting that the graphite powder had 
been sufficiently oxidised to graphene oxide (GO). In the wide-scan spectra 
of olecylamine-modified GO (OAM-nGO), N (1s)-bonding was observed, 
which confirmed the presence of amine groups from oleylamine. The 
presence of –OH (~3400 cm-1), C=O (~1700 cm-1) and C=C (~1600 cm-1) 
functional groups on GO were also observed in the FT-IR spectra shown in 
Figure 5-4.  
 
Figure 5-4 FT-IR spectra of (a) nano-GO (b) oleylamine modified nano-GO and (c) OMA-g-GO 
with ZnS:Mn loadings. 
A comparison between Figures 5 3(c) and (d) suggested that the C-O bond of 
the OMA-nGO was significantly reduced upon conjugation with oleylamine. 
These results indicated that bonding may occur between the epoxy groups 
and the amines, which suppressed the hydrophilic functional group.[17] The 
FT-IR spectrum of OAM-nGO revealed two peaks at ~2855 cm-1 and ~2920 
cm-1 that were associated with the C-H stretch from oleylamine. These peaks 
may also be attributed to the ring opening of the epoxy group (C-O-C), 
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leading to the covalent bonding between the C from GO and the N from 
oleylamine (C-N bond).  
 
Figure 5-5 TEM of ZnS nanoparticles (a) low magnification image of pure ZnS, inset: SAED 
pattern of the ZnS; (b) high magnification image of the ZnS with the clear crystal lattices; (c)-(d) 
Mn doped ZnS nanoparticles exhibiting different emissions: (c) blue emission with 0 wt% Mn; (d) 
white emission with 0.06 wt% Mn; (e) red emission with 0.16 wt% Mn. 
Mn-doped ZnS (ZnS:Mn) nanoparticles  
The ZnS:Mn nanoparticles with three different emission colours were 
successfully prepared via Srivastava’s method.[8] The emission colours can 
be conveniently tuned by adjusting the manganese doping concentration.[18] 
The TEM images of Figure 5 5 showed ZnS:Mn nanoparticles with blue, 
white and red emissions afforded by three different doping concentrations. 
The average diameter of the nanoparticles with three different emissions was 
approximately 5 nm. The as-prepared ZnS:Mn nanoparticles were covered 
with hydrophobic ligands, as confirmed by FT-IR spectra (Figure 5 4). The 
TGA showed that the surface surfactants comprise approximately 47% of the 
total weight of the obtained ZnS:Mn nanoparticles. After washing 
thoroughly with ethanol, the ZnS:Mn nanoparticles were stored in 
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chloroform until further decoration with OAM-nGO nanosheets. 
 
 
Figure 5-6 optical properties of Mn:ZnS prepared using three different doping concentrations, 
e.g., (a) 0 wt% Mn, (b) 0.06 wt% Mn and (c) 0.16 wt% Mn, respectively. The corresponding EDS 
results for (d)-(f) are provided on the right. Inset: Relative distributions of Zn, S and Mn elements 
 
Photoluminescence studies were first performed on pure ZnS (ZnS:0.00Mn2+, 
labelled as S1), as well as on low-Mn-doped ZnS (ZnS:0.06Mn2+, labelled as 
S2) and high-Mn-doped ZnS (ZnS:0.16Mn2+, labelled as S3) nanocrystals.  
 
A comparison of the emission spectra of S1 and S2 in Figure 5-6(a)and(b), 
which were recorded by monitoring the excitation at 300 nm, revealed that S1 
exhibited an intense broad band at 438 nm, which was at a longer wavelength 
(lower energy) than the S1 ZnS band gap emission process (׽335 nm). This 
red-shifted emission was due to the self-activated centre formed between the 
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When Mn2+ dopants were incorporated into the ZnS nanocrystals, the 
characteristic 4T1-6A1 emission (~600 nm) of Mn2+ ions was expected via the 
efficient energy transfer from ZnS host to the Mn2+ ions. This effect is due to 
the strong coupling between the 3d5 electrons of Mn2+ ions and the s-p 
electrons of the ZnS host.  
 
Indeed, the emission bands centred at 438 nm (blue) and 600 nm (orange-red) 
corresponded to the ZnS band-gap emission and the Mn2+ dopants, 
respectively. A slight blue-shift of the Mn2+ doping indicated that energy 
transfer occurred from the photoexcited ZnS to the Mn2+ ion.  
 
Moreover, no additional d-d excitation transitions between the 6A1 ground 
state and the 3d5 configurations were observed in the longer wavelength 
region. Because the energy transition between the ZnS host to the Mn2+ ion 
was so convenient, the intensity of the two emission peaks can be adjusted by 
varying the doping level.  
 
Figure 5-6(d)-(f) provided the relative emission intensities obtained by varying 
the concentration of the Mn2+ dopants in ZnS:Mn nanoparticles, confirming 
the tenability of the overall colour output. EDS results were also provided 
(insets at the upper right corner of Figure 5-6), which identified the 
concentration of Mn2+ dopants.  
 




Figure 5-7 A) AFM image of as-synthesized ZMGO nanocomposites. B) High magnification of a 
ZMGO sample imaged by AFM. C) TEM image at the same scale. D) Cross-sectional analysis 
of the corresponding ZMGO. E) TEM image at a low magnification. F) High-resolution of ZMGO 
nanocomposite (insets: photograph of ZnS nanoparticles and ZMGO nanocomposites under 
nature light (left) and under UV lamp irradiation (right).  
 
Water-soluble ZnS:Mn-nGO (ZMGO) nanocomposites 
The ZMGO nanocomposites can be conveniently prepared using the 
nano-emulsion procedure introduced by Erwin et al. The OAM-nGO provided 
partial hydrophobicity when suspended in chloroform. At the same time, the 
ZnS:Mn nanoparticles were also hydrophobic because they were covered by 
non-polar oleic acid/oleylamine surfactants. Therefore, during the 
ultrasonicated-emulsion, small droplets containing chloroform, ZnS:Mn 
nanoparticles and OAM-nGO were formed and became stabilised. When the 
chloroform was evaporated in the presence of heat, the ZnS:Mn nanoparticles 
interacted with OAM-nGO via Van der Waals force between the hydrophobic 
 




The ZnS:Mn nanoparticles were gradually pushed towards the OAM-nGO by 
the water-chloroform interface, and eventually became interdigitated with the 
hydrophobic chains of OAM-nGO. To investigate the morphology of the 
water-soluble ZMGO composites, AFM images and TEM of the 
corresponding ZMGO nanoparticles were performed. The results were 
provided in Figure 5-7, wherein the insets clearly showed that the red-emitting 
ZnS:Mn nanoparticles were successfully transferred from the non-polar 
organic solution to the aqueous solution with the help of OAM-nGO. In 
comparison with the original red emitting ZnS nanoparticles solution, the 
ZMGO aqueous solution appeared darker under natural light conditions. This 
effect may be due to the existence of black nano-GO in solution. Meanwhile, 
the right side of the photograph displayed the samples under UV irradiation.  
A decrease in the intensity of ZMGO was observed because the presence of 
nano-GO also can lead to electron leakage, which will be discussed later. 
Moreover, Figure 5-7 showed that the obtained ZMGO nanocomposites were 
well-dispersed in water, as no aggregation was observed. Furthermore, the 
ZMGO nanoparticles were no larger than 200 nm in Figure 5-7A. The DLS 
measurement provided consistent results, revealing a Z-average size of ~183 
nm. A single representative ZMGO nanocomposite was shown in Figure 5-7(B) 
(AFM) and Figure 5-7(C) (TEM) on the same scale. The single layer assembly 
of ZnS:Mn nanoparticles can be clearly observed in the image, whereas the 
GO was difficult to see because of its low contrast. Therefore, an AFM cross 
sectional analysis (shown in Figure 5-7 D) of the ZMGO nanocomposites was 
employed to further verify the dimensions of the nanocomposites. The 
thickness of the nanocomposite was approximately 1-2 nm thicker than the 
diameter of the ZnS:Mn nanoparticles, which confirmed the presence of the 
n-GO substrate. The TEM image in Figure 5-7(E) appeared to be consistent 
with the AFM image. Well-dispersed ZnS:Mn nanoparticles can be clearly 
observed in each GO nanosheet. The high resolution TEM image (shown in 
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Figure 5-7 F) also revealed that ZnS:Mn nanoparticles were approximately 6 
nm in diameter and well-aligned with the sheet.  
A lattice pattern of 0.54 nm was identified as ZnS (111) and can be clearly 
observed at high magnification. These results also confirmed that the assembly 
of nanoparticles was single-layered without any overlap or agglomeration. 
 
 
Figure 5-8 TEM images of samples T-2, T-3, T-4 and T-5 (with increasing loading of ZnS 
nanoparticles) (insets: the corresponding DLS measurements). 
 
To optimise the ZMGO nanoparticles assembly and obtain high quality images, 
different emission wavelengths and a variety of loadings should be considered. 
The composition with the highest quantum yield (QY) should be selected, as 
the hydrophobic-hydrophilic transfer will largely quench the emission. Herein, 
the photoluminescence of ZnS:Mn nanoparticles with three distinct colours 
was compared in Figure 5-6. Their basic characteristics such as the mass ratio, 
hydrodynamic size, and quantum yield (QY) were provided in Table 5-1. The 
data revealed that the nanocomposites with red emission exhibited the highest 
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QY as discussed in our previous reports.[14] However, the QY of 16.2% in 
water was still relatively low among semiconductors for cell labelling. A 
further increase in the QY can be afforded by increasing the ZnS:Mn loading.  
Thus, red-emitting ZMGO samples with six different mass ratios of ZnS:Mn 
nanoparticles to nano-GO were prepared as shown in Figure 5-9 and were 
labelled as T1, T2, T3, T4, T5 and T6 (mass ratio: 0.05:1, 0.1:1, 0.2:1, 2.5:1, 
5:1 and 10:1, respectively), according to increasing order of ZnS:Mn loading.  
 
An increase in the amount of ZnS loading per sheet was successfully achieved 
according to the TEM images in Figure 5-8. In addition, no obvious 
aggregation was observed at a low magnification. Moreover, at room 
temperature, the Z-average size was still 150 nm, and this value remained the 
same as the loading increased from 0.05:1 to 5:1, as shown in Figure 5-9(B). 
These results can be explained by the fact that the surface and structure of the 
ZnS nanoparticles were not deteriorated during the assembly.  
 
As specified in the experimental, the entire nanocomposites fabrication 
procedure only involved a short time sonication time and a 60ºC heating 
process, which may not provide sufficient energy to change the structure. Only 
the size of the T6 composites exhibited a significant increase to 378.9 nm 
when the loading ratio reached 10:1. These results suggested that the 
saturation of particle loading was achieved, beyond which agglomeration 
would happen. To preserve the small size of particles for bio application, T5 
was selected as the most suitable composite for further investigation. 
 
 




Figure 5-9 (A) Photograph of red emitting ZMGO nanocomposites aqueous suspension under 
nature lighting (up) and UV lamp irradiation (bottom) conditions. T1-T6 samples contain an 
increasing loading of ZnS:Mn. T1 exhibits the lowest emission intensity, whereasT5 has the 
brightest emission. (B) The DLS results of T1-T6 samples suspended in DI-H2O reveal a 
significant size increase (aggregation) for T6. 
 
The excitation behaviours of ZnS:Mn nanoparticles and ZMGO 
nanocomposites were very similar. As shown in Table 1, the emission peak 
exhibited a negligible shift upon incorporation of ZnS nanoparticles inside 
the GO sheets, which was different from other phase transfer methods such 
as ligand exchange and silica coating. [9] In contrast, the QY of the ZMGO 
nanocomposites exhibited a relatively acceptable decrease compared with 
the original hydrophobic ZnS nanoparticles (from 33.4% to 18.5%).  
Table 5-1 Physical characteristics of ZnS and ZMGO nanocomposites 
      
However, as digital photographs of these samples under natural lighting (top 
photograph) and UV lamp irradiation (bottom photograph) conditions 
demonstrated, the emission of all hydrophilic samples was not sufficiently 
strong. Accordingly, in Figure 5-9(A), a lower ZnS loading resulted in a darker 
transparent solution, due to an increase in the OAM-nGO ratio. The emission 
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intensity of these materials demonstrated a decreasing trend under UV lamp 
irradiation, especially for T1. As a result, all photoluminescence spectra 
exhibited a significant decrease compared with the hydrophobic ZnS, whereas 
the excitation spectra and emission peaks remained at the original wavelength 
(data not shown). The same findings were observed previous reports, wherein 
the photoluminescence of the semiconductors became considerably quenched 
by GO due to fluorescence resonant energy transfer (FRET) [19, 20]. The PL 




Figure 5-10 A) colloidal stability of ZMGO nanocomposites measured at 25°C and 37ºC in 
DI-H2O and PBS solution respectively. B) TEM image of ZMGO-PEG nanocomposites 
dispersed in DI-H2O. (inset: single nanosheet with ZnS:Mn loading) 
 
In order to be used for biomedical applications, the colloidal stability should 
be considered. As known that the negative charged oxygenated groups, such 
as –OH and –COOH on GO, was easily disturbed and screened by the sudden 
change to the ionic condition.[11] To improve the stability of the 
nanocomposites in ionic solution, polyethylene glycol (PEG) was necessary 
to be grafted to the nanocomposites. PEG-modification also prevented 
nanocomposites from protein absorption in the physiological 
environment.[21] The Red emitting ZMGO (red emission) nanocomposites 
were chosen as a model for the PEGylation. The conjugation was carried out 
by applying NHS/EDC chemistry. FT-IR characterization confirmed the 
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successful conjugation of mPEG–NH2 by comparing the transmittances from 
samples ZMGO and ZMGO-PEG.  
 
After the conjugation, the colloidal stability of the nanocomposites was 
recorded by using DLS in Figure 5-10(A). The measurements were 
performed in both DI-H2O and phosphate buffered saline (PBS 1×, pH 7.4) 
solution. The Z-average size of the sample ZMGO-PEG in DI-H2O increased 
to approximately 130 nm, which was slightly bigger than that before the 
PEGylation(~110 nm). The following DLS results showed that the Z-average 
size of the nanocomposites had no further change in DI-H2O at both 25 ºC 
and 37 ºC throughout the 50 hours monitoring. The corresponding TEM 
image (shown in Figure 5-10(B)) also verified that the ZMGO-PEG 
nanocomposites had no aggregation or change in ZnS loading. Hence it was 
implied that the size increment was not due to the aggregation but the PEG 
conjugation.  
 
The stability of the ZMGO-PEG nanocomposites in PBS 1×solution was also 
measured by DLS. This was probably because of slight aggregation induced 
by the interaction between the remnants of oxygenated groups and the ions in 
the PBS solution. At temperature 25 ºC, the Z-average size reached 
approximately 170 nm quickly and thereafter maintained at that size. At 37 
ºC, the stable Z-average size was approximately 5 nm larger than at 25 ºC, 
which was about 175 nm. 
 




Figure 5-11 A) Dose-dependent viability evaluation of NIH/3T3 cells treated with ZMGO-PEG 
with different ZnS loading B) Dark field image of the NIH/3T3 cells tagged with red emitting 
ZMGO-PEG nanocomposite C) Fluorescent image of corresponding cells D) Combined image 
of single cell with the red emission under UV excitation.  
 
The in vitro cellular imaging was also performed on the NIH/3T3 cell lines. 
The red emitting ZMGO-PEG nanocomposites were chosen as the labelling 
agents to demonstrate the cellular imaging. Dose-dependent viability 
evaluation of NIH/3T3 cells in Figure 5-11(A) showed that the cytotoxicity 
of the ZMGO-PEG was very low.The feasibility of using these 
nanocomposites to stain cells was measured with a confocal laser scanning 
microscope (CLSM) with a laser source at UV region. Figure 5-11(B)-(D) 
showed the CLSM images of the NIH/3T3 cells after incubation with red 
emitting ZMGO-PEG nanocomposites for 24 hours at an identical 
concentration of 50µg/mL. It can be observed that the majority of the 
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nanocomposites (red fluorescence) were accumulated in cytoplasm around 
the nuclei, which verified that the as-prepared ZMGO-PEG nanocomposites 
were successful cell labelling agents.  
 
 
Figure 5-12 VSM profiles of hydrophobic ZnS:Mn, hydrophilic ZMGO and PEGylated 
ZMGO-PEG with paramagnetic properties. 
MR studies of the ZMGO, ZMGO-PEG and hydrophilic Gd2O3 were 
performed using VSM to examine their magnetic relaxivity for potential 
application as MRI contrast agents. Magnetisations versus the magnetic field 
measurements were performed at room temperature using a Vibrating Sample 
Magnetometer (VSM). As shown in Figure 5-12, no ferromagnetic hysteresis 
was observed for all nanocomposites. Senthilkumaar et al. reported that 1 
mol% Mn doping ZnS nanorod exhibited the magnetisation of 4 memug-1 at 
15000 G. [22] Herein we reported that ZnS:Mn nanoparticles exhibit 
magnetization of 4.24 memug-1 at 20000 G, which was consistent with the 
previous results. Because the addition of GO and PEG increased the total mass, 
a decrease was observed in the saturated magnetisation of the material. 
Generally, the particles still retain their paramagnetic properties.  
 
 




Figure 5-13 r1, r2 value was obtained by calculating the slope of 1/T1 and 1/T2. All results are 
recorded in Table at right hand side with the value of the different concentration of [Mn] amount 
(0 mM, 0.0625 mM, 0.125 mM, 0.25 mM, 0.5 mM and 1 mM, respectively.). 
 
The r1, r2, and r2 / r1 of ZMGO were calculated from the slopes of the linear 
plots of relaxation rates (1/T1 and 1/T2, respectively ) against Manganese 
concentration [Mn] using a 3T magnet. The results obtained were recorded 
in Figure 5-13. Hopefully, it exhibited considerable r1 values of 0.616 
s-1mM-1[Mn]. It was smaller than Gd-DOTA（r1=3.560 s-1mM-1[Gd]), 
however, it possessed relatively low r2/r1 ratios ( 2.54 ), which proved to be 
potential in T1 MRI contrast agent application. [23] 
5.5 Summary and conclusions 
In summary, we successfully synthesised dual functionality contrast agents 
based on graphene oxide and ZnS:Mn nanoparticles. The ZMGO 
nanocomposites with three different emission colours of blue, white and red 
were prepared and characterised. The average size of all obtained 
nanocomposites was below 130 nm, which was useful for various potential 
bio-applications, especially in vivo bio-applications. The nanocomposites 
contained both MRI and fluorescent labels, whereas the GO provided the 
nanocomposites with superior water solubility due to the presence of oxygen 
functional groups on the edges. Tunable emissions can be obtained by varying 
the Mn doping concentration. Upon hybridisation, the ZMGO nanocomposites 
exhibited bright emissions under UV irradiation as well as promising water 
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solubility. After PEGylation, the nanocomposites exhibited significantly 
improved colloidal stability in PBS. Furthermore, the obtained ZMGO-PEG 
nanocomposite maintained their bright fluorescence and can be successfully 
imaged in vitro. However, the r1 value was 0.616 s-1mM-1, which did not offer 
enough brightness for T1 imaging. Accordingly, the nano-sized 
nanocomposites combining fluorescent and MR contrast agents are promising 
candidates for biomedical cellular imaging applications. 
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6 Ultra Small Iron Oxide Nanoparticles on Graphene Oxide 
for T1 Magnetic Resonance Imaging/fluorescent dual-mode 
contrast agents 
6.1 Introduction 
In the previous sections, nanostructured magnetic resonance (MR) contrast 
agents, such as Gd3+-based and Mn2+-based agents, were investigated, which 
exhibited good T1 properties because of their inherent paramagnetic properties. 
However, the discussion of MRI contrast agents would be incomplete without 
mentioning ultra-small iron oxide nanoparticles (USIO). 
USIO agents were recently reviewed in depth by Laurent et al. and compared 
to other T1 macromolecular agents. [81] USIO particles are crystalline 
structures with the general formula of Fe3+2O3M2+O, where M2+ is a divalent 
metal ion such as iron, manganese, nickel, cobalt, or magnesium. Because of 
the ubiquitous presence of iron in living tissue, the ferrous ion Fe2+ is the most 




Figure 6-1 (A) Crystalline structure of magnetite. (B) Ferrimagnetic alignment observed from 
[1,1,1] plane. 
 
Maghemite/magnetite particles exhibit face-centred cubic packing (a.k.a. cubic 
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close packed) of oxygen that allows for fast electron hopping or continuous 
exchange of electrons between the iron ions occupying the interstitial 
tetrahedral (surrounded by 4 oxygen atoms) and octahedral (surrounded by 8 
oxygen atoms) sites (Figure 6-1(A)). All tetrahedral holes are filled with Fe3+ 
ions, whereas the octahedral sites are filled with the remaining Fe3+ and Fe2+ 
(or vacancies).[90] The magnetic properties of these materials arise from the 
ferrimagnetic alignment of the iron ions. The tetrahedral Fe3+ ions are aligned 
in one direction, whereas all the octahedral ions are in the opposite direction 
(Figure 6-1(B)). In magnetite, the octahedral and tetrahedral Fe3+ ions cancel 
each other out, and the magnetic moment is due to the uncompensated 
octahedral Fe2+ ions. In maghemite, the moment arises from the 
uncompensated octahedral Fe3+ ions. In comparison with single paramagnetic 
ions, each USIO particle has a huge magnetic moment, which gives it a 
considerable advantage for MR applications. 
 
As the diameter of SPIOs greatly influences the localisation of these 
complexes in vivo, these materials are categorised into three types according to 
their size: large oral SPIOs (from 300 nm to 3.5μm), standard SPIOs (from 60 
nm to 150 nm) and ultra-small SPIOs (USPIO) (smaller than 40 nm). For 
example, monocrystalline iron oxide nanoparticles and cross-linked iron oxide 
are classified as USPIOs. Among all the SPIOs, the USIO nanoparticles have 
attracted the most interest. Typically, USIOs have iron crystals of 5–12 nm and 
a prolonged blood half-life that makes it possible to eventually cross capillary 
walls and exhibit more widespread tissue distribution. They can be delivered 
to the interstitium via non-specific vesicular transport and through the 
transendothelial channels while retaining their superparamagnetism. Thus, 
these materials are suitable as T1-weighted contrast agents for cellular MR 
imaging, including MR lymphography (MRL). The USIO size gives these 
particles potential to be used as receptor-directed and magnetically labelled 
MRI cell probes at concentrations as low as 1 μg Fe/g tissue.[91, 92] 
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Moreover, according to numerous findings obtained using experimental 
models or in human stroke patients, the visualisation of macrophage activity in 
vivo with USIO provides a distinct class of cellular imaging. USIO have 
proven to be complementary to the increased BBB permeability observed with 
gadolinium.[63, 86] 
 
The main problem with the use of USIOs as T1 contrast agents is associated 
with their low synthetic yield and complex modification procedures. 
Traditional USIO preparation using the direct hydrophilic method is low 
yielding and time-consuming. Furthermore, poor magnetic properties were 
observed due to a large size distribution. Particularly at the physiological pH 
range, USIOs without a strong surface charge to maintain electrostatic 
repulsion will flocculate in suspension and form large aggregates.[87] As the 
particle size plays an important role in application of these materials, it is 
essential to devise a novel method for stabilising the colloidal USIO. Many 
studies had been conducted, and many methods were proposed, including 
surface modification, the use of protective layers and nanoparticle growth on a 
specific platform. [7-10] 
 
6.2 Literature review 
Long-circulating, superparamagnetic iron oxide with improved magnetic 
resonance (MR) contrast stimulates a great deal of interest in the field of iron 
oxide nanoparticles. [89] The strength of USIO images gradually decreased 
over several days. The margin of tissue enhancement in the presence of a Gd 
chelate became blurred over time due to the diffusion of the agent, whereas the 
margin enhancement with the USIO treatment remained sharp, presumably 
due to the much lower diffusion coefficient (large size) of the particles. More 
and more studies have focused on the size effect that makes USIO an efficient 
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T1 contrast agent. 
 
Traditionally, surface modification is employed when nanoparticles are 
utilised in a biological environment. Monomeric stabilisers such as 
carboxylates[72], phosphates[76] and sulphates [78] are widely used to form 
an electrostatic layer to protect the USIO. For example, Park et al. developed a 
simple one-step synthesis of surface modified USIO with an average particle 
diameter of 1.7 nm.[49] Polyethylene glycol diacid (PEG) surface modified 
USIOs synthesised in triethylene glycol afforded particles that were nearly 
monodisperse in diameter and highly water-dispersible. The PEG-modified 
USPIONs were tested for use as magnetic resonance (MR) contrast agents. 
They exhibited a low r2/r1 relaxivity ratio of 3.4 (r1= 4.46 mM-1s-1and r2= 
15.01 mM-1s-1). In addition, a clear dose-dependent T1 and T2 imaging 
behaviour was observed, indicating that they could be useful as target-specific 
T1 MR contrast agents due to their ultra-small size. This work paved the way 
for the development of USIO for T1 imaging applications. However, this 
method is restricted to the ultra-small size range (1.7 nm), which hinders its 
application to different organs. Methods that are more suitable to universal 
sizes and shapes are preferred. 
 
A thicker layer of coating materials was used to prevent particle-particle 
interaction. [6, 11] In 2008, USIOs were synthesised by co-precipitation of 
iron chloride salts with ammonia, followed by encapsulated in the presence of 
thin (2 nm) layers of silica by Bumb et al.[13] Silica-coated particles have 
been optimised for use as MRI contrast agents. In this case, particles in the 
range of 1 nm to 100 nm could be coated, which represents important progress 
for MR imaging applications. However, the T1 phantom acquisition alone was 
not sufficient due to the low speed of the T1 MRI, which failed to satisfy the 
quick-feedback clinical requirement. 
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At the same time, optical probes allow for bio-imaging with high speed and 
sensitivity. A combination of magnetic and fluorescent imaging techniques 
within a nanostructured system will be beneficial for in vivo disease diagnosis 
and in vitro monitoring of living cells. [92] However, the synthesis of highly 
luminescent biomaterials using ferromagnetic USIO is a difficult due to the 
fluorescence quenching of Fe3O4. Researchers have developed 
lumino-magnetic phosphors for cell imaging applications, but the 
nanophosphor materials are paramagnetic in nature, limiting their 
bio-applications to those with low magnetic field assistance. [23] Graphene 
oxide (GO) is a fairly new graphene-based system with a 2D carbon 
honeycomb lattice decorated with numerous functional groups. These 
functional groups make this material an excellent platform for further 
attachment of nanoparticles and synthesis of hybrid materials. [24] Recently, 
the intrinsic photoluminescence (PL) properties of GO was utilised for cellular 
imaging.[25] There are many reports on the synthesis of iron oxide 
functionalised GO particles by different chemical routes. For example, Yang et 
al. reported the preparation of GO–Fe3O4 hybrids containing 13.4 wt% Fe3O4 
by a chemical precipitation. His method increased the loading efficiency of 
Fe3O4 as drugs. [26] Yu et al. synthesized reduced graphene oxide (RGO) 
nanosheets with Fe3O4 NPs via a high-temperature decomposition of the 
precursor iron(III) acetylacetonate, and proposed its use as a magnetic 
resonance contrast agent.[37] Wang et al. prepared Fe Fe3O4 graphene 
composites by a gas/liquid interface reaction at 180 °C with enhanced cycling 
performance for lithium-ion batteries.[39] Zhang et al. have developed 3D 
hierarchical porous Fe3O4/graphene composites with high lithium storage 
capacity, which also demonstrated application in controlled drug delivery.[50] 
Hu et al. [51] and Cheng et al.[52] synthesised graphene–Fe3O4 composites at 
high temperatures with improved reversible capacity and cyclic stability for 
lithium-ion batteries. Because the above reaction was carried out at a very 
high temperature, it was difficult to control the pore size distribution of the 
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product. Moreover, such composite materials have not been exploited for 
bio-imaging applications.  
6.3  Synthesis procedure 
Synthesis of Graphene Oxide (GO) and surface modification 
Nano-GO was synthesized using modified Hammers’ method.[91] 
Typically, 0.5g graphite (2~15 µm), 0.5 g NaNO3, and H2SO4 were mixed 
together in ice bath, while KMnO4 were added slowly into the mixture. The 
obtained green sticky mixture was left stirring for one hour before it was 
heated up to 35ºC for overnight. Approximately 20 mL of H2O was added 
drop wisely, much heat generated and another 100 mL H2O was added after it 
become stable. After 12 hours, 3 mL H2O2 were added drop by drop into the 
brown solution. The finally product was washed with 4% HCl and DI-H2O 
repeatedly until the solution reaches almost neutral. The obtained graphite 
oxide (nano-GO) solution was ultrasonicated for 2 hours at 20GHz (130W), 
followed by centrifugation at 10000rpm for 30 minutes to remove the 
precipitate which contained large GO sheets. 
 
Hydrothermal reduction of USIO on GO 
0.1 M Fe(OH)3 colloidal solution was first prepared by adding 10 mL of a 
FeCl3 6H2O aqueous solution into 20 mL of a 0.45 M NaHCO3 solution, and 
the obtained solution was stirred for 30 min. Subsequently, 10 mL of an 
aqueous solution of vitamin C in a molar ratio to Fe3+ of 1:3 was gradually 
added. The mixture was further stirred for another 10 min and then 
transferred into a steel-lined Teflon autoclave with a volume of 50 mL. 
Following this, the autoclave was kept at 150OC for 4h. In order to 
investigate the influence of reaction temperature and time on the NPs, 
different series of experiments have been carried out separately (recorded in 
Table 6-1). After the synthesis, the particles were washed three times with 
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water and ethanol and were finally collected by centrifugation (11 000 rpm, 1 
h for each time). The obtained precipitate was easily redispersible in water, 
PBS buffer, and cell culture medium by ultrasonication (180 s, SONOREX 
SUPER RK 510 H, 35 kHz, 640 W) 
 
in vitro cytotoxicity of USIO-GO on NIH/3T3 fibroblast cells 
To assess the cytotoxic effect of the final product USIO-GO complex, in vivo 
cell viability tests was performed by incubating NIH/3T3 cells with the 
nanocomposites at different concentrations for 24 hours using a CCK-8 
assay. NIH/3T3 fibroblast cells were grown in DMEM (Dulbecco’s 
Modified Eagle Medium) culture growth medium (10% bovine calf serum) at 
37 ºC in a 5% CO2 humidified environment. The cells were then transferred 
to 96-well cell culture plate (TPP 96) at an identical concentration of 7.5×104 
cells·mL-1 (0.1 mL). These cells were allowed to be incubated overnight at 
the same conditions before the injection of the USIO-GO nanocomposites. 
Following the incubation, 20 µL of the nanocomposites at different 
concentrations (from 100µg/mL to 1 µg/mL) was added into each well. After 
that, the cells were incubated at 37 ºC in a 5% CO2 environment for 24 hours. 
Before the cell viability test, 10 µL cell counting kit-8 (CCK-8) was added 
into the culture media, followed by 4 hours incubation in the same 
environment. Absorbance readings were analyzed spectrophotometrically at 
355 nm using a FluoStar Optima microplate reader. 
 
in vitro cellular imaging of USIO-GO on NIH/3T3 cells 
To demonstrate the cellular imaging application of the USIO-GO 
nanocomposites, NIH/3T3 fibroblast cells were chosen as a model. The cells 
were grown in DMEM culture growth medium at 37 ºC in a 5% CO2 
humidified environment. The cells were then transferred to 8-well cell 
culture plate at an identical concentration 2.5×104 cells·mL-1 (0.8 mL). The 
estimated number of cells in each well is approximately 2.0×104 cells per 
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well. These cells were cultivated at the same conditions for 24 hours. 
Subsequently 10 µL of the USIO-GO nanocomposites with different 
concentrations were added into desired wells, followed by another 24 hours 
incubation at 37 ºC in a 5% CO2 condition. Following the incubation, the cell 
cultures were rinsed 2 times to remove dead cells and extra nanocomposites. 
The cellular imaging was carried out using a scanning confocal microscope 
(LSCM, Leica, TCS SP5, Germany).. The samples were illuminated with 
diode laser at 352nm 50mW. 
 
6.4 Results and Discussions 
We studied the stability of USIO-GO using zeta potential measurements 
(Malvern Zen 3600 Zetasizer). In addition, the hydrodynamic radius of the 
particles was measured using dynamic light scattering. The zeta potential of 
USIO-GO was –48.7 mV, indicating good stability of the composite. This 
guaranteed a long shelf-life. The hydrodynamic radius of USIO-GO was found 
to be ׽ 583 nm. In situ chemical synthesis allowed Fe3O4 nanoparticles to be 
covalently attached to the surface of GO. [16] Hence, the USIO-GO stable 
suspension was formed through the oxygen functionalities of GO with Fe3O4. 
Small flakes of GO, after sonication for 3 h, were fully suspended in water for 
2 days. A schematic of USIO-GO was shown in Figure 6-2. Epoxy, carboxyl, 
or hydroxyl groups in GO make it possible to form chemical bonds with Fe3O4. 
This type of bonding was further verified by the Fourier transform infrared 
(FTIR) analysis. 
 




Figure 6-2. Scheme of the graphene oxide and iron oxide (GO-ION) formation 
 
XRD pattern 
The XRD pattern of the USIO-GO powder was shown in Figure 6-3. It 
consisted of broad amorphous-like peaks at approximately 24° corresponding 
to GO with a lattice spacing of ׽ 0.39 nm. The XRD results also indicated the 





Figure 6-3. XRD pattern of USIO-GO reveal the presence of the GO peak 
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The FTIR spectra of GO and USIO-GO were provided in Figure 6-4. The 
presence of different types of oxygen functionalities in GO was confirmed by 
peaks corresponding to an oxygen stretching vibration (2900–3600 cm−1, –OH 
vibration), a C=O stretching vibration (1720 cm−1), a C–OH stretching 
vibration (1220 cm−1), and a C–O stretching vibration (1060 cm−1) in Figure 
6-4. Moreover, the aromatic C=C stretching at ׽1600 cm−1 indicated the 
presence of the sp2 hybridised honeycomb lattice. The USIO-GO also 
contained these functional groups, but the positions of the bands were 
red-shifted and the sharpness of the peaks was changed, particularly that of the 
aromatic C=C bonding (Figure 6-4, light blue curve). These results indicated 
changes in the coordination environment of various functional groups in 
USIO-GO. Peaks between 400 and 700 cm−1 corresponded to those of Fe-O in 
Fe3O4. The shift in the peak positions and the modification of C=C bonding 
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A0401 0.01 0.02:1 4 - 
A0402 0.05 0.02:1 4 Black 
A0403 0.1 0.02:1 4 Black 
A0201 0.1 0.02:1 4 Black  
A0202 0.1 0.2:1 4 Black 
A0203 0.1 2:1 4 Brown  
A0301 0.1 0.2:1 2 - 
A0302 0.1 0.2:1 8 
Precipitate with 
clear supernatant 




Of all conditions examined to optimise the sample preparation, three 
parameters were found to play important roles, i.e., the amount of vitamin C, 
the GO amount and the heating time. Table 6-1 provided the results of all 
experiments in series, which were labelled as A0401-A0403, A0201-A0203 
and A0301-A0303. The following discussion compared the results produced 
by changing a given parameter in a series.  
 
6.4.1 Amount of Vitamin C  
Vitamin C acts as both a surfactant and a reduced agent, so it influences the 
final USIO-GO product. Because GO becomes reduced in the presence of 
vitamin C, the remaining vitamin C on the surface of GO further reduces the 
iron precursors and eventually gives rise to USIO.  .   
 




Figure 6-5. TEM images of A04 series (A0401, A0402 and A0403) wherein the amount of 
vitamin C was varied. All other parameters were kept constant. 
 
A controllable and slow condensation process made it possible to avoid the 
adverse effects on size, morphology, and magnetic properties of nanoparticles 
prepared using the traditional co-precipitation method.[92] Not only did 
vitamin C act as an excellent reducing agent by oxidising the C=C double 
bond, but its more oxidised product (dehydro-ascorbic acid, DHAA) also 
served as a stabiliser and capping ligand due to the chemical interactions 
between the carbonyl groups and the FeOx particles. [68] 
To study the effect of vitamin C, three samples with different vitamin C 
concentrations were prepared at the same time (A0401, A0402 and A0403). 
Figure 6-5 provided the 9 TEM images of the three samples, and images in the 
same row were of the same sample at different magnifications. Samples 
A0401 and A0402 exhibited similar morphologies, wherein a layer with 
crystal lattices covered dark contrast sheets. Meanwhile, A0403 exhibited 
distinct particles that were closely arrayed on each GO sheet. The amount of 
vitamin C largely influenced the crystallisation kinetics of iron oxide particles. 
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According to Xiao et al., because vitamin C acted as a reducing, it played a 
key role in the reduction of Fe (OH)3 colloids under mild hydrothermal 
conditions. With a Fe: vitamin C stoichiometric ratio of 2:1 for A0401, 10:1 
for A0402 and 20:1 for A0403, the reduction of Fe3+ to Fe2+ can be precisely 
controlled. With increasing amount of reducing agent, both the quantity and 
quality of iron oxide particles exhibited improvement. Eventually, with a 
stoichiometric ratio of 20:1, sample A0403 exhibited a maximum 
condensation of iron oxide nanoparticles in a single GO sheet. 
 
6.4.2 GO amount  
Figure 6-6 provided TEM images of the A0201-A0203 samples at different 
magnifications. The three TEM images in the first row were obtained from 
sample A0201 at different magnifications. The second row in Figure 6-6 was 
obtained for A0202, and the third row was for A0203.  
 
Figure 6-6. TEM images of A02series (A0201, A0202 and A0203) only comparing amount 
of GO. All other parameters (Vitamin C and Fe precursor) were kept constant. 
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At a low magnification, all samples contained large sheets (approximately 104 
nm2) of high contrast shadow (GO) at the 50 nm scale bar. The second column 
of the same row was the TEM image of a select area with the SEAD pattern 
under a higher magnification. Distinct rings can be observed in the A0201, 
A0202 and A0203 SEAD patterns, which indicated the crystallisation of the 
iron oxide. In addition, discrete dots (with a diameter of approximately 3-5 nm) 
were observed for A0201, confirming the successful reduction of iron 
precursors at a high magnification shown in Figure 6-6. The same phenomena 
were observed for the A0202 and A0203 samples. The last column of the TEM 
images revealed the crystal lattice of the ultra-small iron oxide particles. The 
crystallisation did not change in the presence of varying amounts of GO. We 
proposed that the GO consumed part of the vitamin C, which may result in the 
inefficient of reduction due to the weak reducing capacity of vitamin C. 
However, this effect appeared to be irrelevant for the reduction of iron oxide. 
The large amount of GO (up to in 50 mg in sample A0203, 100 times more 
than that of A0201) did not exhibit a significant influence on the synthesis of 
iron oxide inside of GO sheets. 
6.4.3 Time effect  
To study the high time effect, the samples A0301, A0302 and A0303 were 
prepared using different reaction  time  intervals  (1/2,  2  and  4  h  
respectively)  at  300 ºC. Figure 6-7 provided TEM images of the 
A0301-A0303 samples at different magnifications. The three TEM images in 
the first row were obtained from sample A0301 at different magnifications. 
The second row in Figure 6-7 was obtained for A0202, and the third row was 
for A0303. At a low magnification, all samples contained large sheets 
(approximately 104 nm2) of high contrast shadow (GO) at the 50 nm scale bar. 
The second column of the same row was the TEM image under a higher 
magnification. Discrete dots were observed in A0301, A0302 and A0303, 
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confirming the successful reduction of iron precursors at a high magnification 
shown in Figure 6-7. The last row of sample A0303 contained the largest iron 
oxides among three samples (with a diameter of approximately 15 nm). The 
crystallisation did change in the presence of varying heating time. Time effect 
appeared to be relevant for the reduction of iron oxide. 
 
 
Figure 6-7. TEM images of A03 series (A0301, A0302 and A0303) wherein the heating 
time was varied. All other parameters were kept constant. 
 
  
This should be simply because of the “Ostwald ripening” i.e. small particles 
becomes smaller and large particle becomes larger with prolonging the 
reaction time. 
6.4.4 Characterizations of the optimized USIO-GO  
The presence of iron oxide in USIO-GO was further confirmed by XPS 
analysis. The Fe 2p XPS spectrum of USIO-GO was shown in Figure 6-8. The 
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peaks for Fe 2p 1/2 and Fe 2p 3/2 at 710.9 eV and 725 eV, respectively, 
demonstrated that the iron oxide in the sample was in the form of Fe3O4.  
 
Figure 6-8. Fe 2p X-ray photoelectron spectroscopy (XPS) spectrum of USIO-GO 
TEM images of optimised samples were provided in Figure 6-9. The presence 
of 10 nm Fe3O4 nanoparticles uniformly distributed in GO can be observed in 
the high-resolution TEM (HRTEM) images at different concentrations of 
vitamin C. These results indicated that the reduction of iron oxide was 
complete under optimised conditions (with an appropriate amount of vitamin 
C, GO content and heating time). 
 
Figure 6-9. TEM images of optimized USIO samples prepared with different vitamin C 
loading. All other parameters were kept constant. 
 






To explore the facets of chemical interactions, interfacial effect, and 
associated optical properties of USIO-GO, we characterized the pristine GO, 
Fe3O4, and USIO-GO suspensions (in water) through UV-visible absorption 
spectroscopy. Figure 6-10(a)-(f) showed the absorption spectra of Fe3O4 , 
GO, and USIO-GO. The absorption result revealed that USIO-GO was 
optically transparent in the 700–800 nm range. A blue shift of the absorption 
edge was noticed, when the absorption spectrum of USIO-GO was compared 
to that of Fe3O4. A higher concentration of Fe3O4 nanoparticles in GO 
strengthened such effects and therefore leaded to the blue shift of the 
absorption spectrum. The blue shift of the absorption edge for USIO-GO can 
be attributed to the integration effect in the bandgap due to composite 
formation between GO (1.70 eV) and Fe3O4 ( ׽ 2.9 eV). The absorption peak 
at ׽ 250 nm threw light onto the fact that a strong interface has formed 
between GO and Fe3O4 (since the absorption peaks of pristine GO and Fe3O4 
are observed at ׽ 228 nm and ׽ 354 nm, respectively). To further investigate 
the chemical interaction and the interface formation between GO and Fe3O4, 
rigorous PL studies on the USIO-GO hybrid system were performed. PL 
results were shown in Figure 6-10(d)–(f). In order to confirm the interface 
formation, we excited the hybrid system at 365 nm wavelength, which help 
us to make a comparative study with Fe3O4, shown in Figure 6-10(d) and (e).  
 
 




Figure 6-10. a) UV-vis absorption spectra of GO, and USIO-GO b) Room temperature PL 
emission spectrum of USIO nanoparticles at 365 nm  excitation. c) PL excitation spectrum 
at 416 nm emission of USIO nanoparticles. d) PL emission spectrum of USIO-GO at 365 
nm excitation.  e) PL excitation spectrum at 416 nm emission of USIO-GO Note that an 
additional interface peak appears after GO forms an interface with USIO  . f ) PL emission 
spectrum of USIO-GO at 324 nm excitation.  
 
Interestingly, the PL emission spectrum of the USIO-GO hybrid system 
showed two strong peaks. They can be attributed to Fe3O4 and the other to the 
interface formation between GO and Fe3O4, as expected, through oxygen 
functionalities. In order to ensure that the extra peak represents the interface 
formation, PLE experiment was performed. This could compute the actual 
excitation of the USIO-GO hybrid system. Figure 6-10(b) was the PLE 
spectrum of USIO-GO at 469 nm emission. It showed strong blue peak 
emission centered at 469 nm with estimated color coordinates x = 0.2035, y = 
0.2427 of the USIO-GO nanocomposite at 324 nm excitation wavelength. 
Moreover, we also performed PL emission spectroscopy of the pristine GO 
sample at 324 nm excitation to ensure that the additional peak was due to 
interface formation, shown in Figure 6-10(f). The enhanced luminescence in 
USIO-GO raised from the interface between GO and Fe3O4 nanoparticles 
through oxygen functionalities, that was, carboxyl, carbonyl, epoxy, and 
hydroxyl groups, present in GO nanoparticles. A strong blue emission of the 
hybrid was ascribed to the integration of surface effects of USIO-GO and 
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optical emission of Fe3O4 nanoparticles. Figure 6-10(d) exhibited the PL 
emission spectrum of Fe3O4. An emission peak was observed at 416 nm upon 
excitation at 365 nm wavelength (3.39 eV) and Figure 6-10(e) represented 
the corresponding PLE (excitation) spectrum for Fe3O4 nanoparticles at 416 
nm (2.98 eV) emission of Fe3O4 nanoparticles. The observed results were 
consistent with other reports.[23] 
6.4.5 Cell imaging results 
As hypothesized, USIO-GO hybrid nanosuspensions can be used for 
biological applications such as bioimaging, cell tracking, and drug delivery. 
Therefore, the cytotoxicity of USIO-GO was evaluated using the MTT 
viability assay with human breast cancer cell lines, NIH/3T3, for the 
indicated period of time.  
 
Figure 6-11.  a) In vitro In vitro  fluorescence microscopy images of NIH/3T3 cells 
treated with USIO-GO (50 μ g mL−1 ) for 24 h. i–iii) Low magnification images of NIH/3T3 
cells: i) Phase contrast picture,  ii) fluorescence images of USIO-GO, and iii) overlay of 
images (i) and (ii). iv–vi) High magnification images of an individual NIH/3T3 cell: iv) 
phase contrast picture of an individual NIH/3T3 cell, v) fluorescence image of USIO-GO, 
and vi) overlay of images (iv) and (v). The overlay of the phase contrast and fluorescence 
images clearly demonstrates the localization of USIO in the cellular cytoplasm, suggesting 
its suitability for bioimaging.  
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As shown in Figure 6-11, no marked cell death or proliferation defects were 
observed with cells cultured in USIO-GO suspensions compared to the 
untreated control cells, suggesting that USIO-GO did not pose any 
considerable toxicity problem to the cells. To determine whether the 
USIO-GO hybrid can be used for cellular imaging, we performed in vitro 
cellular imaging studies using the human breast cancer cell line NIH/3T3. 
Figure 6-11 showed fluorescent microscopy images of NIH/3T3 cells treated 
with USIO-GO for 24 h. The blue fluorescent USIO-GO was distributed 
inside the cytoplasm as shown in Figure 6-11(ii)and(v). Figure 
6-11(iii)and(vi) showed that the fluorescent part matched well with the 
outline of the cells. 
 
Figure 6-12 Longitudinal relaxation rates (1/ T1) of SPIONs,Resovist and USIO-GO. 
MR studies of different concentrations of USIO-GO were performed using a 
clinical magnet in order to investigate their potential as MRI contrast agents. 
Typically, Figure 6-12 showed the longtitudinal relaxation rate against [Fe] 
for SPIONs, Resovist and USIO-GO. 1/T1 of three samples exhibited linear 
relationships with respect to [Fe]. The slopes of the relaxation rate versus 
[Fe] lines were used to obtain the r1 relaxivities values. USIO-GO showed 
very weak T1 effect, i.e. r1= 0.8 s-1mM-1. By comparing with SPIONs and 
Resovist®, these results proved that the relaxivity enhancement caused by 
USIO-GOs may be due to the graft of GO. 
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6.5 Summary and conclusions 
In conclusion, we demonstrated a facile synthesis of USIO, which can be used 
as a contrast agent. GO was selected as the substrate for growing USIO. The 
complex allowed for the use of two complementary techniques (T1 MRI and 
optical fluorescence imaging) in a single material. An energy transfer 
mechanism from USIO to GO had been identified from the PL data. The 
nanocomposite exhibited good cell viability with different cancer cell lines, 
which made them viable for intra-cellular imaging application. The surface 
functionalities of GO provided a good platform for the attachment of large 
quantities of aromatic drug molecules, which facilitated the use of USIO for 
multifunctional bioapplications. 
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7 Conclusion and future work 
This thesis explored the synthesis and characterization of the magnetic 
nanomaterials for developing highly efficient clinical imaging agents. 
Magnetic T1 contrast agents based on three different traditional magnetic 
materials (Gd, Mn and Fe) synthesized by wet chemical methods were 
discussed. Various structures were constructed to study the influence of 
factors on T1 imaging performance, including the structure factor 
(controlled assembly), compositional factor (magnetic nanomaterials) and 
modality factor (multi-modalities). The results obtained were summarized 
as the follows:  
a) It was shown that magnetic nanomaterials could act as substitute 
contrast agents for in vitro cell imaging. In this study, three traditional 
materials were successfully synthesized in the nano scale, i.e. hybrid 
Gd2O3 nanoparticles (3-5 nm), Mn-doping ZnS nanoparticles (3-5 nm) 
and iron oxides nanoparticles (2-4 nm). MRI tests proved that, at such 
small size, the magnetic particles exhibited a high degree of T1 
relaxivity. For example, Gd2O3 nanoparticle itself had the r1 value of 
1.529 s-1mM-1(in Chapter 3), Mn doped ZnS had r1 of 0.616 s-1mM-1 (in 
Chapter 5) and iron oxide had r1 of 0.8 s-1mM-1(in Chapter 6). The 
preliminary results showed that Gd2O3 were the best candidate among 
the three. 
b) It was found that the controlled nanoclusters could increase the r1 value 
of Gd2O3. It established a rational analytical solution for contrast agents 
in blood-pool application. A reliable cell imaging technique using such 
contrast agent was established, and the strong MRI image qualities 
would minimize the occurrence of false positives. In Chapter 3, Gd2O3 
nanoparticles were synthesized with three different morphologies. Four 
synthetic factors were investigated, i.e. temperature, time, solvent and 
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surfactant. It was found that temperature strongly influenced the degree 
of Gd2O3 crystallization. The surfactant played a key role to control the 
morphology. The spherical shape was determined to produce the best 
paramagnetic performance, since it possessed the largest surface to 
volume ratio. The comparisons of different Gd2O3 also served as 
primary references for analytical work. Yb:Er codoped Gd2O3 
nanoparticles were then successfully synthesised using a thermal 
decomposition method. They exhibited a high T1 relaxivity with 
r1=1.529 s-1mM-1. The optical properties were successfully incorporated 
to Gd2O3 contrast agents, which were further optimized by altering the 
thickness of the coating. 
c) Controlled aggregation methods were chosen to enhance the MRI 
efficiency. In Chapter 4, it proved that the r1 value of these Gd2O3 
contrast agents could be improved from 1.529 s-1mM-1[Gd] to 7.948 
s-1Mm-1[Gd]. In vitro cell MRI imaging agreed well with theoretical 
prediction, in which Gd2O3 nanoclusters (GNCs) produced a stronger T1 
signal with relatively small intake dose. In particular, the highest r1 
value was achieved for certain Gd2O3 loading concentration (sample 
GNC-2). 
d) Mn-doped ZnS nanoparticles on graphene oxide (ZMGO) were 
synthesized in Chapter 5 for the purpose of dual modal imaging. The 
ZMGO nanocomposites with three different emission colors (blue, 
white and red) were obtained. The average sizes of the nanocomposites 
were below 130 nm range, which facilitated various potential 
bio-applications especially in vivo applications. After the PEGylation, 
the nanocomposite substantially improved the colloidal stability in PBS 
solution. The as-obtained ZMGO-PEG nanocomposite retained the 
bright fluorescence properties, and the in vitro cell imaging using 
ZMGO-PEG was successfully demonstrated. They also possessed T1 
effect which could be detected by MRI. Nanocomposites combining 
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both T1 properties and fluorescence were successfully achieved. 
Moreover, a facile synthesis of ultra small iron oxide (USIO) was 
investigated in Chapter 6. They showed good cell viability with 
NIH-3T3 cancer cell lines. This made it viable for intra-cellular imaging 
applications. USIO also showed T1 effect, which paved the way to the 
further MRI application. 
 
In general, the effectiveness of the magnetic nanomaterials were validated 
in MRI tests. It was found that optimized structure factor (controlled 
aggregation), component factor (magnetic nanomaterials) and modality 
factor (multi-modalities) could contribute to high efficiency for imaging 
probes. The controlled clusters of contrast agents enhanced imaging 
efficiency. Two different approaches were carried out to introduce 
fluorescent properties into MRI contrast agents, which should establish a 
rational solution to overcome the pitfalls of cell imaging of such contrast 
agents. The study of the magnetic nanomaterials is valuable to develop 
multifunctional contrast agents in the future. 
 
It is acknowledged that this study had only performed a preliminary 
analysis on the choices of core materials. The magnetic nanomaterials are 
also not adequate for all influences. 
 
Nevertheless, the need for a method to describe the enhancement 
mechanism was identified. More work should be done to monitor the 
protons activities around magnetic nanomaterials. The main challenge is to 
identify and quantitatively calculate the value of T1 imaging improvement. 
Further work is needed to characterize the interactions between magnetic 
materials and the protons. The simulated models are required to construct 
and to predict the possible impact. To achieve this, a detailed mechanism is 
required. It is also recommended that a standard prototype of the human 
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tissues should be established and mechanism of interacts should be 
developed. 
Future Work  
 
Future work should explore two main research areas. Firstly, as the 
mechanism of cluster effect is still unclear, further investigations on the 
origin of cluster-induced enhancement should be continued. Secondly, 
design and functionalization of magnetic nanomaterials for in vivo 
applications should be carried out. The future plans are listed in details as 
follows: 
(1) More tests about cluster effect should be carried out in ZnS and USIO 
system, which is promising since the cluster could provide the localized 
signal enhancement without aggregation. If the same phenomena could be 
observed in ZnS or USIO system, forming clusters could be seen as an 
effective method to enhance the T1 effect. 
(2) There remains much debate in explaining the effect of different 
morphologies on magnetic relaxivity. Though a detailed study was 
performed with regard to Gd2O3 in Chapter 3, it was questionable whether 
morphology could play the same role in improving the specific surface 
areas in other systems. Mn-doped ZnS with different morphologies should 
be considered as the next candidate to investigate the morphology effect. 
(3) More biological experiments are needed, for example, in vivo study of 
the rat liver and kidney before injection and after injection of the 
nanoparticles should be done. By comparing the coronal images of the rat 
liver and kidney before and after injection of commercial contrast agent 
like Resovist®, the efficiency of the new contrast agents could be assessed. 
Moreover, the MRI signal changes after administration of the nanoparticles, 
should be studied to understand the kinetics of the contrast agents. It would 
be useful to investigate whether the liver or the kidney shows enhanced 
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accumulation of the particles, as well as the time when it meets its 
saturation. If the particles can show larger accumulation in kidney and 
longer time for saturating, it would be more suitable for bio-application. 
Magnetic nanomaterials for the application for in vivo tumour imaging 
should be further explored. Mice with tumour could be fed with 
antibody-treated contrast agents, and 3T MRI scan will be taken 
sequentially. The intensity of the T1 brightness should be normalized by the 
signal in the saline phantom at different time points in tumour, muscles and 
liver. If the contrast agent works well, signal reduction for the liver and 
tumour will be higher as compared to that for the muscles. Furthermore, by 
comparing axial images of tumour (before and after 12 hours of injection) 
and heterogeneity (developed in the tumour site after 12 hours), it can 
reveal whether contrast agents accumulate at the tumour site.  The contrast 
agents’ retention time in the tumour is also critical to the analysis. If the 
retention is long enough, it would show that contrast agents show high 
affinity towards tumour and thus could be applicable as cancer targeting 
contrast agent as well as for therapy. 
(4) The magnetic nanomaterials could be functionalized with targeting 
agents, such as antibodies, to develop the multifunctional particles into 
target-specific imaging probes. As a result, it would be possible to achieve 
more accurate diagnosis for diseases such as cancer. With higher targeting 
efficacy, various side effects caused by targeting agents can be avoided 
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